≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Calculus of lower urinary tract

DOID EFO Endpoint Browser PheWeb

N14_CALCULOWER

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — N21
  • Hospital discharge: ICD-9 — 594
  • Hospital discharge: ICD-8 — 594
  • Cause of death: ICD-10 — N21
  • Cause of death: ICD-9 — 594
  • Cause of death: ICD-8 — 594

2 out of 7 registries used, show all original rules.

2167

4. Check minimum number of events

None

2167

5. Include endpoints

None

2167

6. Filter based on genotype QC (FinnGen only)

2063

Control definitions (FinnGen only)

Control exclude
N14_UROLITHIASIS

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
N20-N23
Name in latin
Urolithiasis viarum urinariarum inferiorum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 15015 2873 11922
Only index persons 12181 2461 9720
Unadjusted period prevalence (%)
Whole population 0.28 0.08 0.33
Only index persons 0.31 0.09 0.37
Median age at first event (years)
Whole population 65.15 55.17 67.47
Only index persons 63.53 52.20 66.39

-FinnGen-

Key figures

All Female Male
Number of individuals 2063 372 1691
Unadjusted period prevalence (%) 0.66 0.13 0.78
Median age at first event (years) 65.60 52.56 68.47

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2167
Matched controls
21670
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
22.0
321.6
244
124
N21.0
ICD-10 Finland
Calculus in bladder
4503599627370496.0
307.7
1489
*
N20.0
ICD-10 Finland
Calculus of kidney
742.1
307.7
421
7
N20.1
ICD-10 Finland
Calculus of ureter
2690.6
307.7
703
*
KH1AD
NOMESCO Finland
CT of urinary organs
22.6
307.7
434
238
N20.9
ICD-10 Finland
Urinary calculus, unspecified
169.3
307.7
412
30
UKC02
NOMESCO Finland
Cystoscopy
9.1
307.7
1328
3225
N21.1
ICD-10 Finland
Calculus in urethra
2373.7
307.7
371
*
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
85.6
307.7
216
28
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
2227.9
307.7
909
7
KED22
NOMESCO Finland
Transurethral resection of prostate
5.9
277.6
624
1392
R31
ICD-10 Finland
Unspecified haematuria
5.3
275.4
755
2001
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
26.4
232.2
162
66
KBE12
NOMESCO Finland
Transluminal endoscopic extraction of calculus of ureter
2268.0
227.0
216
*
UKB02
NOMESCO Finland
Retrograde ureteroscopy
32.4
210.9
137
45
J01EA01
ATC
trimethoprim; systemic
3.9
183.1
759
2645
KAT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of pelvis of kidney
1884.6
174.3
167
*
N21.9
ICD-10 Finland
Calculus of lower urinary tract, unspecified
+∞
163.6
155
*
XKD00
NOMESCO Finland
Uroflowmetry
3.4
163.3
933
3947
R33
ICD-10 Finland
Retention of urine
4.0
162.4
577
1790
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.9
156.2
582
1862
J01MA02
ATC
ciprofloxacin; systemic
3.2
152.8
1284
6744
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.3
140.7
778
3176
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.4
132.5
380
997
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.5
126.9
555
1948
N30.0
ICD-10 Finland
Acute cystitis
3.6
114.4
463
1537
KAE12
NOMESCO Finland
Retrograde ureteronephroscopic lithotripsy in pelvis of kidney
+∞
107.2
102
*
KBV10
NOMESCO Finland
Removal of stent from ureter
23.9
103.0
74
32
5921A
ICD-9 Finland
Calculus of kidney and ureter, Calculus of ureter
+∞
96.6
92
*
G04CA02
ATC
tamsulosin; oral
2.5
96.4
1167
6841
N20.2
ICD-10 Finland
Calculus of kidney with calculus of ureter
959.0
94.7
92
*
59203
ICD-8 Finland
Calculus of kidney and ureter, Calculus ureteris
+∞
94.5
90
*
N40
ICD-10 Finland
Hyperplasia of prostate
2.5
90.4
1131
6667
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
6.9
87.8
140
215
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
27.8
83.9
57
21
KCE00
NOMESCO Finland
Cystolithotomy
839.6
83.1
81
*
KBT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of ureter
+∞
80.7
77
*
N30.9
ICD-10 Finland
Cystitis, unspecified
4.1
72.7
217
577
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
6.4
70.4
120
197
WX320
NOMESCO Finland
Spinalanesthesy
2.3
69.1
711
3742
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
17.9
69.0
56
32
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
7.4
68.5
101
142
N21.8
ICD-10 Finland
Other lower urinary tract calculus
+∞
67.0
64
*
5941A
ICD-9 Finland
Calculus of lower urinary tract, Other calculus in bladder
+∞
63.9
61
*
J01CA08
ATC
pivmecillinam; oral
2.4
61.5
543
2655
KBV00
NOMESCO Finland
Insertion of stent into ureter
14.5
59.7
54
38
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.8
58.9
137
299
TKC22
NOMESCO Finland
Catheterisation instruction
4.5
58.9
152
361
59400
ICD-8 Finland
Calculus of other parts of urinary system, Urethrae
+∞
58.6
56
*
TKC20
NOMESCO Finland
Catheterisation of bladder
2.9
57.0
302
1147
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.5
56.7
451
2096
U07
ICPC
Urine symptom/complaint other
3.0
56.2
277
1010
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
55.3
788
4645
U06
ICPC
Haematuria
4.2
53.1
150
381
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
9.5
52.9
63
68
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
7.2
52.7
79
113
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.4
50.8
437
2094
J01MA12
ATC
levofloxacin; systemic
2.2
49.9
569
3059
KDV10
NOMESCO Finland
Internal urethrotomy
5.3
47.0
96
187
KA3EB
NOMESCO Finland
Antegrade pyelography
11.4
45.9
48
43
5920A
ICD-9 Finland
Calculus of kidney and ureter, Calculus of kidney
+∞
44.9
43
*
N35.9
ICD-10 Finland
Urethral stricture, unspecified
5.3
44.1
90
175
J01MA06
ATC
norfloxacin; oral
2.5
42.3
302
1322
WX402
NOMESCO Finland
General anaesthesia
2.1
41.0
509
2801
SPAT1167
SPAT
Insertion of urinary catheter
3.4
40.6
155
483
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
40.4
632
3770
Z43.5
ICD-10 Finland
Attention to cystostomy
7.3
38.2
56
78
U29
ICPC
Urinary symptom/complaint other
3.7
38.1
123
343
KED33
NOMESCO Finland
Transurethral incision of prostate
4.3
37.4
98
235
KED76
NOMESCO Finland
TUVP
6.6
37.1
60
93
KED52
NOMESCO Finland
Visual laser resection of prostate
4.2
37.1
100
245
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
37.0
365
1831
59401
ICD-8 Finland
Calculus of other parts of urinary system, Vesicae urinariae
+∞
36.6
35
*
KH1LA
NOMESCO Finland
Kinetic X-ray examination of urinary tract with pictures
99.3
35.8
39
*
G04BD12
ATC
mirabegron; oral
2.2
35.8
353
1770
UKD02
NOMESCO Finland
Urethroscopy
8.5
35.7
46
55
59408
ICD-8 Finland
Calculus of other parts of urinary system, Aliae definitae
+∞
35.5
34
*
U95
ICPC
Urinary calculus
352.8
35.0
35
*
TKD00
NOMESCO Finland
Dilatation of urethra
6.9
34.4
53
78
1530
FHL
Urethrocystoscopy
4.6
34.2
82
183
KDE12
NOMESCO Finland
Urethroscopic extraction of calculus of urethra
177.8
33.8
35
*
KCW96
NOMESCO Finland
Other operations on bladder
8.7
33.2
42
49
7327
FHL
Lithotripsy
332.0
33.0
33
*
G04BD08
ATC
solifenacin; oral
2.6
32.0
204
843
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
8.5
31.8
41
49
N99.1
ICD-10 Finland
Postprocedural urethral stricture
7.0
31.4
48
70
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
4.9
31.0
68
141
U05
ICPC
Urination problems other
2.6
30.9
191
777
N32.0
ICD-10 Finland
Bladder-neck obstruction
5.4
30.5
60
113
KCD02
NOMESCO Finland
Transurethral resection of bladder
3.2
29.9
124
406
N13.2
ICD-10 Finland
Hydronephrosis with renal and ureteral calculous obstruction
83.8
29.8
33
*
N02BE01
ATC
paracetamol; systemic, rectal
2.0
27.2
1870
16435
U08
ICPC
Urinary retention
3.1
26.6
112
370
G04CA01
ATC
alfuzosin; oral
1.8
26.5
504
3136
U02
ICPC
Urinary frequency/urgency
2.1
26.5
279
1426
C61
ICD-10 Finland
Malignant neoplasm of prostate
1.8
26.2
431
2565
XJH00
NOMESCO Finland
Transanal ultrasonography
2.1
26.1
269
1363
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
3.4
25.8
96
294
R30.0
ICD-10 Finland
Dysuria
3.1
25.7
112
378
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
5.6
24.9
47
85
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
3.2
24.3
100
326
G04CB01
ATC
finasteride; oral
1.7
24.0
493
3125
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.9
24.0
118
426
N30.2
ICD-10 Finland
Other chronic cystitis
8.7
23.7
30
35
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
23.6
555
3650
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
4.0
23.0
65
165
G04AC01, ,
ATC
4.2
22.7
60
145
N23
ICD-10 Finland
Unspecified renal colic
232.4
22.7
23
*
N30
ICD-10 Finland
Cystitis
2.6
22.6
131
515
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
4.9
22.5
50
105
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.8
22.4
114
419
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
7.1
22.1
33
47
U13
ICPC
Bladder symptom/complaint other
3.2
22.0
87
277
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
3.9
21.8
64
167
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
1.8
21.8
400
2448
KCF02
NOMESCO Finland
Transluminal endoscopic removal of foreign body from bladder
31.5
21.5
28
9
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
5.5
21.2
41
76
SPAT1262
SPAT
Handing over of treatment supplies
1.7
21.0
441
2801
U71
ICPC
Cystitis/urinary infection other
2.8
20.9
108
401
XKC03
NOMESCO Finland
Water cystometry
3.3
20.6
80
252
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
20.5
756
5519
J01DB01
ATC
cefalexin; oral
1.6
20.5
1673
14576
J01MA01
ATC
ofloxacin; systemic
2.0
20.4
227
1180
7179
FHL
Other measure in this category
+∞
19.8
19
*
KAE01
NOMESCO Finland
Nephroscopic nephrolithotomy
+∞
19.8
19
*
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
5.1
19.8
41
81
ZXD05
NOMESCO Finland
Urgent procedure
1.6
19.7
655
4664
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
5.0
19.3
41
83
U01
ICPC
Dysuria/painful urination
2.5
19.2
127
533
KCH42
NOMESCO Finland
Transurethral incision or resection of bladder neck
8.1
18.8
25
31
SPAT1263
SPAT
Sampling
1.5
18.7
822
6210
KA1FN
NOMESCO Finland
Isotope renography
6.3
18.5
31
50
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
7.9
18.3
25
32
J01XE01
ATC
nitrofurantoin; oral
4.6
18.2
43
95
R39.1
ICD-10 Finland
Other difficulties with micturition
2.6
18.1
109
437
Z3231
NOMESCO Finland
Registered nurse
1.6
18.0
590
4168
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
15.4
18.0
29
19
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
17.9
624
4471
7171
FHL
Transurethral removal of ureteral stone
+∞
17.7
17
*
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.6
17.3
417
2735
J01XX05
ATC
methenamine; oral
6.0
17.0
30
51
ZXE00
NOMESCO Finland
One hour or less
1.5
17.0
763
5760
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
16.8
221
1215
N20
ICD-10 Finland
Calculus of kidney and ureter
63.8
16.7
19
*
TKC20, ,
SPAT
4.7
16.6
38
82
KH2AD
NOMESCO Finland
Computed tomography examination of urinary tract stones
171.3
16.5
17
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
16.2
314
1940
WX702
NOMESCO Finland
Supraglottic ventilation device
2.3
16.1
121
537
M03BX01
ATC
baclofen; systemic
3.5
16.1
56
165
204
Kela drug reimbursment
Leukemia lymphatica
3.9
15.8
46
120
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
5.4
15.4
30
56
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
15.4
490
3423
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
2.9
15.3
72
254
E21.0
ICD-10 Finland
Primary hyperparathyroidism
4.3
15.1
39
93
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.1
15.0
152
762
R35
ICD-10 Finland
Polyuria
1.9
14.9
207
1158
WX002
NOMESCO Finland
Sedation and analgesia
1.6
14.9
403
2710
T19.1
ICD-10 Finland
Foreign body in bladder
36.3
14.4
18
5
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
14.2
190
1050
G04BD07
ATC
tolterodine; oral
2.3
14.0
107
479
Z93.5
ICD-10 Finland
Cystostomy status
6.5
13.7
22
34
KDE00
NOMESCO Finland
Urethrolithotomy
+∞
13.6
13
*
KBE22
NOMESCO Finland
Transluminal endoscopic dislodgement of impacted calculus from ureter
+∞
13.6
13
*
N21
ICD-10 Finland
Calculus of lower urinary tract
+∞
13.6
13
*
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.6
13.3
74
286
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
3.1
13.2
54
176
XKD03
NOMESCO Finland
Urethral pressure profilometry
3.3
13.2
48
146
R32
ICD-10 Finland
Unspecified urinary incontinence
2.9
13.1
61
215
OAB50, ,
SPAT
1.8
13.0
190
1079
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
13.0
301
1945
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
12.9
694
5359
N28.8
ICD-10 Finland
Other specified disorders of kidney and ureter
19.2
12.9
19
10
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
3.2
12.8
49
154
59201
ICD-8 Finland
Calculus of kidney and ureter, Calculus renis
+∞
12.5
12
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
12.5
292
1890
G04BD11
ATC
fesoterodine; oral
2.6
12.4
72
284
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.9
12.3
152
817
SPAT1125
SPAT
Stoma care and guidance
3.1
12.3
51
168
N13.0
ICD-10 Finland
Hydronephrosis with ureteropelvic junction obstruction
5.8
12.3
22
38
N30.8
ICD-10 Finland
Other cystitis
5.1
12.2
25
49
B02AA02
ATC
tranexamic acid; systemic
1.8
12.1
193
1125
U04
ICPC
Incontinence urine
2.0
12.1
136
709
UJF32
NOMESCO Finland
Coloscopy
1.5
12.1
546
4075
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.7
12.0
65
248
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
11.9
156
855
G35
ICD-10 Finland
Multiple sclerosis
4.4
11.9
29
66
N35.8
ICD-10 Finland
Other urethral stricture
5.4
11.8
23
43
N39.3
ICD-10 Finland
Stress incontinence
2.4
11.8
83
359
G04CB02
ATC
dutasteride; oral
1.6
11.8
303
2006
N02AX02
ATC
tramadol; systemic, rectal
1.4
11.7
885
7217
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
3.4
11.7
41
122
KDE20
NOMESCO Finland
Removal of foreign body from urethra
3.4
11.7
41
122
C10AC01
ATC
colestyramine; oral
2.9
11.6
53
185
B01AB05
ATC
enoxaparin; parenteral
1.4
11.6
627
4831
5942A
ICD-9 Finland
Calculus of lower urinary tract, Calculus in urethra
+∞
11.5
11
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
11.4
180
1045
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
11.4
643
4985
R50.9
ICD-10 Finland
Fever, unspecified
1.6
11.3
325
2204
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
11.2
1307
11388
SPAT1053
SPAT
Memory test
1.5
11.2
361
2514
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
2.4
11.2
79
343
E83.58
ICD-10 Finland
Idiopathic hypercalciuria
20.1
11.1
16
8
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
2.5
11.1
70
288
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
11.0
933
7728
116
Kela drug reimbursment
Prostate cancer
1.6
10.9
235
1488
109
Kela drug reimbursment
Multiple sclerosis
5.4
10.9
21
39
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
10.9
309
2091
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.9
10.7
126
667
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.2
10.7
85
388
N42.0
ICD-10 Finland
Calculus of prostate
60.3
10.6
12
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.2
10.5
87
404
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
10.5
331
2292
N41.0
ICD-10 Finland
Acute prostatitis
2.4
10.4
72
310
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
10.2
572
4415
K59.1
ICD-10 Finland
Functional diarrhoea
2.0
10.1
107
546
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
4.8
10.0
22
46
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
10.0
294
2003
N02BF01
ATC
gabapentin; oral
1.7
9.9
178
1073
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
9.9
1041
8857
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
9.9
346
2446
SPAT1172
SPAT
Guidance concerning hydration
2.6
9.7
55
216
G04BD04
ATC
oxybutynin; oral, transdermal
2.0
9.6
104
535
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
9.6
327
2298
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
8.4
9.6
20
24
R03DA05
ATC
aminophylline; systemic, rectal
4.0
9.5
26
65
N03AX12
ATC
[U] gabapentin; oral
1.5
9.5
292
2009
U70
ICPC
Pyelonephritis/pyelitis
3.2
9.5
36
113
KBE00
NOMESCO Finland
Ureterolithotomy
100.5
9.4
10
*
D06
ICPC
Abdominal pain localized other
1.8
9.4
137
778
KEE02
NOMESCO Finland
Urethroscopic prostatolithotomy
+∞
9.4
9
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.1
9.4
82
390
KA3GB
NOMESCO Finland
Retrograde pyelography
12.4
9.4
16
13
TKE00
NOMESCO Finland
Needle biopsy of prostate
1.8
9.3
149
870
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
3.3
9.0
33
101
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
9.0
766
6291
1520
FHL
Ureteropyeloscopy
36.8
9.0
11
*
6000A
ICD-9 Finland
Hyperplasia of prostate[HYPERPLASIA PROSTATAE]
2.4
9.0
58
242
KH1CB
NOMESCO Finland
Urography with X-ray
18.7
8.9
13
7
D01
ICPC
Abdominal pain/cramps general
1.7
8.9
184
1152
WZC30
NOMESCO Finland
Teaching
1.5
8.9
334
2392
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
2.9
8.9
40
139
M54.5
ICD-10 Finland
Low back pain
1.4
8.7
594
4713
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
8.7
533
4158
A07EC02
ATC
mesalazine; oral, rectal
2.0
8.7
95
491
M01AB05
ATC
diclofenac; systemic, rectal
1.3
8.7
1197
10504
ZXC10
NOMESCO Finland
Use of laser
2.5
8.7
51
204
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
6.6
8.7
21
32
A98
ICPC
Health maint/preventive medicine
1.5
8.6
1879
17663
SPAT1301
SPAT
No procedures
1.4
8.6
599
4768
G82.2
ICD-10 Finland
Paraplegia, unspecified
4.8
8.6
19
40
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
8.5
169
1047
KH1AE, ,
SPAT
2.8
8.5
41
148
163
Kela drug reimbursment
Abiraterone and enzalutamide
2.7
8.5
44
165
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
1.6
8.5
207
1351
N02AA05
ATC
oxycodone; systemic
1.4
8.4
424
3202
L02BB04
ATC
enzalutamide; oral
2.7
8.3
43
161
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.6
8.3
173
1085
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
8.3
255
1753
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.9
8.3
94
493
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
2.4
8.2
55
234
N86
ICPC
Multiple sclerosis
7.6
8.2
18
24
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
8.1
1345
12045
G04AA01, ,
ATC
4.6
8.1
19
42
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
8.1
458
3524
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
2.3
8.1
57
248
A03
ICPC
Fever
1.5
8.0
253
1747
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.1
8.0
73
354
SPAT1255
SPAT
Intravenous administration of medicine
1.7
7.9
145
880
7451
FHL
Transurethral adenoma removal
2.7
7.9
42
160
Z25.1
ICD-10 Finland
Need for immunization against influenza
1.9
7.9
103
566
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
7.9
566
4520
L28
ICPC
Limited function/disability (L)
1.4
7.8
398
3009
R42
ICD-10 Finland
Dizziness and giddiness
1.4
7.8
433
3322
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
7.8
295
2115
U28
ICPC
Limited function/disability (U)
2.8
7.8
37
133
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
7.7
795
6675
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.4
7.7
27
81
R10.0
ICD-10 Finland
Acute abdomen
2.2
7.6
60
274
JN4AD
NOMESCO Finland
Body CT examination
1.5
7.5
265
1872
S29
ICPC
Skin symptom/complaint other
1.4
7.5
366
2746
7172
FHL
Ureterotomy, involves stone removal
80.4
7.4
8
*
KCF00
NOMESCO Finland
Cystotomy and removal of foreign body from bladder
80.4
7.4
8
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
7.4
685
5662
T90
ICPC
Diabetes non-insulin dependent
1.3
7.3
533
4256
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
7.3
202
1356
SPAT1168
SPAT
Catheterisation training
3.6
7.3
23
64
59404, ,
ICD-8 Finland
+∞
7.3
7
*
Q05.2
ICD-10 Finland
Lumbar spina bifida with hydrocephalus
+∞
7.3
7
*
KH1ZT
NOMESCO Finland
Removal of stone or foreign body from uringary tract with radiological guidance
+∞
7.3
7
*
59209
ICD-8 Finland
Calculus of kidney and ureter, Unspecified
+∞
7.3
7
*
G82.5
ICD-10 Finland
Tetraplegia, unspecified
10.9
7.3
13
12
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
9.4
7.3
14
15
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
7.3
548
4398
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.6
7.2
160
1021
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.7
7.2
36
133
G04BE03
ATC
sildenafil; oral
2.4
7.2
49
211
R53
ICD-10 Finland
Malaise and fatigue
1.4
7.1
445
3470
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
7.1
779
6572
U99
ICPC
Urinary disease other
3.4
7.1
25
75
WX725
NOMESCO Finland
Noninvasive ventilation
1.8
7.1
107
616
TJF80
NOMESCO Finland
Ostomy education
3.0
7.0
29
96
N02
ICD-10 Finland
Recurrent and persistent haematuria
10.1
7.0
13
13
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
7.0
689
5729
KE1AE
NOMESCO Finland
Percutaneous utlrasound examination fo prostata
4.2
7.0
18
43
M54.8
ICD-10 Finland
Other dorsalgia
2.0
7.0
68
338
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
3.9
7.0
20
52
SPAT1254
SPAT
Administration of medicine
1.4
7.0
288
2096
KH1DD
NOMESCO Finland
CT urography of urinary organs
6.3
6.9
17
27
N06AX21
ATC
duloxetine; oral
1.6
6.9
165
1072
J01CA04
ATC
amoxicillin; systemic
1.3
6.9
1501
13769
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.8
6.9
98
555
KGH10
NOMESCO Finland
Operation for phimosis
1.9
6.8
80
425
ZXC14
NOMESCO Finland
Other special laser technic
8.3
6.8
14
17
SPAT1138
SPAT
Guidance concerning bowel function
2.8
6.8
33
120
A10BA02
ATC
metformin; oral
1.3
6.8
626
5157
R11
ICD-10 Finland
Nausea and vomiting
1.6
6.8
141
885
G82.0
ICD-10 Finland
Flaccid paraplegia
9.3
6.8
13
14
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.6
6.8
177
1174
A41.8
ICD-10 Finland
Other specified sepsis
2.2
6.7
54
249
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
1.8
6.7
93
521
R52.2
ICD-10 Finland
Other chronic pain
2.1
6.7
63
309
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
6.7
302
2231
L02AE02
ATC
leuprorelin; implant, parenteral
1.6
6.7
158
1023
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
6.6
681
5688
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
6.6
261
1885
ZX120
NOMESCO Finland
Intravenous
1.5
6.6
181
1215
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
3.5
6.6
22
64
XX9LA
NOMESCO Finland
Complementary kinetic X-ray examination without contrast
3.4
6.6
23
69
A07EA02
ATC
hydrocortisone; rectal
2.4
6.5
42
176
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
6.5
561
4575
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
6.5
335
2531
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.4
6.5
262
1897
KH1AT
NOMESCO Finland
Urinary tract cathetrisation with ultrasound guidance
5.3
6.5
18
34
KCB00
NOMESCO Finland
Biopsy of bladder
5.3
6.5
18
34
T83.0
ICD-10 Finland
Mechanical complication of urinary (indwelling) catheter
5.7
6.4
17
30
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
6.4
233
1655
ZXA05
NOMESCO Finland
Left side
1.3
6.4
462
3676
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
6.4
315
2365
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.3
614
5084
QBG10
NOMESCO Finland
Excision and repair of bedsore of trunk
8.2
6.3
13
16
Y77
ICPC
Malignant neoplasm prostate
1.7
6.3
113
683
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
6.3
505
4078
KAE00
NOMESCO Finland
Nephrolithotomy
+∞
6.3
6
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.0
6.2
68
353
M79.6
ICD-10 Finland
Pain in limb
1.3
6.2
715
6047
N28.1
ICD-10 Finland
Cyst of kidney
2.4
6.2
39
162
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.0
6.2
64
326
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
6.2
174
1173
ZXA10
NOMESCO Finland
Bilateral
1.4
6.2
343
2622
M01AH01
ATC
celecoxib; oral
1.4
6.2
290
2158
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
4.0
6.2
17
43
R30.9
ICD-10 Finland
Painful micturition, unspecified
3.4
6.1
21
62
A28
ICPC
Limited function/disability NOS
1.3
6.1
398
3117
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.4
6.1
334
2548
SPAT1312
SPAT
General health counselling
1.3
6.1
522
4250
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.9
6.1
68
356
KK1XE
NOMESCO Finland
Other ultrasound examination of retroperitoneal space and genito-urinary tract
12.6
6.1
10
8
K05.1
ICD-10 Finland
Chronic gingivitis
1.8
6.1
92
531
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.0
6.0
65
336
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
3.5
6.0
20
58

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Urology
34 [38004474]
1.2e+00
1.9e+00
2.8e+00
8.1e+00
3.8e+00
3.0e+00
1.7e+00
cases:28.58%
controls:11.12%
cases:30.50%
controls:6.40%
cases:16.09%
controls:1.20%
cases:62.30%
controls:0.05%
cases:30.44%
controls:1.01%
cases:57.68%
controls:6.10%
cases:42.38%
controls:12.37%
595
2306
1487
18430
635
1327
1447
19409
335
249
1747
20487
1297
10
785
20726
631
210
1442
20491
1156
1224
848
18829
717
2074
975
14694
Unspecified haematuria
R31 [45553726]
1.3e+00
2.8e+00
3.9e+00
1.0e+50
3.5e+00
2.4e+00
1.3e+00
cases:6.05%
controls:1.76%
cases:9.65%
controls:0.62%
cases:5.96%
controls:0.13%
cases:4.08%
controls:0.00%
cases:2.99%
controls:0.09%
cases:6.59%
controls:0.65%
cases:8.39%
controls:2.41%
126
364
1956
20372
201
128
1881
20608
124
27
1958
20709
85
0
1997
20736
62
19
2011
20682
132
130
1872
19923
142
404
1550
16364
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
5.4e-01
1.4e+00
3.3e+00
5.0e+00
2.6e+00
1.6e+00
6.4e-01
cases:12.92%
controls:7.99%
cases:15.99%
controls:4.33%
cases:13.21%
controls:0.58%
cases:3.55%
controls:0.02%
cases:7.67%
controls:0.59%
cases:17.42%
controls:4.27%
cases:19.50%
controls:11.37%
269
1657
1813
19079
333
897
1749
19839
275
120
1807
20616
74
5
2008
20731
159
123
1914
20578
349
856
1655
19197
330
1906
1362
14862
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
5.5e-01
1.5e+00
3.2e+00
5.0e+00
2.6e+00
1.6e+00
6.1e-01
cases:22.29%
controls:14.25%
cases:26.61%
controls:7.48%
cases:23.29%
controls:1.20%
cases:5.43%
controls:0.04%
cases:13.80%
controls:1.22%
cases:28.94%
controls:7.94%
cases:31.26%
controls:19.78%
464
2955
1618
17781
554
1551
1528
19185
485
248
1597
20488
113
8
1969
20728
286
253
1787
20448
580
1592
1424
18461
529
3316
1163
13452
Retention of urine
R33 [45587507]
1.6e+00
2.4e+00
3.8e+00
—
3.6e+00
2.4e+00
9.7e-01
cases:6.96%
controls:1.55%
cases:6.20%
controls:0.60%
cases:3.07%
controls:0.07%
—
—
cases:3.04%
controls:0.09%
cases:6.99%
controls:0.71%
cases:5.67%
controls:2.23%
145
322
1937
20414
129
125
1953
20611
64
15
2018
20721
—
63
18
2010
20683
140
142
1864
19911
96
374
1596
16394
Cystoscopic insertion of stent into ureter
KBV02 [2001305891]
2.8e+00
4.3e+00
1.0e+50
1.0e+50
1.0e+50
4.2e+00
3.1e+00
cases:1.44%
controls:0.09%
cases:1.78%
controls:0.02%
cases:0.34%
controls:0.00%
cases:1.25%
controls:0.00%
cases:1.16%
controls:0.00%
cases:1.70%
controls:0.02%
cases:2.84%
controls:0.13%
30
18
2052
20718
37
5
2045
20731
7
0
2075
20736
26
0
2056
20736
24
0
2049
20701
34
5
1970
20048
48
21
1644
16747
Cystoscopy
UKC02 [2001306005]
1.3e+00
2.2e+00
3.1e+00
—
3.1e+00
2.8e+00
1.9e+00
cases:11.62%
controls:3.34%
cases:11.00%
controls:1.31%
cases:4.13%
controls:0.20%
—
—
cases:2.75%
controls:0.13%
cases:18.21%
controls:1.28%
cases:20.09%
controls:3.62%
242
692
1840
20044
229
272
1853
20464
86
42
1996
20694
—
57
27
2016
20674
365
257
1639
19796
340
607
1352
16161
nitrofurantoin; oral
J01XE01 [21603058]
1.3e+00
2.3e+00
3.5e+00
1.0e+50
3.5e+00
2.3e+00
1.4e+00
cases:3.99%
controls:1.17%
cases:3.99%
controls:0.40%
cases:1.30%
controls:0.04%
cases:0.24%
controls:0.00%
cases:1.54%
controls:0.05%
cases:3.54%
controls:0.37%
cases:6.21%
controls:1.64%
83
243
1999
20493
83
83
1999
20653
27
8
2055
20728
5
0
2077
20736
32
10
2041
20691
71
74
1933
19979
105
275
1587
16493
Outpatient Hospital
22 [8756]
4.1e-01
8.3e-01
1.2e+00
6.9e+00
2.6e+00
1.5e+00
6.8e-01
cases:35.01%
controls:26.38%
cases:16.57%
controls:8.00%
cases:2.98%
controls:0.96%
cases:19.50%
controls:0.02%
cases:12.11%
controls:1.02%
cases:25.65%
controls:6.89%
cases:31.62%
controls:18.94%
729
5470
1353
15266
345
1659
1737
19077
62
199
2020
20537
406
5
1676
20731
251
211
1822
20490
514
1381
1490
18672
535
3176
1157
13592
CT of urinary organs
KH1AD [2001306328]
2.8e+00
3.8e+00
—
1.0e+50
—
3.9e+00
3.3e+00
cases:2.31%
controls:0.14%
cases:2.40%
controls:0.05%
—
—
cases:6.10%
controls:0.00%
—
—
cases:3.34%
controls:0.07%
cases:5.32%
controls:0.21%
48
29
2034
20707
50
11
2032
20725
—
127
0
1955
20736
—
67
14
1937
20039
90
35
1602
16733
trimethoprim; oral, parenteral
J01EA01 [21602931]
1.5e+00
2.3e+00
3.0e+00
1.0e+50
3.4e+00
2.2e+00
1.2e+00
cases:12.68%
controls:3.18%
cases:12.10%
controls:1.33%
cases:3.70%
controls:0.20%
cases:0.72%
controls:0.00%
cases:5.55%
controls:0.20%
cases:10.68%
controls:1.33%
cases:14.54%
controls:4.66%
264
660
1818
20076
252
276
1830
20460
77
41
2005
20695
15
0
2067
20736
115
42
1958
20659
214
267
1790
19786
246
782
1446
15986
methenamine; oral
J01XX05 [21603065]
1.8e+00
2.3e+00
2.3e+00
—
2.7e+00
2.4e+00
1.9e+00
cases:1.15%
controls:0.20%
cases:0.96%
controls:0.10%
cases:0.38%
controls:0.04%
—
—
cases:0.48%
controls:0.03%
cases:1.20%
controls:0.11%
cases:1.60%
controls:0.24%
24
41
2058
20695
20
21
2062
20715
8
8
2074
20728
—
10
7
2063
20694
24
22
1980
20031
27
41
1665
16727
Urinary tract infection, site not specified
N39.0 [45548665]
1.3e+00
2.3e+00
3.4e+00
1.0e+50
2.8e+00
1.9e+00
1.1e+00
cases:4.90%
controls:1.33%
cases:4.56%
controls:0.47%
cases:1.34%
controls:0.04%
cases:0.77%
controls:0.00%
cases:1.45%
controls:0.09%
cases:3.89%
controls:0.58%
cases:6.91%
controls:2.36%
102
276
1980
20460
95
98
1987
20638
28
9
2054
20727
16
0
2066
20736
30
18
2043
20683
78
117
1926
19936
117
396
1575
16372
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
4.1e-01
1.3e+00
2.8e+00
4.7e+00
2.0e+00
1.2e+00
5.3e-01
cases:22.09%
controls:15.88%
cases:23.49%
controls:8.01%
cases:16.14%
controls:1.12%
cases:2.55%
controls:0.02%
cases:7.72%
controls:1.14%
cases:23.95%
controls:8.33%
cases:31.03%
controls:20.87%
460
3293
1622
17443
489
1661
1593
19075
336
232
1746
20504
53
5
2029
20731
160
235
1913
20466
480
1671
1524
18382
525
3500
1167
13268
Inpatient Hospital
21 [8717]
3.8e-01
7.7e-01
1.3e+00
6.3e+00
2.3e+00
1.2e+00
5.4e-01
cases:42.17%
controls:33.28%
cases:22.38%
controls:11.79%
cases:5.48%
controls:1.59%
cases:25.79%
controls:0.06%
cases:14.62%
controls:1.62%
cases:28.74%
controls:10.76%
cases:37.71%
controls:26.10%
878
6900
1204
13836
466
2445
1616
18291
114
330
1968
20406
537
13
1545
20723
303
336
1770
20365
576
2158
1428
17895
638
4376
1054
12392
Emergency Room Visit
ER [9203]
3.9e-01
9.6e-01
1.8e+00
6.4e+00
1.9e+00
7.5e-01
5.1e-01
cases:42.32%
controls:33.18%
cases:27.04%
controls:12.42%
cases:9.61%
controls:1.65%
cases:19.12%
controls:0.04%
cases:10.08%
controls:1.62%
cases:22.50%
controls:12.03%
cases:43.44%
controls:31.67%
881
6880
1201
13856
563
2576
1519
18160
200
343
1882
20393
398
8
1684
20728
209
335
1864
20366
451
2412
1553
17641
735
5310
957
11458
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
9.9e-01
2.0e+00
3.1e+00
—
3.6e+00
1.9e+00
1.1e+00
cases:16.04%
controls:6.60%
cases:13.26%
controls:2.10%
cases:3.70%
controls:0.17%
—
—
cases:6.17%
controls:0.19%
cases:12.18%
controls:1.98%
cases:18.03%
controls:6.83%
334
1369
1748
19367
276
436
1806
20300
77
36
2005
20700
—
128
39
1945
20662
244
397
1760
19656
305
1145
1387
15623
Bacteria identified in Urine by Culture
630-4 [3026008]
9.1e-01
1.8e+00
3.5e+00
—
3.1e+00
2.0e+00
8.9e-01
cases:11.00%
controls:4.75%
cases:13.59%
controls:2.44%
cases:10.95%
controls:0.37%
—
—
cases:7.81%
controls:0.37%
cases:16.57%
controls:2.70%
cases:17.49%
controls:8.05%
229
985
1853
19751
283
505
1799
20231
228
77
1854
20659
—
162
76
1911
20625
332
541
1672
19512
296
1349
1396
15419
Insertion of urinary catheter
SPAT1167 [2001700268]
1.3e+00
1.8e+00
2.6e+00
—
3.2e+00
2.1e+00
1.1e+00
cases:1.59%
controls:0.44%
cases:1.30%
controls:0.22%
cases:0.67%
controls:0.05%
—
—
cases:0.58%
controls:0.02%
cases:1.60%
controls:0.19%
cases:1.95%
controls:0.65%
33
91
2049
20645
27
45
2055
20691
14
10
2068
20726
—
12
5
2061
20696
32
39
1972
20014
33
109
1659
16659
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
3.2e-01
8.5e-01
2.1e+00
4.3e+00
2.5e+00
1.5e+00
5.4e-01
cases:11.14%
controls:8.36%
cases:8.02%
controls:3.59%
cases:4.37%
controls:0.57%
cases:1.83%
controls:0.02%
cases:6.37%
controls:0.56%
cases:12.87%
controls:3.34%
cases:17.02%
controls:10.66%
232
1734
1850
19002
167
744
1915
19992
91
118
1991
20618
38
5
2044
20731
132
115
1941
20586
258
670
1746
19383
288
1788
1404
14980
Urine symptom/complaint other
U07 [2002001142]
1.2e+00
2.5e+00
3.5e+00
—
2.2e+00
1.7e+00
1.0e+00
cases:2.11%
controls:0.63%
cases:2.74%
controls:0.24%
cases:0.77%
controls:0.02%
—
—
cases:0.58%
controls:0.07%
cases:1.95%
controls:0.36%
cases:3.19%
controls:1.18%
44
130
2038
20606
57
50
2025
20686
16
5
2066
20731
—
12
14
2061
20687
39
73
1965
19980
54
198
1638
16570
Acute cystitis
N30.0 [45601724]
1.4e+00
2.4e+00
2.7e+00
1.0e+50
2.8e+00
1.7e+00
1.0e+00
cases:3.70%
controls:0.97%
cases:4.42%
controls:0.42%
cases:1.01%
controls:0.07%
cases:0.38%
controls:0.00%
cases:0.92%
controls:0.06%
cases:2.99%
controls:0.55%
cases:5.50%
controls:2.03%
77
202
2005
20534
92
88
1990
20648
21
14
2061
20722
8
0
2074
20736
19
12
2054
20689
60
111
1944
19942
93
341
1599
16427
Acute tubulo-interstitial nephritis
N10 [45543856]
9.0e-01
2.1e+00
3.0e+00
—
2.8e+00
1.8e+00
9.9e-01
cases:3.75%
controls:1.56%
cases:4.37%
controls:0.58%
cases:1.63%
controls:0.08%
—
—
cases:1.64%
controls:0.10%
cases:4.19%
controls:0.73%
cases:6.15%
controls:2.37%
78
323
2004
20413
91
121
1991
20615
34
17
2048
20719
—
34
20
2039
20681
84
147
1920
19906
104
398
1588
16370
Malignant neoplasm of prostate
C61 [45547509]
7.3e-01
9.5e-01
1.4e+00
4.5e+00
1.6e+00
1.3e+00
9.6e-01
cases:9.37%
controls:4.76%
cases:8.65%
controls:3.53%
cases:3.94%
controls:0.97%
cases:6.53%
controls:0.08%
cases:4.39%
controls:0.94%
cases:12.03%
controls:3.60%
cases:12.65%
controls:5.24%
195
986
1887
19750
180
733
1902
20003
82
201
2000
20535
136
16
1946
20720
91
194
1982
20507
241
722
1763
19331
214
879
1478
15889
Catheterisation of bladder
TKC20 [2001306020]
1.1e+00
1.9e+00
2.1e+00
1.0e+50
2.7e+00
2.2e+00
1.2e+00
cases:3.03%
controls:0.98%
cases:2.31%
controls:0.35%
cases:0.38%
controls:0.05%
cases:1.01%
controls:0.00%
cases:0.68%
controls:0.04%
cases:2.94%
controls:0.32%
cases:3.61%
controls:1.07%
63
203
2019
20533
48
72
2034
20664
8
10
2074
20726
21
0
2061
20736
14
9
2059
20692
59
65
1945
19988
61
180
1631
16588
Urinary tract ultrasound examination
KH1AE [2001306329]
1.3e+00
2.4e+00
3.7e+00
1.0e+50
—
2.3e+00
1.5e+00
cases:2.45%
controls:0.70%
cases:2.88%
controls:0.27%
cases:0.96%
controls:0.02%
cases:1.78%
controls:0.00%
—
—
cases:2.54%
controls:0.26%
cases:4.31%
controls:0.98%
51
146
2031
20590
60
57
2022
20679
20
5
2062
20731
37
0
2045
20736
—
51
53
1953
20000
73
165
1619
16603
sulfadiazine and trimethoprim
J01EE02 [21602962]
9.5e-01
2.0e+00
2.8e+00
—
2.7e+00
1.7e+00
9.7e-01
cases:7.01%
controls:2.83%
cases:5.67%
controls:0.79%
cases:1.39%
controls:0.09%
—
—
cases:1.30%
controls:0.09%
cases:4.44%
controls:0.85%
cases:6.26%
controls:2.47%
146
587
1936
20149
118
164
1964
20572
29
18
2053
20718
—
27
19
2046
20682
89
170
1915
19883
106
414
1586
16354
Uroflowmetry
44856007 [4261340]
9.9e-01
1.7e+00
2.4e+00
—
1.9e+00
2.8e+00
1.3e+00
cases:11.96%
controls:4.79%
cases:8.21%
controls:1.56%
cases:2.02%
controls:0.19%
—
—
cases:0.82%
controls:0.13%
cases:17.56%
controls:1.29%
cases:12.88%
controls:3.97%
249
994
1833
19742
171
324
1911
20412
42
39
2040
20697
—
17
26
2056
20675
352
258
1652
19795
218
665
1474
16103
Ultrasound measurement of residual urine
KC1EE [2001305918]
9.4e-01
1.7e+00
2.3e+00
—
2.3e+00
2.7e+00
1.2e+00
cases:8.69%
controls:3.60%
cases:6.34%
controls:1.26%
cases:1.25%
controls:0.13%
—
—
cases:1.06%
controls:0.11%
cases:14.42%
controls:1.13%
cases:10.34%
controls:3.40%
181
746
1901
19990
132
262
1950
20474
26
27
2056
20709
—
22
22
2051
20679
289
226
1715
19827
175
570
1517
16198
Kidney ultrasound examination
KA1AE [2001305627]
1.1e+00
2.3e+00
—
1.0e+50
2.9e+00
2.7e+00
2.0e+00
cases:0.67%
controls:0.22%
cases:0.86%
controls:0.09%
—
—
cases:0.62%
controls:0.00%
cases:0.43%
controls:0.02%
cases:0.60%
controls:0.04%
cases:1.71%
controls:0.23%
14
46
2068
20690
18
18
2064
20718
—
13
0
2069
20736
9
5
2064
20696
12
8
1992
20045
29
39
1663
16729
Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]
7.6e-01
1.8e+00
3.3e+00
1.0e+50
2.7e+00
1.8e+00
6.8e-01
cases:2.88%
controls:1.36%
cases:4.56%
controls:0.75%
cases:3.99%
controls:0.15%
cases:0.34%
controls:0.00%
cases:1.88%
controls:0.14%
cases:5.29%
controls:0.95%
cases:5.26%
controls:2.74%
60
283
2022
20453
95
155
1987
20581
83
31
1999
20705
7
0
2075
20736
39
28
2034
20673
106
191
1898
19862
89
459
1603
16309
Microorganisms panel - Urine sediment
58435-9 [40761536]
8.4e-01
1.6e+00
3.2e+00
1.0e+50
2.7e+00
1.5e+00
1.0e+00
cases:3.84%
controls:1.69%
cases:4.32%
controls:0.91%
cases:2.69%
controls:0.11%
cases:0.48%
controls:0.00%
cases:1.50%
controls:0.10%
cases:3.89%
controls:0.86%
cases:5.14%
controls:1.95%
80
351
2002
20385
90
189
1992
20547
56
23
2026
20713
10
0
2072
20736
31
21
2042
20680
78
173
1926
19880
87
327
1605
16441
Emergency Medicine
93 [38004510]
3.1e-01
7.9e-01
1.8e+00
5.1e+00
1.8e+00
6.8e-01
3.7e-01
cases:17.00%
controls:13.09%
cases:15.27%
controls:7.53%
cases:6.20%
controls:1.07%
cases:6.77%
controls:0.04%
cases:5.93%
controls:1.06%
cases:14.82%
controls:8.13%
cases:28.66%
controls:21.67%
354
2715
1728
18021
318
1562
1764
19174
129
221
1953
20515
141
9
1941
20727
123
219
1950
20482
297
1631
1707
18422
485
3633
1207
13135
Percutaneous puncture of bladder
TKC10 [2001306019]
2.8e+00
2.9e+00
—
1.0e+50
1.0e+50
3.2e+00
1.7e+00
cases:1.54%
controls:0.09%
cases:0.91%
controls:0.05%
—
—
cases:0.82%
controls:0.00%
cases:0.24%
controls:0.00%
cases:1.80%
controls:0.07%
cases:1.60%
controls:0.29%
32
19
2050
20717
19
10
2063
20726
—
17
0
2065
20736
5
0
2068
20701
36
15
1968
20038
27
49
1665
16719
Other and unspecified hydronephrosis
N13.3 [45553432]
2.1e+00
3.2e+00
—
1.0e+50
—
3.1e+00
2.1e+00
cases:0.77%
controls:0.10%
cases:1.34%
controls:0.06%
—
—
cases:1.20%
controls:0.00%
—
—
cases:1.35%
controls:0.06%
cases:1.71%
controls:0.22%
16
20
2066
20716
28
12
2054
20724
—
25
0
2057
20736
—
27
12
1977
20041
29
37
1663
16731
Malignant neoplasm: Bladder, unspecified
C67.9 [45571528]
1.1e+00
1.4e+00
2.0e+00
1.0e+50
2.3e+00
2.0e+00
1.5e+00
cases:1.01%
controls:0.34%
cases:0.91%
controls:0.23%
cases:0.34%
controls:0.04%
cases:1.15%
controls:0.00%
cases:0.43%
controls:0.04%
cases:1.65%
controls:0.22%
cases:1.71%
controls:0.41%
21
71
2061
20665
19
48
2063
20688
7
9
2075
20727
24
0
2058
20736
9
9
2064
20692
33
44
1971
20009
29
68
1663
16700
Attention to cystostomy
Z43.5 [45556833]
2.4e+00
2.8e+00
—
—
—
3.1e+00
1.9e+00
cases:0.38%
controls:0.03%
cases:0.48%
controls:0.03%
—
—
—
—
—
—
cases:0.90%
controls:0.04%
cases:1.18%
controls:0.17%
8
7
2074
20729
10
6
2072
20730
—
—
—
18
8
1986
20045
20
29
1672
16739
Sequelae of injury of spinal cord
T91.3 [45546766]
2.4e+00
2.4e+00
—
—
—
2.4e+00
2.9e+00
cases:0.43%
controls:0.04%
cases:0.43%
controls:0.04%
—
—
—
—
—
—
cases:0.50%
controls:0.04%
cases:0.89%
controls:0.05%
9
8
2073
20728
9
8
2073
20728
—
—
—
10
9
1994
20044
15
8
1677
16760
Multiple sclerosis
G35 [45571794]
2.0e+00
2.2e+00
2.4e+00
1.0e+50
—
2.0e+00
1.6e+00
cases:1.06%
controls:0.14%
cases:0.86%
controls:0.10%
cases:0.48%
controls:0.04%
cases:0.43%
controls:0.00%
—
—
cases:0.80%
controls:0.11%
cases:0.95%
controls:0.20%
22
30
2060
20706
18
20
2064
20716
10
9
2072
20727
9
0
2073
20736
—
16
22
1988
20031
16
33
1676
16735
pivmecillinam; oral
J01CA08 [21602827]
1.0e+00
1.8e+00
2.6e+00
—
2.4e+00
1.4e+00
8.4e-01
cases:7.40%
controls:2.80%
cases:5.86%
controls:1.00%
cases:1.39%
controls:0.11%
—
—
cases:1.35%
controls:0.13%
cases:3.89%
controls:1.03%
cases:7.92%
controls:3.59%
154
581
1928
20155
122
208
1960
20528
29
22
2053
20714
—
28
26
2045
20675
78
207
1926
19846
134
602
1558
16166
baclofen; oral, parenteral
M03BX01 [21604115]
2.2e+00
3.0e+00
—
—
—
2.8e+00
2.0e+00
cases:1.10%
controls:0.13%
cases:1.10%
controls:0.05%
—
—
—
—
—
—
cases:1.10%
controls:0.07%
cases:1.18%
controls:0.16%
23
26
2059
20710
23
11
2059
20725
—
—
—
22
14
1982
20039
20
27
1672
16741
mirabegron; oral
G04BD12 [43534790]
7.1e-01
1.4e+00
1.4e+00
3.0e+00
1.3e+00
1.2e+00
9.5e-01
cases:3.79%
controls:1.91%
cases:5.28%
controls:1.33%
cases:1.63%
controls:0.40%
cases:0.48%
controls:0.02%
cases:1.45%
controls:0.41%
cases:4.39%
controls:1.38%
cases:7.09%
controls:2.87%
79
396
2003
20340
110
275
1972
20461
34
82
2048
20654
10
5
2072
20731
30
84
2043
20617
88
277
1916
19776
120
482
1572
16286
Cytology report of Urine Cyto stain
47525-1 [3049717]
8.9e-01
2.2e+00
4.1e+00
—
—
1.5e+00
1.3e+00
cases:2.88%
controls:1.20%
cases:4.47%
controls:0.54%
cases:5.38%
controls:0.10%
—
—
—
—
cases:2.64%
controls:0.60%
cases:4.67%
controls:1.36%
60
249
2022
20487
93
111
1989
20625
112
20
1970
20716
—
—
53
120
1951
19933
79
228
1613
16540
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
5.8e-01
1.4e+00
3.1e+00
—
2.5e+00
1.5e+00
7.3e-01
cases:7.83%
controls:4.54%
cases:8.55%
controls:2.21%
cases:5.91%
controls:0.28%
—
—
cases:3.81%
controls:0.33%
cases:9.38%
controls:2.21%
cases:11.58%
controls:5.92%
163
942
1919
19794
178
458
1904
20278
123
59
1959
20677
—
79
69
1994
20632
188
444
1816
19609
196
993
1496
15775
Hyperplasia of prostate
N40 [45563015]
7.9e-01
1.3e+00
2.1e+00
—
2.9e+00
2.1e+00
6.6e-01
cases:17.77%
controls:8.91%
cases:14.12%
controls:4.15%
cases:5.48%
controls:0.72%
—
—
cases:9.79%
controls:0.61%
cases:24.55%
controls:3.94%
cases:18.85%
controls:10.73%
370
1848
1712
18888
294
860
1788
19876
114
149
1968
20587
—
203
126
1870
20575
492
791
1512
19262
319
1799
1373
14969
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
7.7e-01
1.5e+00
2.4e+00
—
2.8e+00
1.6e+00
7.8e-01
cases:5.48%
controls:2.61%
cases:3.94%
controls:0.92%
cases:1.10%
controls:0.10%
—
—
cases:1.88%
controls:0.12%
cases:4.14%
controls:0.86%
cases:6.74%
controls:3.22%
114
541
1968
20195
82
191
2000
20545
23
21
2059
20715
—
39
25
2034
20676
83
172
1921
19881
114
540
1578
16228
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
5.8e-01
1.4e+00
3.2e+00
—
2.6e+00
1.5e+00
5.7e-01
cases:11.48%
controls:6.79%
cases:14.75%
controls:3.95%
cases:12.15%
controls:0.57%
—
—
cases:7.43%
controls:0.62%
cases:15.82%
controls:4.13%
cases:17.43%
controls:10.63%
239
1408
1843
19328
307
820
1775
19916
253
119
1829
20617
—
154
128
1919
20573
317
828
1687
19225
295
1783
1397
14985
Pain localized to other parts of lower abdomen
R10.3 [45534426]
6.1e-01
1.5e+00
3.4e+00
1.0e+50
1.8e+00
1.4e+00
8.8e-01
cases:3.41%
controls:1.88%
cases:2.26%
controls:0.50%
cases:1.25%
controls:0.04%
cases:0.96%
controls:0.00%
cases:0.39%
controls:0.06%
cases:2.15%
controls:0.55%
cases:5.02%
controls:2.14%
71
390
2011
20346
47
104
2035
20632
26
9
2056
20727
20
0
2062
20736
8
13
2065
20688
43
110
1961
19943
85
359
1607
16409
Urinary bladder endoscopic botulin therapy
KCV12 [2001305987]
2.3e+00
2.6e+00
—
1.0e+50
—
2.4e+00
2.3e+00
cases:0.53%
controls:0.05%
cases:0.43%
controls:0.03%
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.50%
controls:0.04%
cases:0.95%
controls:0.10%
11
11
2071
20725
9
7
2073
20729
—
5
0
2077
20736
—
10
9
1994
20044
16
16
1676
16752
Osmolality of Urine
2695-5 [3026782]
5.7e-01
1.4e+00
3.1e+00
—
2.4e+00
1.5e+00
6.2e-01
cases:8.21%
controls:4.83%
cases:7.88%
controls:2.13%
cases:5.52%
controls:0.27%
—
—
cases:3.23%
controls:0.30%
cases:8.43%
controls:1.93%
cases:9.57%
controls:5.37%
171
1001
1911
19735
164
441
1918
20295
115
56
1967
20680
—
67
63
2006
20638
169
387
1835
19666
162
900
1530
15868
Malignant neoplasm: Overlapping lesion of bladder
C67.8 [45532924]
1.2e+00
1.4e+00
1.8e+00
—
1.8e+00
1.8e+00
1.4e+00
cases:1.59%
controls:0.46%
cases:1.78%
controls:0.42%
cases:0.67%
controls:0.12%
—
—
cases:0.82%
controls:0.13%
cases:2.69%
controls:0.46%
cases:2.90%
controls:0.70%
33
96
2049
20640
37
88
2045
20648
14
24
2068
20712
—
17
27
2056
20674
54
93
1950
19960
49
118
1643
16650
Kidney transplant status
Z94.0 [45566477]
1.3e+00
1.5e+00
2.1e+00
—
1.7e+00
1.5e+00
1.3e+00
cases:0.58%
controls:0.16%
cases:0.77%
controls:0.17%
cases:0.48%
controls:0.06%
—
—
cases:0.43%
controls:0.08%
cases:0.70%
controls:0.15%
cases:0.65%
controls:0.18%
12
33
2070
20703
16
35
2066
20701
10
12
2072
20724
—
9
16
2064
20685
14
30
1990
20023
11
30
1681
16738
Leukocytes [#/volume] in Urine
30405-5 [3018095]
5.6e-01
1.4e+00
3.1e+00
—
2.5e+00
1.4e+00
5.1e-01
cases:12.01%
controls:7.26%
cases:15.71%
controls:4.30%
cases:12.54%
controls:0.65%
—
—
cases:7.57%
controls:0.70%
cases:16.47%
controls:4.50%
cases:18.20%
controls:11.83%
250
1506
1832
19230
327
892
1755
19844
261
135
1821
20601
—
157
144
1916
20557
330
903
1674
19150
308
1983
1384
14785
Outpatient Visit
OP [9202]
2.9e-01
5.2e-01
8.4e-01
4.9e+00
1.3e+00
1.0e+00
6.0e-01
cases:74.88%
controls:69.06%
cases:64.02%
controls:51.29%
cases:21.61%
controls:10.64%
cases:33.91%
controls:0.38%
cases:29.81%
controls:10.70%
cases:74.35%
controls:50.65%
cases:85.22%
controls:75.97%
1559
14321
523
6415
1333
10635
749
10101
450
2207
1632
18529
706
79
1376
20657
618
2215
1455
18486
1490
10157
514
9896
1442
12738
250
4030
Urinary retention
U08 [2002001143]
1.5e+00
2.2e+00
2.5e+00
—
—
2.2e+00
1.0e+00
cases:1.20%
controls:0.26%
cases:1.01%
controls:0.11%
cases:0.29%
controls:0.02%
—
—
—
—
cases:0.85%
controls:0.09%
cases:1.12%
controls:0.41%
25
54
2057
20682
21
23
2061
20713
6
5
2076
20731
—
—
17
19
1987
20034
19
69
1673
16699
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
6.3e-01
1.3e+00
3.2e+00
—
2.6e+00
1.4e+00
3.8e-01
cases:5.52%
controls:3.01%
cases:6.72%
controls:1.90%
cases:6.44%
controls:0.28%
—
—
cases:3.52%
controls:0.28%
cases:7.49%
controls:2.03%
cases:7.74%
controls:5.43%
115
624
1967
20112
140
394
1942
20342
134
59
1948
20677
—
73
58
2000
20643
150
408
1854
19645
131
910
1561
15858
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
5.4e-01
1.3e+00
3.1e+00
—
2.5e+00
1.4e+00
5.3e-01
cases:9.65%
controls:5.89%
cases:11.53%
controls:3.41%
cases:9.17%
controls:0.44%
—
—
cases:5.74%
controls:0.50%
cases:12.43%
controls:3.39%
cases:14.48%
controls:9.02%
201
1221
1881
19515
240
707
1842
20029
191
91
1891
20645
—
119
104
1954
20597
249
680
1755
19373
245
1513
1447
15255
Emergency Room and Inpatient Visit
ERIP [262]
3.7e-01
7.1e-01
1.3e+00
4.3e+00
1.6e+00
6.3e-01
2.8e-01
cases:6.58%
controls:4.64%
cases:6.20%
controls:3.14%
cases:1.83%
controls:0.49%
cases:2.02%
controls:0.03%
cases:2.60%
controls:0.51%
cases:6.99%
controls:3.84%
cases:14.83%
controls:11.63%
137
963
1945
19773
129
652
1953
20084
38
102
2044
20634
42
6
2040
20730
54
106
2019
20595
140
771
1864
19282
251
1950
1441
14818
Bacteria [Presence] in Urine
87829-8 [36304419]
5.4e-01
1.3e+00
3.0e+00
—
2.5e+00
1.3e+00
5.0e-01
cases:9.13%
controls:5.52%
cases:10.37%
controls:3.18%
cases:8.02%
controls:0.42%
—
—
cases:5.45%
controls:0.45%
cases:10.68%
controls:3.07%
cases:13.06%
controls:8.38%
190
1145
1892
19591
216
660
1866
20076
167
87
1915
20649
—
113
93
1960
20608
214
615
1790
19438
221
1405
1471
15363
Bacteria [#/volume] in Urine by Culture
100906-7 [1761482]
5.1e-01
1.5e+00
3.3e+00
1.0e+50
2.7e+00
1.6e+00
3.7e-01
cases:1.34%
controls:0.82%
cases:1.63%
controls:0.36%
cases:1.39%
controls:0.05%
cases:0.34%
controls:0.00%
cases:0.48%
controls:0.03%
cases:1.85%
controls:0.37%
cases:1.95%
controls:1.35%
28
169
2054
20567
34
74
2048
20662
29
11
2053
20725
7
0
2075
20736
10
7
2063
20694
37
75
1967
19978
33
227
1659
16541
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
5.5e-01
1.3e+00
3.1e+00
—
2.5e+00
1.3e+00
3.8e-01
cases:4.85%
controls:2.85%
cases:6.68%
controls:1.98%
cases:6.29%
controls:0.30%
—
—
cases:3.57%
controls:0.31%
cases:7.44%
controls:2.11%
cases:8.27%
controls:5.83%
101
590
1981
20146
139
410
1943
20326
131
63
1951
20673
—
74
65
1999
20636
149
423
1855
19630
140
978
1552
15790
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
5.8e-01
1.5e+00
3.0e+00
—
2.2e+00
1.2e+00
5.2e-01
cases:8.89%
controls:5.16%
cases:10.47%
controls:2.55%
cases:6.20%
controls:0.34%
—
—
cases:2.99%
controls:0.33%
cases:9.03%
controls:2.87%
cases:13.36%
controls:8.41%
185
1070
1897
19666
218
529
1864
20207
129
71
1953
20665
—
62
68
2011
20633
181
575
1823
19478
226
1410
1466
15358
Neuromuscular dysfunction of bladder, unspecified
N31.9 [45592128]
2.2e+00
2.4e+00
—
—
—
2.3e+00
2.1e+00
cases:0.67%
controls:0.08%
cases:0.38%
controls:0.03%
—
—
—
—
—
—
cases:0.45%
controls:0.04%
cases:0.65%
controls:0.08%
14
16
2068
20720
8
7
2074
20729
—
—
—
9
9
1995
20044
11
14
1681
16754
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
2.8e-01
6.9e-01
1.4e+00
3.9e+00
1.9e+00
4.1e-01
3.7e-01
cases:15.32%
controls:12.06%
cases:6.96%
controls:3.61%
cases:2.26%
controls:0.57%
cases:1.59%
controls:0.03%
cases:3.47%
controls:0.54%
cases:5.79%
controls:3.91%
cases:15.19%
controls:10.97%
319
2501
1763
18235
145
748
1937
19988
47
118
2035
20618
33
7
2049
20729
72
111
2001
20590
116
785
1888
19268
257
1839
1435
14929
Spinalanesthesia
WX320 [2001310799]
4.9e-01
1.0e+00
6.9e-01
1.0e+50
4.1e+00
2.4e+00
8.9e-01
cases:5.62%
controls:3.52%
cases:2.88%
controls:1.08%
cases:0.24%
controls:0.12%
cases:3.36%
controls:0.00%
cases:3.86%
controls:0.07%
cases:9.68%
controls:0.92%
cases:8.16%
controls:3.52%
117
729
1965
20007
60
224
2022
20512
5
25
2077
20711
70
0
2012
20736
80
14
1993
20687
194
185
1810
19868
138
590
1554
16178
General Surgery
2 [38004447]
5.6e-01
1.1e+00
2.4e+00
—
2.5e+00
1.5e+00
6.8e-01
cases:29.44%
controls:19.28%
cases:16.28%
controls:5.85%
cases:7.35%
controls:0.71%
—
—
cases:9.50%
controls:0.85%
cases:20.96%
controls:5.83%
cases:28.07%
controls:16.45%
613
3998
1469
16738
339
1213
1743
19523
153
148
1929
20588
—
197
175
1876
20526
420
1170
1584
18883
475
2758
1217
14010
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
2.5e-01
5.5e-01
1.5e+00
3.6e+00
1.6e+00
6.6e-01
4.1e-01
cases:16.14%
controls:13.02%
cases:11.48%
controls:6.96%
cases:4.95%
controls:1.11%
cases:2.26%
controls:0.06%
cases:4.73%
controls:0.95%
cases:13.27%
controls:7.32%
cases:25.30%
controls:18.37%
336
2699
1746
18037
239
1444
1843
19292
103
230
1979
20506
47
13
2035
20723
98
196
1975
20505
266
1467
1738
18586
428
3080
1264
13688
Adenocarcinoma, NOS, of prostate gland
8140/3-C61.9 [44499685]
8.6e-01
1.1e+00
2.3e+00
—
2.7e+00
1.5e+00
2.2e-01
cases:4.85%
controls:2.10%
cases:1.59%
controls:0.54%
cases:0.29%
controls:0.03%
—
—
cases:0.58%
controls:0.04%
cases:1.60%
controls:0.34%
cases:1.89%
controls:1.53%
101
436
1981
20300
33
111
2049
20625
6
6
2076
20730
—
12
8
2061
20693
32
69
1972
19984
32
256
1660
16512
Abdominal CT examination
JN3AD [2001305554]
5.5e-01
1.4e+00
3.1e+00
—
2.0e+00
1.3e+00
7.3e-01
cases:1.63%
controls:0.95%
cases:1.92%
controls:0.48%
cases:0.72%
controls:0.03%
—
—
cases:0.48%
controls:0.06%
cases:1.70%
controls:0.49%
cases:3.96%
controls:1.95%
34
196
2048
20540
40
100
2042
20636
15
7
2067
20729
—
10
13
2063
20688
34
98
1970
19955
67
327
1625
16441
One hour or less
ZXE00 [2001311394]
4.0e-01
8.9e-01
1.5e+00
1.0e+50
3.0e+00
1.8e+00
8.2e-01
cases:9.61%
controls:6.64%
cases:3.94%
controls:1.65%
cases:0.67%
controls:0.15%
cases:2.93%
controls:0.00%
cases:3.18%
controls:0.16%
cases:7.49%
controls:1.26%
cases:9.57%
controls:4.45%
200
1376
1882
19360
82
343
2000
20393
14
31
2068
20705
61
0
2021
20736
66
34
2007
20667
150
253
1854
19800
162
746
1530
16022
Other and unspecified abdominal pain
R10.4 [45568113]
6.8e-01
1.1e+00
2.8e+00
—
2.0e+00
9.4e-01
9.0e-01
cases:7.68%
controls:4.03%
cases:3.94%
controls:1.29%
cases:2.02%
controls:0.13%
—
—
cases:1.21%
controls:0.16%
cases:3.29%
controls:1.31%
cases:10.34%
controls:4.48%
160
836
1922
19900
82
268
2000
20468
42
27
2040
20709
—
25
33
2048
20668
66
263
1938
19790
175
751
1517
16017
Transurethral resection of prostate
KED22 [2001306138]
1.4e+00
2.1e+00
—
1.0e+50
—
3.7e+00
1.3e+00
cases:4.66%
controls:1.21%
cases:2.35%
controls:0.31%
—
—
cases:5.00%
controls:0.00%
—
—
cases:9.18%
controls:0.25%
cases:4.14%
controls:1.14%
97
251
1985
20485
49
64
2033
20672
—
104
0
1978
20736
—
184
50
1820
20003
70
191
1622
16577
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
4.8e-01
1.3e+00
2.8e+00
—
2.2e+00
1.1e+00
4.4e-01
cases:12.25%
controls:7.99%
cases:14.55%
controls:4.32%
cases:9.27%
controls:0.62%
—
—
cases:4.78%
controls:0.57%
cases:13.07%
controls:4.64%
cases:18.50%
controls:12.78%
255
1656
1827
19080
303
895
1779
19841
193
128
1889
20608
—
99
117
1974
20584
262
930
1742
19123
313
2143
1379
14625
Urination problems other
U05 [2002001140]
1.2e+00
1.8e+00
—
—
2.3e+00
2.0e+00
1.0e+00
cases:2.02%
controls:0.59%
cases:1.15%
controls:0.20%
—
—
—
—
cases:0.39%
controls:0.04%
cases:1.75%
controls:0.23%
cases:2.42%
controls:0.91%
42
122
2040
20614
24
41
2058
20695
—
—
8
8
2065
20693
35
47
1969
20006
41
152
1651
16616
Visual laser resection of prostate
KED52 [2001306140]
1.7e+00
2.1e+00
—
1.0e+50
—
3.1e+00
1.4e+00
cases:1.06%
controls:0.19%
cases:0.48%
controls:0.06%
—
—
cases:0.53%
controls:0.00%
—
—
cases:0.85%
controls:0.04%
cases:0.59%
controls:0.14%
22
39
2060
20697
10
12
2072
20724
—
11
0
2071
20736
—
17
8
1987
20045
10
24
1682
16744
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
4.0e-01
1.3e+00
2.7e+00
—
2.3e+00
1.2e+00
5.0e-01
cases:8.41%
controls:5.79%
cases:10.61%
controls:3.26%
cases:6.77%
controls:0.49%
—
—
cases:4.29%
controls:0.43%
cases:10.48%
controls:3.57%
cases:14.48%
controls:9.35%
175
1201
1907
19535
221
676
1861
20060
141
102
1941
20634
—
89
89
1984
20612
210
715
1794
19338
245
1567
1447
15201
Other specified diseases of spinal cord
G95.8 [45586324]
2.4e+00
2.3e+00
—
—
—
3.1e+00
2.7e+00
cases:0.38%
controls:0.03%
cases:0.24%
controls:0.02%
—
—
—
—
—
—
cases:0.55%
controls:0.02%
cases:0.83%
controls:0.05%
8
7
2074
20729
5
5
2077
20731
—
—
—
11
5
1993
20048
14
9
1678
16759
Bladder symptom/complaint other
U13 [2002001144]
1.4e+00
2.6e+00
—
—
—
2.8e+00
1.5e+00
cases:0.96%
controls:0.25%
cases:0.82%
controls:0.06%
—
—
—
—
—
—
cases:1.05%
controls:0.06%
cases:1.00%
controls:0.23%
20
51
2062
20685
17
13
2065
20723
—
—
—
21
13
1983
20040
17
38
1675
16730
Urinary tract cathetrisation with X-ray guidance
KH1BT [2001305794]
—
2.7e+00
—
—
—
3.1e+00
2.5e+00
—
—
cases:0.48%
controls:0.03%
—
—
—
—
—
—
cases:0.65%
controls:0.03%
cases:0.71%
controls:0.06%
—
10
7
2072
20729
—
—
—
13
6
1991
20047
12
10
1680
16758
Cells panel - Urine sediment
58434-2 [40761535]
2.4e-01
1.0e+00
2.9e+00
—
2.2e+00
1.4e+00
7.7e-01
cases:2.40%
controls:1.90%
cases:2.45%
controls:0.91%
cases:2.31%
controls:0.13%
—
—
cases:0.96%
controls:0.11%
cases:2.94%
controls:0.77%
cases:4.26%
controls:2.02%
50
393
2032
20343
51
189
2031
20547
48
27
2034
20709
—
20
23
2053
20678
59
154
1945
19899
72
338
1620
16430
Leukocytes [Presence] in Urine
33052-2 [3045414]
6.8e-01
1.3e+00
2.9e+00
—
2.3e+00
9.9e-01
7.3e-01
cases:0.62%
controls:0.32%
cases:1.34%
controls:0.38%
cases:0.86%
controls:0.05%
—
—
cases:0.48%
controls:0.05%
cases:1.45%
controls:0.54%
cases:4.26%
controls:2.11%
13
66
2069
20670
28
79
2054
20657
18
10
2064
20726
—
10
10
2063
20691
29
109
1975
19944
72
353
1620
16415
General Practice
1 [38004446]
2.0e-01
5.9e-01
1.3e+00
4.4e+00
1.1e+00
4.9e-01
2.7e-01
cases:17.00%
controls:14.42%
cases:10.47%
controls:6.11%
cases:3.27%
controls:0.90%
cases:3.12%
controls:0.04%
cases:2.85%
controls:0.98%
cases:10.88%
controls:6.95%
cases:23.40%
controls:18.92%
354
2990
1728
17746
218
1266
1864
19470
68
187
2014
20549
65
8
2017
20728
59
202
2014
20499
218
1394
1786
18659
396
3173
1296
13595
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
4.9e-01
1.3e+00
2.7e+00
—
2.1e+00
1.1e+00
4.1e-01
cases:13.93%
controls:9.03%
cases:17.39%
controls:5.29%
cases:10.85%
controls:0.81%
—
—
cases:5.89%
controls:0.74%
cases:15.97%
controls:5.97%
cases:23.29%
controls:16.76%
290
1872
1792
18864
362
1097
1720
19639
226
168
1856
20568
—
122
154
1951
20547
320
1198
1684
18855
394
2810
1298
13958
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
4.9e-01
1.3e+00
2.7e+00
—
2.1e+00
1.1e+00
4.0e-01
cases:14.22%
controls:9.24%
cases:17.77%
controls:5.36%
cases:11.00%
controls:0.81%
—
—
cases:5.89%
controls:0.76%
cases:16.22%
controls:6.05%
cases:23.40%
controls:17.03%
296
1915
1786
18821
370
1111
1712
19625
229
168
1853
20568
—
122
157
1951
20544
325
1214
1679
18839
396
2855
1296
13913
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
4.8e-01
1.3e+00
2.7e+00
—
2.1e+00
1.1e+00
4.2e-01
cases:14.31%
controls:9.34%
cases:17.72%
controls:5.43%
cases:11.00%
controls:0.82%
—
—
cases:5.98%
controls:0.77%
cases:16.07%
controls:6.06%
cases:23.82%
controls:17.06%
298
1937
1784
18799
369
1126
1713
19610
229
171
1853
20565
—
124
160
1949
20541
322
1216
1682
18837
403
2861
1289
13907
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
3.5e-01
1.1e+00
2.1e+00
—
2.9e+00
1.3e+00
5.9e-01
cases:3.22%
controls:2.28%
cases:3.07%
controls:1.05%
cases:1.06%
controls:0.13%
—
—
cases:2.12%
controls:0.12%
cases:3.69%
controls:0.99%
cases:4.91%
controls:2.77%
67
473
2015
20263
64
217
2018
20519
22
27
2060
20709
—
44
25
2029
20676
74
199
1930
19854
83
465
1609
16303
pH of Urine
2756-5 [3015736]
4.6e-01
1.3e+00
2.7e+00
—
2.1e+00
1.0e+00
3.8e-01
cases:11.00%
controls:7.27%
cases:13.02%
controls:3.93%
cases:8.31%
controls:0.59%
—
—
cases:4.20%
controls:0.54%
cases:11.63%
controls:4.45%
cases:17.79%
controls:12.87%
229
1507
1853
19229
271
815
1811
19921
173
122
1909
20614
—
87
111
1986
20590
233
892
1771
19161
301
2158
1391
14610
Calcium [Moles/time] in 24 hour Urine
14637-3 [3010838]
1.1e+00
2.1e+00
—
—
—
2.4e+00
2.3e+00
cases:0.77%
controls:0.25%
cases:0.58%
controls:0.07%
—
—
—
—
—
—
cases:1.25%
controls:0.12%
cases:2.25%
controls:0.22%
16
51
2066
20685
12
14
2070
20722
—
—
—
25
24
1979
20029
38
37
1654
16731
Transurethral incision of prostate
KED33 [2001306139]
1.0e+00
2.7e+00
—
1.0e+50
—
3.7e+00
1.6e+00
cases:0.48%
controls:0.17%
cases:0.48%
controls:0.03%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.20%
controls:0.03%
cases:0.77%
controls:0.16%
10
35
2072
20701
10
7
2072
20729
—
7
0
2075
20736
—
24
6
1980
20047
13
26
1679
16742
Scheduled procedure
ZXD10 [2001311387]
3.2e-01
6.9e-01
1.6e+00
1.0e+50
2.7e+00
1.7e+00
1.0e+00
cases:8.79%
controls:6.56%
cases:3.27%
controls:1.67%
cases:0.77%
controls:0.16%
cases:3.07%
controls:0.00%
cases:2.60%
controls:0.19%
cases:6.74%
controls:1.31%
cases:9.81%
controls:3.79%
183
1360
1899
19376
68
347
2014
20389
16
34
2066
20702
64
0
2018
20736
54
39
2019
20662
135
263
1869
19790
166
636
1526
16132
General anesthesia, balanced
WX408 [2001310808]
3.8e-01
1.1e+00
—
1.0e+50
3.1e+00
2.1e+00
1.2e+00
cases:5.86%
controls:4.08%
cases:2.69%
controls:0.92%
—
—
cases:2.21%
controls:0.00%
cases:1.69%
controls:0.08%
cases:5.24%
controls:0.67%
cases:6.62%
controls:2.16%
122
846
1960
19890
56
191
2026
20545
—
46
0
2036
20736
35
16
2038
20685
105
134
1899
19919
112
363
1580
16405
Rectal ultrasound examination of prostate
KE1BE [2001306106]
7.7e-01
1.5e+00
1.9e+00
—
1.7e+00
1.6e+00
4.9e-01
cases:5.33%
controls:2.53%
cases:2.98%
controls:0.68%
cases:0.34%
controls:0.05%
—
—
cases:0.39%
controls:0.07%
cases:2.64%
controls:0.56%
cases:3.31%
controls:2.06%
111
525
1971
20211
62
141
2020
20595
7
10
2075
20726
—
8
15
2065
20686
53
113
1951
19940
56
346
1636
16422
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.3e-01
5.8e-01
1.3e+00
3.4e+00
1.4e+00
4.8e-01
2.6e-01
cases:29.83%
controls:27.17%
cases:28.48%
controls:18.26%
cases:12.25%
controls:3.83%
cases:8.36%
controls:0.30%
cases:13.89%
controls:3.75%
cases:27.64%
controls:19.12%
cases:43.44%
controls:37.14%
621
5633
1461
15103
593
3786
1489
16950
255
795
1827
19941
174
63
1908
20673
288
777
1785
19924
554
3835
1450
16218
735
6227
957
10541
Specific gravity of Urine by Test strip
5811-5 [3000330]
5.0e-01
1.3e+00
3.1e+00
1.0e+50
1.7e+00
1.3e+00
4.2e-01
cases:1.78%
controls:1.08%
cases:2.11%
controls:0.58%
cases:1.73%
controls:0.08%
cases:0.34%
controls:0.00%
cases:0.48%
controls:0.09%
cases:2.20%
controls:0.63%
cases:3.25%
controls:2.16%
37
224
2045
20512
44
121
2038
20615
36
16
2046
20720
7
0
2075
20736
10
19
2063
20682
44
127
1960
19926
55
362
1637
16406
Acute prostatitis
N41.0 [45563017]
1.1e+00
2.5e+00
—
—
—
2.3e+00
1.3e+00
cases:0.67%
controls:0.22%
cases:0.72%
controls:0.06%
—
—
—
—
—
—
cases:0.30%
controls:0.03%
cases:0.89%
controls:0.23%
14
46
2068
20690
15
12
2067
20724
—
—
—
6
6
1998
20047
15
39
1677
16729
ABO and Rh group [Type] in Blood
882-1 [3003694]
3.7e-01
9.1e-01
2.1e+00
1.0e+50
2.8e+00
1.1e+00
-1.9e-01
cases:5.96%
controls:4.20%
cases:3.22%
controls:1.33%
cases:1.06%
controls:0.13%
cases:0.62%
controls:0.00%
cases:2.41%
controls:0.15%
cases:3.94%
controls:1.32%
cases:4.20%
controls:5.01%
124
871
1958
19865
67
275
2015
20461
22
27
2060
20709
13
0
2069
20736
50
32
2023
20669
79
265
1925
19788
71
840
1621
15928
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
2.9e-01
5.1e-01
9.8e-01
3.7e+00
1.0e+00
4.2e-01
3.3e-01
cases:12.82%
controls:9.96%
cases:9.75%
controls:6.09%
cases:3.41%
controls:1.30%
cases:2.64%
controls:0.07%
cases:3.28%
controls:1.21%
cases:8.98%
controls:6.10%
cases:19.74%
controls:15.01%
267
2065
1815
18671
203
1263
1879
19473
71
270
2011
20466
55
14
2027
20722
68
250
2005
20451
180
1224
1824
18829
334
2517
1358
14251
EKG study
11524-6 [3013512]
2.4e-01
5.1e-01
1.5e+00
2.7e+00
1.4e+00
6.2e-01
4.8e-01
cases:9.75%
controls:7.80%
cases:7.25%
controls:4.50%
cases:2.45%
controls:0.56%
cases:0.43%
controls:0.03%
cases:2.36%
controls:0.57%
cases:8.43%
controls:4.73%
cases:17.55%
controls:11.62%
203
1618
1879
19118
151
933
1931
19803
51
117
2031
20619
9
6
2073
20730
49
119
2024
20582
169
948
1835
19105
297
1949
1395
14819
Cystitis, unspecified
N30.9 [45606488]
1.5e+00
2.5e+00
—
1.0e+50
—
2.1e+00
1.1e+00
cases:1.59%
controls:0.34%
cases:1.39%
controls:0.12%
—
—
cases:0.24%
controls:0.00%
—
—
cases:1.20%
controls:0.15%
cases:2.07%
controls:0.70%
33
71
2049
20665
29
25
2053
20711
—
5
0
2077
20736
—
24
30
1980
20023
35
117
1657
16651
Other operations on bladder
KCW96 [2001305992]
1.9e+00
—
—
—
—
2.8e+00
2.5e+00
cases:0.43%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.03%
cases:0.71%
controls:0.06%
9
14
2073
20722
—
—
—
—
10
6
1994
20047
12
10
1680
16758
Inpatient Visit
IP [9201]
4.2e-01
7.5e-01
9.4e-01
—
2.9e+00
1.5e+00
5.7e-01
cases:10.66%
controls:7.27%
cases:6.58%
controls:3.22%
cases:1.01%
controls:0.40%
—
—
cases:5.64%
controls:0.33%
cases:14.67%
controls:3.57%
cases:17.26%
controls:10.54%
222
1508
1860
19228
137
667
1945
20069
21
82
2061
20654
—
117
69
1956
20632
294
715
1710
19338
292
1768
1400
15000
Physiologic investigation of micturition
XKD06 [2001306098]
1.3e+00
2.2e+00
—
—
—
2.4e+00
1.3e+00
cases:1.30%
controls:0.37%
cases:0.62%
controls:0.07%
—
—
—
—
—
—
cases:0.75%
controls:0.07%
cases:0.95%
controls:0.27%
27
76
2055
20660
13
15
2069
20721
—
—
—
15
14
1989
20039
16
45
1676
16723
Supraglottic ventilation device
WX702 [2001310818]
5.1e-01
1.4e+00
—
1.0e+50
3.2e+00
2.5e+00
6.6e-01
cases:0.77%
controls:0.46%
cases:0.53%
controls:0.13%
—
—
cases:0.58%
controls:0.00%
cases:0.58%
controls:0.02%
cases:1.25%
controls:0.10%
cases:1.12%
controls:0.58%
16
96
2066
20640
11
27
2071
20709
—
12
0
2070
20736
12
5
2061
20696
25
21
1979
20032
19
98
1673
16670
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.1e-01
3.6e-01
1.4e+00
3.3e+00
1.4e+00
3.3e-01
1.9e-01
cases:25.55%
controls:23.57%
cases:28.10%
controls:21.41%
cases:17.00%
controls:4.61%
cases:6.68%
controls:0.27%
cases:17.08%
controls:4.76%
cases:29.09%
controls:22.75%
cases:40.96%
controls:36.43%
532
4888
1550
15848
585
4440
1497
16296
354
955
1728
19781
139
55
1943
20681
354
985
1719
19716
583
4563
1421
15490
693
6109
999
10659
Urinary symptom/complaint other
U29 [2002001149]
1.2e+00
2.4e+00
—
—
—
2.2e+00
1.2e+00
cases:0.96%
controls:0.29%
cases:1.30%
controls:0.12%
—
—
—
—
—
—
cases:0.75%
controls:0.08%
cases:1.12%
controls:0.36%
20
61
2062
20675
27
24
2055
20712
—
—
—
15
16
1989
20037
19
60
1673
16708
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
5.5e-01
1.3e+00
2.6e+00
1.0e+50
1.7e+00
8.8e-01
2.4e-01
cases:5.96%
controls:3.52%
cases:6.92%
controls:2.01%
cases:3.94%
controls:0.29%
cases:0.72%
controls:0.00%
cases:1.59%
controls:0.31%
cases:5.69%
controls:2.45%
cases:10.05%
controls:8.10%
124
730
1958
20006
144
417
1938
20319
82
61
2000
20675
15
0
2067
20736
33
64
2040
20637
114
491
1890
19562
170
1358
1522
15410
Counselling and guidance which enhance independent living
R2130 [2001310196]
2.3e-01
3.3e-01
2.0e+00
1.0e+50
2.7e+00
1.6e+00
6.4e-01
cases:1.34%
controls:1.07%
cases:0.67%
controls:0.48%
cases:0.38%
controls:0.05%
cases:0.48%
controls:0.00%
cases:0.68%
controls:0.04%
cases:1.80%
controls:0.37%
cases:2.66%
controls:1.43%
28
222
2054
20514
14
100
2068
20636
8
11
2074
20725
10
0
2072
20736
14
9
2059
20692
36
74
1968
19979
45
239
1647
16529
tamsulosin; oral
G04CA02 [21602669]
5.8e-01
7.7e-01
9.0e-01
2.8e+00
1.4e+00
4.9e-01
1.9e-01
cases:18.49%
controls:11.27%
cases:15.37%
controls:7.76%
cases:5.48%
controls:2.30%
cases:1.73%
controls:0.11%
cases:7.48%
controls:1.95%
cases:12.03%
controls:7.72%
cases:15.43%
controls:13.07%
385
2336
1697
18400
320
1609
1762
19127
114
477
1968
20259
36
23
2046
20713
155
404
1918
20297
241
1548
1763
18505
261
2191
1431
14577
Dysuria/painful urination
U01 [2002001137]
5.6e-01
2.4e+00
2.6e+00
—
—
1.8e+00
8.4e-01
cases:0.91%
controls:0.53%
cases:1.30%
controls:0.12%
cases:0.34%
controls:0.02%
—
—
—
—
cases:0.80%
controls:0.13%
cases:1.00%
controls:0.44%
19
109
2063
20627
27
24
2055
20712
7
5
2075
20731
—
—
16
26
1988
20027
17
73
1675
16695
Extensive abdominal CT
JN3BD [2001305556]
6.0e-01
1.6e+00
2.4e+00
1.0e+50
—
1.4e+00
8.5e-01
cases:2.11%
controls:1.17%
cases:1.39%
controls:0.29%
cases:0.38%
controls:0.03%
cases:0.77%
controls:0.00%
—
—
cases:0.75%
controls:0.19%
cases:2.01%
controls:0.87%
44
242
2038
20494
29
61
2053
20675
8
7
2074
20729
16
0
2066
20736
—
15
38
1989
20015
34
146
1658
16622
Catheterisation instruction
TKC22 [2001306021]
1.3e+00
1.6e+00
—
—
—
2.6e+00
1.3e+00
cases:1.30%
controls:0.35%
cases:0.77%
controls:0.16%
—
—
—
—
—
—
cases:1.10%
controls:0.08%
cases:1.30%
controls:0.36%
27
73
2055
20663
16
33
2066
20703
—
—
—
22
16
1982
20037
22
60
1670
16708
Transluminal endoscopic removal of stent from ureter
KBV12 [2001305895]
3.2e+00
—
1.0e+50
1.0e+50
1.0e+50
—
3.7e+00
cases:1.01%
controls:0.04%
—
—
cases:0.24%
controls:0.00%
cases:0.58%
controls:0.00%
cases:0.34%
controls:0.00%
—
—
cases:1.60%
controls:0.04%
21
9
2061
20727
—
5
0
2077
20736
12
0
2070
20736
7
0
2066
20701
—
27
7
1665
16761
Stress incontinence
N39.3 [45539046]
1.2e+00
1.8e+00
—
—
—
2.4e+00
1.5e+00
cases:0.77%
controls:0.24%
cases:0.67%
controls:0.11%
—
—
—
—
—
—
cases:1.30%
controls:0.12%
cases:1.12%
controls:0.26%
16
50
2066
20686
14
23
2068
20713
—
—
—
26
25
1978
20028
19
43
1673
16725
norfloxacin; oral
J01MA06 [21603013]
1.3e+00
2.3e+00
—
—
—
2.1e+00
1.1e+00
cases:2.79%
controls:0.78%
cases:1.63%
controls:0.17%
—
—
—
—
—
—
cases:1.50%
controls:0.18%
cases:1.83%
controls:0.63%
58
161
2024
20575
34
35
2048
20701
—
—
—
30
36
1974
20017
31
105
1661
16663
Transurethral resection of bladder
KCD02 [2001305938]
8.7e-01
1.9e+00
—
1.0e+50
—
2.8e+00
1.2e+00
cases:0.96%
controls:0.41%
cases:0.82%
controls:0.12%
—
—
cases:0.96%
controls:0.00%
—
—
cases:1.40%
controls:0.08%
cases:1.30%
controls:0.40%
20
84
2062
20652
17
25
2065
20711
—
20
0
2062
20736
—
28
17
1976
20036
22
67
1670
16701
Internal urethrotomy
KDV10 [2001306084]
1.6e+00
—
—
1.0e+50
1.0e+50
3.1e+00
2.1e+00
cases:0.77%
controls:0.15%
—
—
—
—
cases:0.91%
controls:0.00%
cases:0.43%
controls:0.00%
cases:0.85%
controls:0.04%
cases:0.77%
controls:0.10%
16
32
2066
20704
—
—
19
0
2063
20736
9
0
2064
20701
17
8
1987
20045
13
16
1679
16752
Urethral stricture, unspecified
N35.9 [45543870]
8.9e-01
1.9e+00
—
1.0e+50
—
2.8e+00
2.1e+00
cases:0.48%
controls:0.20%
cases:0.77%
controls:0.12%
—
—
cases:0.77%
controls:0.00%
—
—
cases:1.40%
controls:0.09%
cases:1.77%
controls:0.22%
10
41
2072
20695
16
24
2066
20712
—
16
0
2066
20736
—
28
18
1976
20035
30
37
1662
16731
Urethroscopic internal urethrotomy
KDV12 [2001306085]
1.6e+00
3.0e+00
—
1.0e+50
1.0e+50
—
2.2e+00
cases:0.91%
controls:0.19%
cases:0.67%
controls:0.03%
—
—
cases:0.82%
controls:0.00%
cases:0.53%
controls:0.00%
—
—
cases:1.36%
controls:0.16%
19
40
2063
20696
14
7
2068
20729
—
17
0
2065
20736
11
0
2062
20701
—
23
26
1669
16742
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
6.4e-02
3.3e-01
1.4e+00
3.3e+00
1.4e+00
3.0e-01
1.6e-01
cases:36.17%
controls:34.70%
cases:37.85%
controls:30.49%
cases:23.05%
controls:6.75%
cases:9.32%
controls:0.39%
cases:22.82%
controls:6.85%
cases:38.57%
controls:31.78%
cases:52.07%
controls:47.98%
753
7195
1329
13541
788
6322
1294
14414
480
1399
1602
19337
194
81
1888
20655
473
1418
1600
19283
773
6373
1231
13680
881
8045
811
8723
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
3.4e-01
7.7e-01
1.7e+00
—
2.1e+00
1.2e+00
5.7e-01
cases:8.12%
controls:5.92%
cases:5.19%
controls:2.46%
cases:2.16%
controls:0.40%
—
—
cases:2.99%
controls:0.38%
cases:7.44%
controls:2.36%
cases:12.06%
controls:7.16%
169
1227
1913
19509
108
511
1974
20225
45
83
2037
20653
—
62
78
2011
20623
149
473
1855
19580
204
1201
1488
15567
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
8.0e-02
3.1e-01
1.2e+00
3.3e+00
1.4e+00
2.8e-01
1.7e-01
cases:34.77%
controls:32.99%
cases:34.25%
controls:27.65%
cases:17.29%
controls:5.71%
cases:8.98%
controls:0.38%
cases:20.26%
controls:5.82%
cases:35.13%
controls:28.95%
cases:50.18%
controls:45.91%
724
6840
1358
13896
713
5733
1369
15003
360
1184
1722
19552
187
79
1895
20657
420
1205
1653
19496
704
5806
1300
14247
849
7698
843
9070
CBC panel - Blood by Automated count
58410-2 [40761511]
5.8e-02
3.6e-01
1.2e+00
3.1e+00
1.4e+00
3.8e-01
2.0e-01
cases:31.60%
controls:30.36%
cases:28.15%
controls:21.41%
cases:12.97%
controls:4.18%
cases:4.66%
controls:0.22%
cases:14.62%
controls:4.16%
cases:28.89%
controls:21.74%
cases:43.79%
controls:38.84%
658
6296
1424
14440
586
4439
1496
16297
270
867
1812
19869
97
45
1985
20691
303
862
1770
19839
579
4360
1425
15693
741
6513
951
10255
Haematuria
U06 [2002001141]
1.4e+00
2.7e+00
—
—
—
1.4e+00
1.1e+00
cases:1.20%
controls:0.31%
cases:1.78%
controls:0.12%
—
—
—
—
—
—
cases:0.55%
controls:0.13%
cases:1.36%
controls:0.44%
25
64
2057
20672
37
25
2045
20711
—
—
—
11
27
1993
20026
23
73
1669
16695
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
2.1e-01
4.3e-01
9.3e-01
3.5e+00
8.1e-01
3.5e-01
3.5e-01
cases:21.90%
controls:18.48%
cases:17.58%
controls:12.18%
cases:5.67%
controls:2.32%
cases:2.88%
controls:0.09%
cases:5.11%
controls:2.33%
cases:16.47%
controls:12.18%
cases:32.74%
controls:25.45%
456
3831
1626
16905
366
2526
1716
18210
118
481
1964
20255
60
18
2022
20718
106
483
1967
20218
330
2443
1674
17610
554
4268
1138
12500
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
8.4e-02
3.2e-01
1.3e+00
3.3e+00
1.4e+00
3.0e-01
1.7e-01
cases:34.68%
controls:32.81%
cases:34.05%
controls:27.34%
cases:17.20%
controls:5.54%
cases:9.08%
controls:0.37%
cases:20.26%
controls:5.71%
cases:34.98%
controls:28.59%
cases:49.88%
controls:45.71%
722
6803
1360
13933
709
5670
1373
15066
358
1148
1724
19588
189
77
1893
20659
420
1181
1653
19520
701
5733
1303
14320
844
7665
848
9103
Normoblasts [#/volume] in Blood
715-3 [3021589]
9.4e-02
4.3e-01
1.2e+00
3.0e+00
1.2e+00
4.3e-01
2.7e-01
cases:9.08%
controls:8.33%
cases:10.13%
controls:6.86%
cases:4.61%
controls:1.48%
cases:1.68%
controls:0.08%
cases:4.97%
controls:1.48%
cases:11.18%
controls:7.55%
cases:17.79%
controls:14.13%
189
1728
1893
19008
211
1422
1871
19314
96
306
1986
20430
35
17
2047
20719
103
306
1970
20395
224
1513
1780
18540
301
2370
1391
14398
Retrograde ureteroscopy
UKB02 [2001305907]
2.7e+00
—
—
1.0e+50
1.0e+50
—
3.9e+00
cases:0.58%
controls:0.04%
—
—
—
—
cases:0.86%
controls:0.00%
cases:0.68%
controls:0.00%
—
—
cases:1.42%
controls:0.03%
12
8
2070
20728
—
—
18
0
2064
20736
14
0
2059
20701
—
24
5
1668
16763
Erythrocytes [Presence] in Urine
33051-4 [3045424]
—
1.7e+00
3.0e+00
—
—
1.1e+00
7.2e-01
—
—
cases:0.86%
controls:0.16%
cases:0.48%
controls:0.02%
—
—
—
—
cases:0.85%
controls:0.28%
cases:2.07%
controls:1.02%
—
18
33
2064
20703
10
5
2072
20731
—
—
17
56
1987
19997
35
171
1657
16597
Supplier / Service Provider
OMOP5117446 [33004]
-8.0e-01
-5.8e-01
-1.3e-01
—
2.7e+00
2.5e+00
2.7e+00
cases:13.83%
controls:26.41%
cases:4.61%
controls:7.94%
cases:0.72%
controls:0.82%
—
—
cases:1.54%
controls:0.10%
cases:6.14%
controls:0.54%
cases:14.13%
controls:1.13%
288
5476
1794
15260
96
1647
1986
19089
15
170
2067
20566
—
32
21
2041
20680
123
108
1881
19945
239
190
1453
16578
Urine culture
117010004 [4024509]
—
1.7e+00
2.5e+00
—
2.3e+00
1.1e+00
5.2e-01
—
—
cases:0.77%
controls:0.14%
cases:0.58%
controls:0.05%
—
—
cases:0.39%
controls:0.04%
cases:0.65%
controls:0.21%
cases:1.60%
controls:0.95%
—
16
29
2066
20707
12
10
2070
20726
—
8
8
2065
20693
13
42
1991
20011
27
160
1665
16608
Crohn disease of small intestine
K50.0 [45596324]
2.0e+00
1.9e+00
—
—
—
2.3e+00
2.2e+00
cases:0.62%
controls:0.08%
cases:0.29%
controls:0.04%
—
—
—
—
—
—
cases:0.45%
controls:0.04%
cases:0.77%
controls:0.09%
13
17
2069
20719
6
9
2076
20727
—
—
—
9
9
1995
20044
13
15
1679
16753
Neoplasm of uncertain or unknown behaviour: Bladder
D41.4 [45537910]
1.3e+00
2.3e+00
—
1.0e+50
—
2.8e+00
2.1e-01
cases:0.72%
controls:0.19%
cases:0.86%
controls:0.09%
—
—
cases:1.06%
controls:0.00%
—
—
cases:1.30%
controls:0.08%
cases:0.35%
controls:0.29%
15
40
2067
20696
18
18
2064
20718
—
22
0
2060
20736
—
26
16
1978
20037
6
48
1686
16720
Incontinence urine
U04 [2002001139]
5.3e-01
1.7e+00
1.1e+00
—
2.6e+00
1.2e+00
1.0e+00
cases:0.86%
controls:0.51%
cases:1.25%
controls:0.24%
cases:0.24%
controls:0.08%
—
—
cases:0.43%
controls:0.03%
cases:1.05%
controls:0.32%
cases:2.25%
controls:0.83%
18
106
2064
20630
26
50
2056
20686
5
16
2077
20720
—
9
7
2064
20694
21
64
1983
19989
38
139
1654
16629
tranexamic acid; oral, parenteral
B02AA02 [21601036]
7.0e-01
1.4e+00
—
—
3.1e+00
1.1e+00
4.4e-01
cases:1.68%
controls:0.84%
cases:0.86%
controls:0.21%
—
—
—
—
cases:0.77%
controls:0.03%
cases:0.80%
controls:0.27%
cases:1.24%
controls:0.80%
35
174
2047
20562
18
43
2064
20693
—
—
16
7
2057
20694
16
54
1988
19999
21
134
1671
16634
12 lead EKG panel
34534-8 [3044889]
4.0e-02
2.1e-01
1.2e+00
3.0e+00
1.7e+00
4.4e-01
3.6e-02
cases:19.60%
controls:18.98%
cases:12.63%
controls:10.49%
cases:4.13%
controls:1.24%
cases:0.77%
controls:0.04%
cases:6.17%
controls:1.20%
cases:15.12%
controls:10.31%
cases:25.41%
controls:24.74%
408
3935
1674
16801
263
2176
1819
18560
86
258
1996
20478
16
8
2066
20728
128
249
1945
20452
303
2067
1701
17986
430
4149
1262
12619
alfuzosin; oral
G04CA01 [21602668]
7.1e-01
9.5e-01
7.5e-01
2.5e+00
1.0e+00
4.6e-01
2.4e-01
cases:7.54%
controls:3.85%
cases:5.81%
controls:2.34%
cases:1.54%
controls:0.73%
cases:0.34%
controls:0.03%
cases:1.83%
controls:0.67%
cases:3.89%
controls:2.50%
cases:5.91%
controls:4.72%
157
798
1925
19938
121
485
1961
20251
32
152
2050
20584
7
6
2075
20730
38
138
2035
20563
78
502
1926
19551
100
792
1592
15976
solifenacin; oral
G04BD08 [21602641]
7.8e-01
1.5e+00
1.1e+00
—
1.6e+00
1.5e+00
9.7e-01
cases:2.02%
controls:0.94%
cases:2.11%
controls:0.49%
cases:0.43%
controls:0.14%
—
—
cases:0.53%
controls:0.11%
cases:2.10%
controls:0.45%
cases:2.36%
controls:0.91%
42
194
2040
20542
44
102
2038
20634
9
29
2073
20707
—
11
23
2062
20678
42
91
1962
19962
40
153
1652
16615
Other specified urinary incontinence
N39.4 [45577525]
7.2e-01
1.3e+00
2.6e+00
—
1.7e+00
1.7e+00
7.9e-01
cases:1.10%
controls:0.54%
cases:0.86%
controls:0.25%
cases:0.38%
controls:0.03%
—
—
cases:0.24%
controls:0.04%
cases:1.40%
controls:0.26%
cases:2.01%
controls:0.92%
23
112
2059
20624
18
51
2064
20685
8
6
2074
20730
—
5
9
2068
20692
28
53
1976
20000
34
154
1658
16614
More than one and less than three hours
ZXE10 [2001311401]
2.5e-01
8.6e-01
9.9e-01
1.0e+50
2.8e+00
1.7e+00
9.0e-01
cases:7.64%
controls:6.05%
cases:3.17%
controls:1.37%
cases:0.34%
controls:0.13%
cases:2.55%
controls:0.00%
cases:2.32%
controls:0.14%
cases:5.89%
controls:1.12%
cases:8.51%
controls:3.66%
159
1255
1923
19481
66
284
2016
20452
7
26
2075
20710
53
0
2029
20736
48
30
2025
20671
118
224
1886
19829
144
613
1548
16155
Orchitis, epididymitis and epididymo-orchitis without abscess
N45.9 [45548671]
9.9e-01
1.6e+00
—
—
—
2.6e+00
1.0e+00
cases:0.72%
controls:0.27%
cases:0.48%
controls:0.10%
—
—
—
—
—
—
cases:0.55%
controls:0.04%
cases:1.06%
controls:0.38%
15
56
2067
20680
10
20
2072
20716
—
—
—
11
8
1993
20045
18
64
1674
16704
Specific gravity of Urine by Refractometry
5810-7 [3019150]
2.9e-01
1.0e+00
2.5e+00
—
1.9e+00
8.1e-01
2.0e-01
cases:6.20%
controls:4.72%
cases:7.11%
controls:2.66%
cases:4.76%
controls:0.40%
—
—
cases:2.41%
controls:0.39%
cases:6.44%
controls:2.97%
cases:9.81%
controls:8.16%
129
978
1953
19758
148
551
1934
20185
99
83
1983
20653
—
50
80
2023
20621
129
596
1875
19457
166
1369
1526
15399
tamsulosin and dutasteride
G04CA52 [21602673]
5.8e-01
7.5e-01
9.2e-01
3.4e+00
5.3e-01
5.5e-01
9.6e-03
cases:6.68%
controls:3.86%
cases:6.34%
controls:3.09%
cases:2.45%
controls:0.99%
cases:0.72%
controls:0.02%
cases:1.59%
controls:0.94%
cases:5.64%
controls:3.32%
cases:5.61%
controls:5.56%
139
800
1943
19936
132
641
1950
20095
51
205
2031
20531
15
5
2067
20731
33
195
2040
20506
113
666
1891
19387
95
933
1597
15835
Platelets [#/volume] in Blood
26515-7 [3007461]
5.1e-02
3.0e-01
1.2e+00
3.2e+00
1.3e+00
2.7e-01
1.2e-01
cases:36.84%
controls:35.65%
cases:38.04%
controls:31.33%
cases:20.27%
controls:7.26%
cases:9.46%
controls:0.43%
cases:22.05%
controls:7.34%
cases:39.17%
controls:32.88%
cases:52.36%
controls:49.46%
767
7393
1315
13343
792
6497
1290
14239
422
1506
1660
19230
197
89
1885
20647
457
1519
1616
19182
785
6594
1219
13459
886
8294
806
8474
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
4.6e-02
3.0e-01
1.2e+00
3.2e+00
1.3e+00
2.7e-01
1.2e-01
cases:36.84%
controls:35.77%
cases:38.14%
controls:31.46%
cases:20.27%
controls:7.32%
cases:9.51%
controls:0.43%
cases:22.09%
controls:7.37%
cases:39.32%
controls:33.01%
cases:52.42%
controls:49.54%
767
7418
1315
13318
794
6523
1288
14213
422
1517
1660
19219
198
89
1884
20647
458
1525
1615
19176
788
6619
1216
13434
887
8307
805
8461
MCH [Entitic mass]
28539-5 [3035941]
4.9e-02
2.9e-01
1.2e+00
3.2e+00
1.3e+00
2.7e-01
1.1e-01
cases:36.84%
controls:35.70%
cases:37.99%
controls:31.38%
cases:20.22%
controls:7.27%
cases:9.46%
controls:0.43%
cases:22.05%
controls:7.35%
cases:39.17%
controls:32.89%
cases:52.30%
controls:49.47%
767
7402
1315
13334
791
6506
1291
14230
421
1508
1661
19228
197
89
1885
20647
457
1521
1616
19180
785
6596
1219
13457
885
8295
807
8473
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
4.8e-02
2.9e-01
1.2e+00
3.2e+00
1.3e+00
2.7e-01
1.1e-01
cases:36.84%
controls:35.73%
cases:38.04%
controls:31.42%
cases:20.22%
controls:7.28%
cases:9.46%
controls:0.43%
cases:22.05%
controls:7.35%
cases:39.17%
controls:32.93%
cases:52.36%
controls:49.50%
767
7410
1315
13326
792
6515
1290
14221
421
1510
1661
19226
197
89
1885
20647
457
1521
1616
19180
785
6604
1219
13449
886
8300
806
8468
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
4.8e-02
2.9e-01
1.2e+00
3.2e+00
1.3e+00
2.7e-01
1.1e-01
cases:36.84%
controls:35.73%
cases:37.99%
controls:31.43%
cases:20.27%
controls:7.28%
cases:9.46%
controls:0.43%
cases:22.05%
controls:7.35%
cases:39.17%
controls:32.96%
cases:52.36%
controls:49.50%
767
7410
1315
13326
791
6517
1291
14219
422
1510
1660
19226
197
89
1885
20647
457
1521
1616
19180
785
6609
1219
13444
886
8300
806
8468
Leukocytes [#/volume] in Blood
26464-8 [3010813]
4.9e-02
2.9e-01
1.2e+00
3.2e+00
1.3e+00
2.8e-01
1.2e-01
cases:36.89%
controls:35.75%
cases:38.09%
controls:31.43%
cases:20.27%
controls:7.31%
cases:9.41%
controls:0.43%
cases:22.05%
controls:7.37%
cases:39.32%
controls:32.97%
cases:52.42%
controls:49.49%
768
7414
1314
13322
793
6517
1289
14219
422
1515
1660
19221
196
89
1886
20647
457
1525
1616
19176
788
6611
1216
13442
887
8299
805
8469
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
4.7e-02
2.9e-01
1.2e+00
3.2e+00
1.3e+00
2.8e-01
1.2e-01
cases:36.84%
controls:35.75%
cases:38.04%
controls:31.41%
cases:20.27%
controls:7.30%
cases:9.46%
controls:0.43%
cases:22.05%
controls:7.38%
cases:39.27%
controls:32.93%
cases:52.36%
controls:49.48%
767
7413
1315
13323
792
6514
1290
14222
422
1514
1660
19222
197
90
1885
20646
457
1528
1616
19173
787
6603
1217
13450
886
8297
806
8471
Other primary hyperparathyroidism
E21.09 [2000501463]
1.5e+00
2.0e+00
—
—
—
3.1e+00
2.9e+00
cases:0.34%
controls:0.08%
cases:0.24%
controls:0.03%
—
—
—
—
—
—
cases:0.55%
controls:0.02%
cases:1.12%
controls:0.06%
7
16
2075
20720
5
7
2077
20729
—
—
—
11
5
1993
20048
19
10
1673
16758
Short blood count panel - Blood
55429-5 [40758558]
9.7e-02
4.5e-01
9.7e-01
3.3e+00
8.5e-01
4.5e-01
2.3e-01
cases:5.14%
controls:4.69%
cases:4.27%
controls:2.77%
cases:1.68%
controls:0.64%
cases:0.91%
controls:0.03%
cases:1.50%
controls:0.65%
cases:4.39%
controls:2.85%
cases:8.45%
controls:6.82%
107
972
1975
19764
89
575
1993
20161
35
133
2047
20603
19
7
2063
20729
31
134
2042
20567
88
571
1916
19482
143
1143
1549
15625
Neoplasm of uncertain or unknown behaviour: Kidney
D41.0 [45581311]
1.3e-01
1.4e+00
2.2e+00
—
2.5e+00
1.1e+00
5.7e-01
cases:0.43%
controls:0.38%
cases:0.62%
controls:0.16%
cases:0.34%
controls:0.04%
—
—
cases:0.34%
controls:0.03%
cases:0.55%
controls:0.19%
cases:0.65%
controls:0.37%
9
79
2073
20657
13
33
2069
20703
7
8
2075
20728
—
7
6
2066
20695
11
38
1993
20015
11
62
1681
16706
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
1.8e-01
5.3e-01
9.7e-01
2.2e+00
1.2e+00
7.1e-01
4.1e-01
cases:11.67%
controls:9.94%
cases:9.51%
controls:5.81%
cases:2.83%
controls:1.09%
cases:0.67%
controls:0.08%
cases:3.33%
controls:1.05%
cases:12.18%
controls:6.35%
cases:21.93%
controls:15.71%
243
2062
1839
18674
198
1204
1884
19532
59
226
2023
20510
14
16
2068
20720
69
218
2004
20483
244
1274
1760
18779
371
2634
1321
14134
Dysuria
R30.0 [45592416]
1.3e+00
2.8e+00
—
—
—
1.8e+00
5.5e-01
cases:0.96%
controls:0.27%
cases:1.15%
controls:0.07%
—
—
—
—
—
—
cases:0.50%
controls:0.08%
cases:0.71%
controls:0.41%
20
56
2062
20680
24
14
2058
20722
—
—
—
10
16
1994
20037
12
69
1680
16699
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
2.2e-01
9.7e-01
2.3e+00
—
1.8e+00
8.0e-01
1.9e-01
cases:4.90%
controls:3.96%
cases:6.34%
controls:2.50%
cases:4.03%
controls:0.41%
—
—
cases:2.41%
controls:0.40%
cases:5.99%
controls:2.78%
cases:9.22%
controls:7.78%
102
821
1980
19915
132
518
1950
20218
84
85
1998
20651
—
50
82
2023
20619
120
557
1884
19496
156
1305
1536
15463
Internal Medicine
11 [38004456]
7.9e-02
4.5e-01
7.6e-01
3.4e+00
6.9e-01
3.0e-01
2.4e-01
cases:26.27%
controls:24.78%
cases:15.61%
controls:10.58%
cases:3.46%
controls:1.65%
cases:1.92%
controls:0.06%
cases:3.09%
controls:1.57%
cases:13.22%
controls:10.12%
cases:28.61%
controls:23.97%
547
5138
1535
15598
325
2194
1757
18542
72
342
2010
20394
40
13
2042
20723
64
324
2009
20377
265
2030
1739
18023
484
4020
1208
12748
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-2.0e-02
1.7e-01
1.1e+00
3.3e+00
1.3e+00
2.0e-01
5.5e-02
cases:21.85%
controls:22.19%
cases:22.09%
controls:19.27%
cases:12.54%
controls:4.48%
cases:6.82%
controls:0.27%
cases:14.66%
controls:4.65%
cases:23.75%
controls:20.36%
cases:33.98%
controls:32.75%
455
4602
1627
16134
460
3996
1622
16740
261
928
1821
19808
142
57
1940
20679
304
962
1769
19739
476
4082
1528
15971
575
5492
1117
11276
enzalutamide; oral
L02BB04 [45893476]
1.5e+00
1.7e+00
1.7e+00
—
1.6e+00
1.4e+00
1.1e+00
cases:0.29%
controls:0.06%
cases:0.62%
controls:0.12%
cases:0.43%
controls:0.08%
—
—
cases:0.39%
controls:0.08%
cases:0.55%
controls:0.14%
cases:0.77%
controls:0.25%
6
13
2076
20723
13
24
2069
20712
9
17
2073
20719
—
8
17
2065
20684
11
28
1993
20025
13
42
1679
16726
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
3.0e-01
3.4e-01
6.7e-01
3.1e+00
1.2e+00
7.3e-01
4.8e-01
cases:9.65%
controls:7.33%
cases:4.03%
controls:2.91%
cases:1.20%
controls:0.62%
cases:0.77%
controls:0.03%
cases:1.83%
controls:0.56%
cases:5.74%
controls:2.86%
cases:10.87%
controls:7.01%
201
1520
1881
19216
84
604
1998
20132
25
128
2057
20608
16
7
2066
20729
38
116
2035
20585
115
573
1889
19480
184
1176
1508
15592
Laboratory Visit
OMOP4822461 [32036]
4.9e-02
2.4e-01
1.3e+00
3.0e+00
1.0e+00
2.5e-01
8.7e-02
cases:39.87%
controls:38.70%
cases:42.75%
controls:37.04%
cases:35.78%
controls:12.72%
cases:14.22%
controls:0.85%
cases:29.38%
controls:12.79%
cases:44.96%
controls:38.85%
cases:54.61%
controls:52.46%
830
8024
1252
12712
890
7681
1192
13055
745
2637
1337
18099
296
176
1786
20560
609
2648
1464
18053
901
7790
1103
12263
924
8796
768
7972
General anaesthesia
WX402 [2001310806]
4.7e-01
8.2e-01
—
1.0e+50
2.9e+00
1.6e+00
5.5e-01
cases:2.79%
controls:1.76%
cases:2.45%
controls:1.09%
—
—
cases:1.20%
controls:0.00%
cases:1.83%
controls:0.11%
cases:4.94%
controls:1.09%
cases:5.50%
controls:3.24%
58
365
2024
20371
51
227
2031
20509
—
25
0
2057
20736
38
22
2035
20679
99
218
1905
19835
93
544
1599
16224
Bladder-neck obstruction
N32.0 [45567838]
6.1e-01
1.7e+00
—
1.0e+50
—
3.4e+00
2.4e+00
cases:0.24%
controls:0.13%
cases:0.34%
controls:0.06%
—
—
cases:0.38%
controls:0.00%
—
—
cases:0.85%
controls:0.03%
cases:0.83%
controls:0.08%
5
27
2077
20709
7
13
2075
20723
—
8
0
2074
20736
—
17
6
1987
20047
14
13
1678
16755
Postprocedural urethral stricture
N99.1 [45543906]
1.0e+00
2.7e+00
—
1.0e+50
—
—
3.0e+00
cases:0.34%
controls:0.12%
cases:0.43%
controls:0.03%
—
—
cases:0.53%
controls:0.00%
—
—
—
—
cases:1.36%
controls:0.07%
7
25
2075
20711
9
6
2073
20730
—
11
0
2071
20736
—
—
23
12
1669
16756
Cystoscopic destruction of tumour of bladder
KCD32 [2001305945]
1.4e+00
1.8e+00
—
—
—
2.4e+00
1.8e+00
cases:0.53%
controls:0.13%
cases:0.24%
controls:0.04%
—
—
—
—
—
—
cases:0.45%
controls:0.04%
cases:0.65%
controls:0.11%
11
27
2071
20709
5
8
2077
20728
—
—
—
9
8
1995
20045
11
18
1681
16750
Lavation of bladder for coagulated blood
KCW02 [2001306014]
1.3e+00
2.0e+00
—
1.0e+50
1.0e+50
2.3e+00
1.3e+00
cases:0.38%
controls:0.10%
cases:0.34%
controls:0.04%
—
—
cases:0.24%
controls:0.00%
cases:0.24%
controls:0.00%
cases:0.55%
controls:0.05%
cases:0.71%
controls:0.20%
8
21
2074
20715
7
9
2075
20727
—
5
0
2077
20736
5
0
2068
20701
11
11
1993
20042
12
34
1680
16734
Ultrasound examination of uterus and parametria
LC2AE [2001306543]
1.5e+00
1.7e+00
—
—
—
2.5e+00
8.5e-01
cases:0.77%
controls:0.18%
cases:0.38%
controls:0.07%
—
—
—
—
—
—
cases:0.35%
controls:0.03%
cases:0.47%
controls:0.20%
16
37
2066
20699
8
15
2074
20721
—
—
—
7
6
1997
20047
8
34
1684
16734
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
7.3e-02
4.2e-01
8.3e-01
3.0e+00
6.6e-01
3.3e-01
2.5e-01
cases:12.20%
controls:11.44%
cases:11.00%
controls:7.51%
cases:3.94%
controls:1.77%
cases:2.02%
controls:0.10%
cases:3.38%
controls:1.78%
cases:10.38%
controls:7.66%
cases:19.86%
controls:16.12%
254
2373
1828
18363
229
1558
1853
19178
82
366
2000
20370
42
21
2040
20715
70
369
2003
20332
208
1537
1796
18516
336
2703
1356
14065
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
2.0e-01
5.3e-01
9.4e-01
1.8e+00
1.2e+00
6.9e-01
3.1e-01
cases:10.81%
controls:9.06%
cases:8.50%
controls:5.19%
cases:2.45%
controls:0.97%
cases:0.43%
controls:0.07%
cases:2.94%
controls:0.88%
cases:10.43%
controls:5.53%
cases:17.67%
controls:13.54%
225
1878
1857
18858
177
1077
1905
19659
51
201
2031
20535
9
15
2073
20721
61
182
2012
20519
209
1108
1795
18945
299
2271
1393
14497
Bacteria identified in Blood by Culture
600-7 [3023368]
2.6e-01
9.4e-01
1.5e+00
—
1.8e+00
8.0e-01
4.5e-01
cases:6.53%
controls:5.14%
cases:6.29%
controls:2.56%
cases:1.49%
controls:0.34%
—
—
cases:2.27%
controls:0.39%
cases:6.39%
controls:2.96%
cases:13.12%
controls:8.77%
136
1065
1946
19671
131
530
1951
20206
31
71
2051
20665
—
47
80
2026
20621
128
594
1876
19459
222
1470
1470
15298
Oncology Clinic/Center
261QX0200X [38004268]
5.2e-01
6.3e-01
1.5e+00
—
2.1e+00
7.2e-01
1.3e-01
cases:10.95%
controls:6.81%
cases:4.23%
controls:2.29%
cases:0.62%
controls:0.14%
—
—
cases:1.59%
controls:0.20%
cases:3.84%
controls:1.90%
cases:7.86%
controls:6.97%
228
1413
1854
19323
88
475
1994
20261
13
30
2069
20706
—
33
42
2040
20659
77
381
1927
19672
133
1169
1559
15599
Lower urinary tract urodynamic studies
252896003 [4099392]
1.2e+00
1.7e+00
—
—
—
2.2e+00
2.0e+00
cases:0.67%
controls:0.21%
cases:0.34%
controls:0.06%
—
—
—
—
—
—
cases:0.75%
controls:0.08%
cases:0.89%
controls:0.12%
14
44
2068
20692
7
13
2075
20723
—
—
—
15
16
1989
20037
15
20
1677
16748
Office Visit
OMOP4822458 [581477]
2.9e-01
7.4e-01
9.6e-01
—
2.1e+00
8.6e-01
4.2e-01
cases:10.90%
controls:8.41%
cases:4.95%
controls:2.42%
cases:0.82%
controls:0.31%
—
—
cases:2.36%
controls:0.31%
cases:5.14%
controls:2.23%
cases:9.87%
controls:6.71%
227
1743
1855
18993
103
502
1979
20234
17
65
2065
20671
—
49
64
2024
20637
103
448
1901
19605
167
1125
1525
15643
Interstitial cystitis (chronic)
N30.1 [45596860]
2.9e+00
—
—
—
—
—
2.4e+00
cases:0.43%
controls:0.02%
—
—
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.04%
9
5
2073
20731
—
—
—
—
—
8
7
1684
16761
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
2.0e-01
7.1e-01
1.3e+00
—
1.7e+00
1.0e+00
5.3e-01
cases:5.00%
controls:4.11%
cases:3.75%
controls:1.88%
cases:1.25%
controls:0.33%
—
—
cases:1.69%
controls:0.31%
cases:4.84%
controls:1.81%
cases:8.51%
controls:5.18%
104
853
1978
19883
78
389
2004
20347
26
69
2056
20667
—
35
64
2038
20637
97
362
1907
19691
144
869
1548
15899
Pathology report gross observation
24419-4 [3002256]
3.8e-01
8.4e-01
—
1.0e+50
2.3e+00
1.6e+00
4.9e-01
cases:3.07%
controls:2.13%
cases:1.78%
controls:0.78%
—
—
cases:0.86%
controls:0.00%
cases:1.06%
controls:0.11%
cases:3.99%
controls:0.82%
cases:4.37%
controls:2.71%
64
442
2018
20294
37
161
2045
20575
—
18
0
2064
20736
22
22
2051
20679
80
165
1924
19888
74
455
1618
16313
Upper gastrointestinal surgery
106 [44777669]
3.5e-01
8.1e-01
1.3e+00
—
1.4e+00
8.3e-01
5.9e-01
cases:13.40%
controls:9.83%
cases:8.45%
controls:3.94%
cases:2.11%
controls:0.59%
—
—
cases:2.32%
controls:0.60%
cases:8.18%
controls:3.76%
cases:17.85%
controls:10.73%
279
2038
1803
18698
176
818
1906
19918
44
122
2038
20614
—
48
125
2025
20576
164
753
1840
19300
302
1799
1390
14969
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
5.0e-01
4.7e-01
1.6e+00
—
2.3e+00
7.6e-01
2.9e-01
cases:3.41%
controls:2.10%
cases:2.07%
controls:1.30%
cases:1.01%
controls:0.21%
—
—
cases:1.50%
controls:0.15%
cases:2.99%
controls:1.43%
cases:5.73%
controls:4.34%
71
436
2011
20300
43
269
2039
20467
21
43
2061
20693
—
31
32
2042
20669
60
286
1944
19767
97
727
1595
16041
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-9.7e-02
3.1e-03
9.1e-01
3.1e+00
1.0e+00
-5.8e-03
-1.4e-01
cases:24.16%
controls:25.98%
cases:21.57%
controls:21.51%
cases:11.62%
controls:5.01%
cases:6.24%
controls:0.29%
cases:13.31%
controls:5.11%
cases:22.11%
controls:22.21%
cases:32.80%
controls:35.98%
503
5387
1579
15349
449
4461
1633
16275
242
1039
1840
19697
130
60
1952
20676
276
1057
1797
19644
443
4453
1561
15600
555
6033
1137
10735
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
2.5e-01
8.4e-01
2.3e+00
—
1.9e+00
2.9e-01
2.1e-01
cases:1.30%
controls:1.02%
cases:1.34%
controls:0.58%
cases:0.67%
controls:0.07%
—
—
cases:0.53%
controls:0.08%
cases:0.95%
controls:0.71%
cases:2.90%
controls:2.36%
27
211
2055
20525
28
121
2054
20615
14
14
2068
20722
—
11
16
2062
20685
19
143
1985
19910
49
395
1643
16373
Cholangitis
K83.0 [45552955]
1.3e+00
2.0e+00
—
—
—
1.8e+00
1.2e+00
cases:0.34%
controls:0.10%
cases:0.29%
controls:0.04%
—
—
—
—
—
—
cases:0.40%
controls:0.06%
cases:0.77%
controls:0.23%
7
20
2075
20716
6
8
2076
20728
—
—
—
8
13
1996
20040
13
38
1679
16730
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
2.0e-01
1.1e+00
2.1e+00
1.0e+50
1.8e+00
4.4e-01
3.4e-01
cases:1.15%
controls:0.95%
cases:1.39%
controls:0.48%
cases:0.58%
controls:0.07%
cases:0.34%
controls:0.00%
cases:0.48%
controls:0.08%
cases:0.85%
controls:0.55%
cases:2.72%
controls:1.95%
24
196
2058
20540
29
100
2053
20636
12
14
2070
20722
7
0
2075
20736
10
16
2063
20685
17
110
1987
19943
46
327
1646
16441
ofloxacin; oral, parenteral
J01MA01 [21603008]
1.3e+00
2.3e+00
—
—
—
1.4e+00
8.2e-01
cases:2.50%
controls:0.71%
cases:1.44%
controls:0.14%
—
—
—
—
—
—
cases:0.65%
controls:0.16%
cases:1.06%
controls:0.47%
52
148
2030
20588
30
29
2052
20707
—
—
—
13
32
1991
20021
18
79
1674
16689
INR in Blood by Coagulation assay
34714-6 [3032080]
1.4e-01
3.5e-01
4.3e-01
2.8e+00
6.2e-01
3.6e-01
3.6e-01
cases:14.17%
controls:12.53%
cases:10.85%
controls:7.91%
cases:4.56%
controls:3.00%
cases:2.45%
controls:0.15%
cases:5.45%
controls:3.00%
cases:11.28%
controls:8.11%
cases:22.34%
controls:16.69%
295
2599
1787
18137
226
1641
1856
19095
95
623
1987
20113
51
32
2031
20704
113
621
1960
20080
226
1626
1778
18427
378
2799
1314
13969
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
2.8e-01
4.5e-01
1.4e+00
—
1.6e+00
6.9e-01
4.8e-01
cases:9.03%
controls:6.97%
cases:3.22%
controls:2.07%
cases:0.91%
controls:0.24%
—
—
cases:1.16%
controls:0.23%
cases:4.09%
controls:2.10%
cases:11.41%
controls:7.37%
188
1446
1894
19290
67
429
2015
20307
19
49
2063
20687
—
24
48
2049
20653
82
421
1922
19632
193
1236
1499
15532
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
2.4e-01
4.0e-01
1.5e+00
—
1.8e+00
8.1e-01
3.7e-01
cases:7.78%
controls:6.20%
cases:4.37%
controls:2.98%
cases:1.87%
controls:0.41%
—
—
cases:2.07%
controls:0.36%
cases:5.74%
controls:2.64%
cases:10.82%
controls:7.75%
162
1285
1920
19451
91
618
1991
20118
39
86
2043
20650
—
43
74
2030
20627
115
529
1889
19524
183
1300
1509
15468
Essential (primary) hypertension
I10 [45591453]
-4.8e-02
1.9e-01
4.1e-01
3.7e+00
7.1e-01
2.8e-01
2.0e-01
cases:20.89%
controls:21.69%
cases:13.45%
controls:11.34%
cases:2.79%
controls:1.86%
cases:3.65%
controls:0.10%
cases:3.81%
controls:1.91%
cases:14.72%
controls:11.58%
cases:31.32%
controls:27.15%
435
4498
1647
16238
280
2352
1802
18384
58
386
2024
20350
76
20
2006
20716
79
396
1994
20305
295
2322
1709
17731
530
4552
1162
12216
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
3.9e-01
9.7e-01
2.0e+00
1.0e+50
1.9e+00
2.3e-01
1.8e-01
cases:1.15%
controls:0.78%
cases:1.20%
controls:0.46%
cases:0.48%
controls:0.07%
cases:0.34%
controls:0.00%
cases:0.48%
controls:0.07%
cases:0.75%
controls:0.59%
cases:2.48%
controls:2.08%
24
162
2058
20574
25
95
2057
20641
10
14
2072
20722
7
0
2075
20736
10
15
2063
20686
15
119
1989
19934
42
348
1650
16420
Sepsis due to other Gram-negative organisms
A41.5 [45556902]
8.2e-01
2.1e+00
—
1.0e+50
—
1.5e+00
1.2e+00
cases:0.72%
controls:0.32%
cases:0.72%
controls:0.09%
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.70%
controls:0.15%
cases:1.48%
controls:0.47%
15
66
2067
20670
15
18
2067
20718
—
5
0
2077
20736
—
14
30
1990
20023
25
78
1667
16690
Primary hyperparathyroidism
E21.0 [45571667]
1.2e+00
—
—
—
—
2.5e+00
2.3e+00
cases:0.24%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.03%
cases:1.00%
controls:0.10%
5
15
2077
20721
—
—
—
—
7
6
1997
20047
17
17
1675
16751
Multiple sclerosis
N86 [2002000786]
2.6e+00
2.3e+00
—
—
—
2.3e+00
2.2e+00
cases:0.38%
controls:0.03%
cases:0.24%
controls:0.02%
—
—
—
—
—
—
cases:0.25%
controls:0.02%
cases:0.41%
controls:0.05%
8
6
2074
20730
5
5
2077
20731
—
—
—
5
5
1999
20048
7
8
1685
16760
Urinary calculus, unspecified
N20.9 [45558141]
—
—
—
1.0e+50
1.0e+50
—
4.7e+00
—
—
—
—
—
—
cases:1.54%
controls:0.00%
cases:1.54%
controls:0.00%
—
—
cases:5.20%
controls:0.05%
—
—
—
32
0
2050
20736
32
0
2041
20701
—
88
8
1604
16760
enoxaparin; parenteral
B01AB05 [21600976]
2.3e-01
7.5e-01
1.2e+00
—
1.5e+00
8.2e-01
4.7e-01
cases:6.63%
controls:5.35%
cases:3.55%
controls:1.72%
cases:0.77%
controls:0.24%
—
—
cases:0.96%
controls:0.21%
cases:3.39%
controls:1.52%
cases:7.27%
controls:4.69%
138
1110
1944
19626
74
356
2008
20380
16
50
2066
20686
—
20
43
2053
20658
68
305
1936
19748
123
786
1569
15982
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
KCD05 [2001305939]
8.6e-01
2.4e+00
—
—
—
2.3e+00
1.0e+00
cases:0.43%
controls:0.18%
cases:0.48%
controls:0.04%
—
—
—
—
—
—
cases:0.45%
controls:0.04%
cases:0.47%
controls:0.17%
9
38
2073
20698
10
9
2072
20727
—
—
—
9
9
1995
20044
8
29
1684
16739
Cystoscopy and bladder biopsy
UKC05 [2001306006]
5.6e-01
—
—
—
—
2.5e+00
2.2e+00
cases:0.34%
controls:0.19%
—
—
—
—
—
—
—
—
cases:0.75%
controls:0.06%
cases:1.12%
controls:0.13%
7
40
2075
20696
—
—
—
—
15
12
1989
20041
19
22
1673
16746
Unspecified urinary incontinence
R32 [45606803]
1.2e+00
2.0e+00
—
—
-1.0e+50
1.6e+00
1.1e+00
cases:0.48%
controls:0.15%
cases:0.48%
controls:0.07%
—
—
—
—
cases:0.00%
controls:0.02%
cases:0.50%
controls:0.10%
cases:0.95%
controls:0.32%
10
31
2072
20705
10
14
2072
20722
—
—
0
5
2073
20696
10
20
1994
20033
16
53
1676
16715
Case Management Agency
251B00000X [38004193]
6.1e-02
1.3e-01
5.9e-01
3.4e+00
5.2e-01
1.8e-01
8.4e-02
cases:61.19%
controls:59.73%
cases:56.10%
controls:53.00%
cases:33.81%
controls:22.00%
cases:27.47%
controls:1.29%
cases:31.93%
controls:21.79%
cases:59.78%
controls:55.37%
cases:73.52%
controls:71.86%
1274
12385
808
8351
1168
10990
914
9746
704
4562
1378
16174
572
268
1510
20468
662
4510
1411
16191
1198
11103
806
8950
1244
12049
448
4719
Cutaneous ureteroenterostomy
KBJ10 [2001305876]
-1.0e+50
—
—
—
—
2.6e+00
2.0e+00
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.02%
cases:0.35%
controls:0.05%
0
15
2082
20721
—
—
—
—
7
5
1997
20048
6
8
1686
16760
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
3.4e-01
6.1e-01
1.4e+00
—
1.4e+00
4.7e-01
3.5e-01
cases:7.30%
controls:5.33%
cases:4.37%
controls:2.43%
cases:1.20%
controls:0.28%
—
—
cases:1.25%
controls:0.30%
cases:4.24%
controls:2.69%
cases:11.23%
controls:8.15%
152
1105
1930
19631
91
504
1991
20232
25
59
2057
20677
—
26
63
2047
20638
85
540
1919
19513
190
1367
1502
15401
Treatment plan or consultation
WZC00 [2001310885]
3.5e-01
5.5e-01
1.1e+00
—
1.3e+00
9.1e-01
3.8e-01
cases:6.72%
controls:4.84%
cases:3.22%
controls:1.89%
cases:0.72%
controls:0.24%
—
—
cases:0.96%
controls:0.26%
cases:4.19%
controls:1.73%
cases:8.27%
controls:5.83%
140
1004
1942
19732
67
391
2015
20345
15
49
2067
20687
—
20
53
2053
20648
84
346
1920
19707
140
978
1552
15790
Urgent procedure
ZXD05 [2001311386]
3.4e-01
8.0e-01
9.5e-01
—
2.1e+00
9.1e-01
4.5e-01
cases:6.10%
controls:4.42%
cases:2.50%
controls:1.14%
cases:0.34%
controls:0.13%
—
—
cases:1.01%
controls:0.12%
cases:2.35%
controls:0.96%
cases:5.79%
controls:3.76%
127
917
1955
19819
52
237
2030
20499
7
27
2075
20709
—
21
25
2052
20676
47
192
1957
19861
98
631
1594
16137
oxycodone; oral, parenteral
N02AA05 [21604260]
3.2e-01
7.1e-01
1.2e+00
—
1.5e+00
7.1e-01
4.9e-01
cases:2.07%
controls:1.51%
cases:1.87%
controls:0.93%
cases:1.10%
controls:0.32%
—
—
cases:1.21%
controls:0.28%
cases:2.59%
controls:1.29%
cases:5.38%
controls:3.38%
43
313
2039
20423
39
192
2043
20544
23
67
2059
20669
—
25
58
2048
20643
52
259
1952
19794
91
566
1601
16202
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
1.3e-01
2.2e-01
3.6e-01
2.4e+00
9.1e-01
3.7e-01
3.7e-01
cases:34.20%
controls:31.27%
cases:21.33%
controls:17.82%
cases:5.04%
controls:3.58%
cases:1.15%
controls:0.11%
cases:7.86%
controls:3.31%
cases:24.55%
controls:18.31%
cases:47.04%
controls:38.04%
712
6485
1370
14251
444
3695
1638
17041
105
743
1977
19993
24
23
2058
20713
163
686
1910
20015
492
3671
1512
16382
796
6378
896
10390
Urinary frequency/urgency
U02 [2002001138]
4.5e-01
1.8e+00
—
—
2.2e+00
7.1e-01
6.1e-01
cases:2.16%
controls:1.38%
cases:2.35%
controls:0.41%
—
—
—
—
cases:0.39%
controls:0.04%
cases:0.75%
controls:0.37%
cases:2.66%
controls:1.47%
45
287
2037
20449
49
86
2033
20650
—
—
8
9
2065
20692
15
74
1989
19979
45
246
1647
16522
Urinary disease other
U99 [2002001204]
2.0e+00
—
—
—
—
2.5e+00
1.3e+00
cases:0.43%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.02%
cases:0.30%
controls:0.08%
9
12
2073
20724
—
—
—
—
6
5
1998
20048
5
14
1687
16754
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
1.4e-01
5.9e-01
1.6e+00
1.0e+50
1.7e+00
5.7e-01
2.4e-01
cases:1.87%
controls:1.63%
cases:1.92%
controls:1.07%
cases:0.77%
controls:0.16%
cases:0.53%
controls:0.00%
cases:0.77%
controls:0.14%
cases:2.15%
controls:1.22%
cases:4.43%
controls:3.51%
39
339
2043
20397
40
222
2042
20514
16
33
2066
20703
11
0
2071
20736
16
28
2057
20673
43
245
1961
19808
75
588
1617
16180
Dilatation of urethra
TKD00 [2001306101]
—
—
—
1.0e+50
—
2.6e+00
1.8e+00
—
—
—
—
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.35%
controls:0.02%
cases:0.59%
controls:0.10%
—
—
—
7
0
2075
20736
—
7
5
1997
20048
10
16
1682
16752
Isotope renography
KA1FN [2001305633]
2.0e+00
—
—
—
—
—
2.4e+00
cases:0.34%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.05%
7
9
2075
20727
—
—
—
—
—
10
9
1682
16759
Other difficulties with micturition
R39.1 [45534441]
7.8e-01
1.0e+00
2.0e+00
1.0e+50
2.0e+00
1.6e+00
8.5e-01
cases:1.01%
controls:0.46%
cases:0.53%
controls:0.19%
cases:0.29%
controls:0.04%
cases:0.67%
controls:0.00%
cases:0.24%
controls:0.03%
cases:0.75%
controls:0.16%
cases:1.30%
controls:0.56%
21
96
2061
20640
11
40
2071
20696
6
8
2076
20728
14
0
2068
20736
5
7
2068
20694
15
32
1989
20021
22
94
1670
16674
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
3.1e-01
7.2e-01
1.8e+00
1.0e+50
1.9e+00
4.6e-01
1.6e-01
cases:1.68%
controls:1.24%
cases:1.59%
controls:0.78%
cases:0.62%
controls:0.11%
cases:0.53%
controls:0.00%
cases:0.58%
controls:0.09%
cases:1.40%
controls:0.89%
cases:3.49%
controls:2.99%
35
257
2047
20479
33
161
2049
20575
13
22
2069
20714
11
0
2071
20736
12
18
2061
20683
28
178
1976
19875
59
502
1633
16266
Infectious Disease
44 [38004484]
5.4e-01
9.4e-01
2.0e+00
—
1.3e+00
9.3e-01
4.1e-01
cases:2.74%
controls:1.62%
cases:1.68%
controls:0.66%
cases:0.62%
controls:0.09%
—
—
cases:0.34%
controls:0.10%
cases:1.60%
controls:0.63%
cases:2.90%
controls:1.95%
57
336
2025
20400
35
137
2047
20599
13
18
2069
20718
—
7
20
2066
20681
32
127
1972
19926
49
327
1643
16441
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
4.0e-01
8.5e-01
1.8e+00
—
—
8.3e-01
8.9e-01
cases:1.54%
controls:1.03%
cases:1.30%
controls:0.56%
cases:0.43%
controls:0.07%
—
—
—
—
cases:1.20%
controls:0.52%
cases:4.02%
controls:1.69%
32
214
2050
20522
27
116
2055
20620
9
15
2073
20721
—
—
24
105
1980
19948
68
284
1624
16484
Handing over of treatment supplies
SPAT1262 [2001700363]
3.8e-01
6.2e-01
7.8e-01
—
1.3e+00
7.4e-01
5.2e-01
cases:7.30%
controls:5.09%
cases:5.00%
controls:2.76%
cases:1.20%
controls:0.55%
—
—
cases:1.93%
controls:0.53%
cases:5.74%
controls:2.83%
cases:9.10%
controls:5.63%
152
1055
1930
19681
104
573
1978
20163
25
115
2057
20621
—
40
110
2033
20591
115
568
1889
19485
154
944
1538
15824
cefalexin; oral
J01DB01 [21602870]
3.1e-01
6.0e-01
1.1e+00
—
1.4e+00
5.1e-01
4.1e-01
cases:32.52%
controls:26.14%
cases:14.46%
controls:8.48%
cases:2.59%
controls:0.89%
—
—
cases:3.86%
controls:0.96%
cases:13.07%
controls:8.32%
cases:34.52%
controls:25.83%
677
5421
1405
15315
301
1758
1781
18978
54
185
2028
20551
—
80
199
1993
20502
262
1668
1742
18385
584
4332
1108
12436
Body CT examination
JN4AD [2001310897]
4.1e-01
1.1e+00
1.9e+00
—
7.8e-01
8.8e-01
4.8e-01
cases:1.44%
controls:0.96%
cases:2.11%
controls:0.72%
cases:0.43%
controls:0.07%
—
—
cases:0.24%
controls:0.11%
cases:1.90%
controls:0.79%
cases:3.43%
controls:2.14%
30
199
2052
20537
44
149
2038
20587
9
14
2073
20722
—
5
23
2068
20678
38
159
1966
19894
58
359
1634
16409
Obstetrics / Gynecology
16 [38004461]
3.4e-01
7.7e-01
1.6e+00
—
1.3e+00
6.0e-01
3.2e-01
cases:5.48%
controls:3.95%
cases:3.41%
controls:1.62%
cases:1.30%
controls:0.27%
—
—
cases:1.21%
controls:0.33%
cases:2.79%
controls:1.55%
cases:5.73%
controls:4.21%
114
820
1968
19916
71
335
2011
20401
27
56
2055
20680
—
25
68
2048
20633
56
310
1948
19743
97
706
1595
16062
lidocaine; ointment
D04AB01 [21602020]
1.4e+00
1.9e+00
—
—
-1.0e+50
1.1e+00
9.4e-01
cases:0.86%
controls:0.22%
cases:0.77%
controls:0.11%
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.45%
controls:0.14%
cases:1.24%
controls:0.49%
18
46
2064
20690
16
23
2066
20713
—
—
0
7
2073
20694
9
29
1995
20024
21
82
1671
16686
Respiratory and circulatory monitoring
WX700 [2001310817]
1.9e-03
3.8e-01
—
1.0e+50
2.4e+00
1.2e+00
6.9e-01
cases:2.45%
controls:2.45%
cases:1.10%
controls:0.76%
—
—
cases:0.62%
controls:0.00%
cases:0.82%
controls:0.08%
cases:2.40%
controls:0.75%
cases:4.43%
controls:2.27%
51
507
2031
20229
23
157
2059
20579
—
13
0
2069
20736
17
16
2056
20685
48
150
1956
19903
75
380
1617
16388
lidocaine
C05AD01 [21601618]
1.4e+00
1.9e+00
—
—
-1.0e+50
1.1e+00
9.3e-01
cases:0.86%
controls:0.22%
cases:0.77%
controls:0.11%
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.45%
controls:0.14%
cases:1.24%
controls:0.49%
18
46
2064
20690
16
23
2066
20713
—
—
0
7
2073
20694
9
29
1995
20024
21
83
1671
16685
Intravenous general anesthesia
WX404 [2001310807]
3.4e-01
6.0e-01
—
1.0e+50
1.9e+00
1.5e+00
8.1e-01
cases:3.51%
controls:2.52%
cases:1.10%
controls:0.61%
—
—
cases:0.91%
controls:0.00%
cases:0.53%
controls:0.08%
cases:2.10%
controls:0.49%
cases:2.84%
controls:1.28%
73
523
2009
20213
23
126
2059
20610
—
19
0
2063
20736
11
16
2062
20685
42
98
1962
19955
48
215
1644
16553
Flaccid neuropathic bladder, not elsewhere classified
N31.2 [45543864]
1.7e+00
—
—
—
—
—
2.5e+00
cases:0.43%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.06%
9
17
2073
20719
—
—
—
—
—
12
10
1680
16758
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
9.6e-02
7.6e-01
2.0e+00
1.0e+50
2.1e+00
2.3e-01
-2.9e-02
cases:0.86%
controls:0.79%
cases:0.96%
controls:0.45%
cases:0.48%
controls:0.06%
cases:0.29%
controls:0.00%
cases:0.43%
controls:0.05%
cases:0.65%
controls:0.52%
cases:1.83%
controls:1.88%
18
163
2064
20573
20
94
2062
20642
10
13
2072
20723
6
0
2076
20736
9
11
2064
20690
13
104
1991
19949
31
316
1661
16452
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
7.6e-02
7.8e-01
2.0e+00
1.0e+50
2.1e+00
2.3e-01
-3.9e-02
cases:0.82%
controls:0.76%
cases:0.96%
controls:0.44%
cases:0.48%
controls:0.06%
cases:0.29%
controls:0.00%
cases:0.43%
controls:0.05%
cases:0.65%
controls:0.52%
cases:1.77%
controls:1.84%
17
157
2065
20579
20
92
2062
20644
10
13
2072
20723
6
0
2076
20736
9
11
2064
20690
13
104
1991
19949
30
309
1662
16459
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
2.0e-01
2.9e-01
1.4e+00
—
2.0e+00
6.8e-01
2.7e-01
cases:6.20%
controls:5.14%
cases:3.75%
controls:2.83%
cases:1.83%
controls:0.44%
—
—
cases:3.18%
controls:0.43%
cases:4.99%
controls:2.59%
cases:8.75%
controls:6.82%
129
1066
1953
19670
78
587
2004
20149
38
91
2044
20645
—
66
90
2007
20611
100
520
1904
19533
148
1143
1544
15625
Urethrocystoscopy
1530 [2000100185]
2.1e+00
—
—
1.0e+50
—
—
2.0e+00
cases:0.38%
controls:0.05%
—
—
—
—
cases:0.86%
controls:0.00%
—
—
—
—
cases:0.41%
controls:0.05%
8
10
2074
20726
—
—
18
0
2064
20736
—
—
7
9
1685
16759
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
-1.5e-01
5.5e-01
1.6e+00
—
1.8e+00
7.8e-01
3.4e-01
cases:1.39%
controls:1.62%
cases:1.15%
controls:0.67%
cases:0.53%
controls:0.11%
—
—
cases:0.53%
controls:0.09%
cases:1.55%
controls:0.71%
cases:2.54%
controls:1.83%
29
335
2053
20401
24
139
2058
20597
11
23
2071
20713
—
11
19
2062
20682
31
143
1973
19910
43
307
1649
16461
Medical doctor
Z2221 [2001311556]
1.8e-01
4.7e-01
1.2e+00
—
1.3e+00
8.0e-01
8.9e-01
cases:5.62%
controls:4.72%
cases:2.45%
controls:1.54%
cases:0.72%
controls:0.23%
—
—
cases:0.68%
controls:0.19%
cases:2.94%
controls:1.35%
cases:6.80%
controls:2.91%
117
978
1965
19758
51
320
2031
20416
15
47
2067
20689
—
14
40
2059
20661
59
270
1945
19783
115
488
1577
16280
Hyperplasia of prostate[HYPERPLASIA PROSTATAE]
6000A [2000404725]
1.6e+00
—
—
1.0e+50
—
2.5e+00
—
cases:0.48%
controls:0.10%
—
—
—
—
cases:0.67%
controls:0.00%
—
—
cases:0.30%
controls:0.02%
—
—
10
20
2072
20716
—
—
14
0
2068
20736
—
6
5
1998
20048
—
Base excess in Venous blood by calculation
1927-3 [3002032]
1.7e-01
6.6e-01
1.6e+00
1.0e+50
1.8e+00
5.4e-01
2.5e-01
cases:1.92%
controls:1.63%
cases:2.02%
controls:1.06%
cases:0.77%
controls:0.15%
cases:0.53%
controls:0.00%
cases:0.82%
controls:0.14%
cases:2.10%
controls:1.23%
cases:4.43%
controls:3.49%
40
337
2042
20399
42
219
2040
20517
16
32
2066
20704
11
0
2071
20736
17
28
2056
20673
42
246
1962
19807
75
585
1617
16183
Sedation and analgesia
WX002 [2001310758]
2.1e-01
6.0e-01
—
1.0e+50
2.1e+00
1.1e+00
8.9e-01
cases:3.70%
controls:3.03%
cases:1.49%
controls:0.82%
—
—
cases:0.38%
controls:0.00%
cases:0.58%
controls:0.07%
cases:2.10%
controls:0.71%
cases:5.61%
controls:2.37%
77
629
2005
20107
31
170
2051
20566
—
8
0
2074
20736
12
15
2061
20686
42
142
1962
19911
95
398
1597
16370
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
3.7e-01
7.6e-01
1.6e+00
—
1.1e+00
8.9e-01
8.1e-01
cases:1.54%
controls:1.07%
cases:1.44%
controls:0.68%
cases:0.48%
controls:0.10%
—
—
cases:0.24%
controls:0.08%
cases:1.55%
controls:0.64%
cases:4.73%
controls:2.16%
32
222
2050
20514
30
141
2052
20595
10
20
2072
20716
—
5
17
2068
20684
31
128
1973
19925
80
362
1612
16406
Nephrology
39 [38004479]
3.5e-01
6.3e-01
7.8e-01
1.8e+00
5.7e-01
1.0e+00
6.2e-01
cases:1.78%
controls:1.26%
cases:1.83%
controls:0.98%
cases:0.77%
controls:0.35%
cases:0.34%
controls:0.06%
cases:0.68%
controls:0.38%
cases:2.84%
controls:1.04%
cases:3.19%
controls:1.74%
37
261
2045
20475
38
204
2044
20532
16
73
2066
20663
7
12
2075
20724
14
79
2059
20622
57
208
1947
19845
54
291
1638
16477
Transanal ultrasonography
XJH00 [2001305132]
1.0e+00
1.7e+00
—
1.0e+50
—
1.3e+00
4.8e-01
cases:2.93%
controls:1.09%
cases:1.25%
controls:0.24%
—
—
cases:1.54%
controls:0.00%
—
—
cases:0.85%
controls:0.22%
cases:1.18%
controls:0.73%
61
226
2021
20510
26
50
2056
20686
—
32
0
2050
20736
—
17
45
1987
20008
20
123
1672
16645
Other specified sepsis
A41.8 [45595587]
1.4e+00
2.2e+00
—
—
—
1.8e+00
4.8e-01
cases:0.38%
controls:0.09%
cases:0.43%
controls:0.05%
—
—
—
—
—
—
cases:0.45%
controls:0.07%
cases:0.47%
controls:0.29%
8
19
2074
20717
9
10
2073
20726
—
—
—
9
15
1995
20038
8
49
1684
16719
pH of Venous blood
2746-6 [3012544]
1.6e-01
6.5e-01
1.6e+00
—
1.8e+00
5.2e-01
2.6e-01
cases:2.02%
controls:1.72%
cases:2.07%
controls:1.09%
cases:0.77%
controls:0.16%
—
—
cases:0.82%
controls:0.14%
cases:2.05%
controls:1.23%
cases:4.55%
controls:3.55%
42
357
2040
20379
43
225
2039
20511
16
34
2066
20702
—
17
29
2056
20672
41
247
1963
19806
77
595
1615
16173
pH of Capillary blood
2745-8 [3009343]
3.7e-01
7.3e-01
1.5e+00
—
1.1e+00
8.9e-01
8.5e-01
cases:1.54%
controls:1.07%
cases:1.39%
controls:0.68%
cases:0.43%
controls:0.10%
—
—
cases:0.24%
controls:0.08%
cases:1.50%
controls:0.62%
cases:4.67%
controls:2.05%
32
221
2050
20515
29
140
2053
20596
9
20
2073
20716
—
5
16
2068
20685
30
124
1974
19929
79
344
1613
16424
pH of Specimen
17433-4 [3019225]
2.2e-01
7.0e-01
1.6e+00
—
1.1e+00
9.1e-01
7.8e-01
cases:2.50%
controls:2.01%
cases:2.16%
controls:1.09%
cases:0.58%
controls:0.12%
—
—
cases:0.53%
controls:0.18%
cases:2.45%
controls:1.00%
cases:5.02%
controls:2.37%
52
416
2030
20320
45
225
2037
20511
12
25
2070
20711
—
11
37
2062
20664
49
201
1955
19852
85
398
1607
16370
Malignant neoplasm prostate
Y77 [2002001445]
6.2e-01
8.3e-01
1.3e+00
—
8.1e-01
1.0e+00
7.7e-01
cases:1.54%
controls:0.83%
cases:1.30%
controls:0.57%
cases:0.53%
controls:0.14%
—
—
cases:0.34%
controls:0.15%
cases:1.50%
controls:0.55%
cases:2.19%
controls:1.02%
32
172
2050
20564
27
118
2055
20618
11
29
2071
20707
—
7
31
2066
20670
30
111
1974
19942
37
171
1655
16597
Cystitis/urinary infection other
U71 [2002001191]
6.4e-01
1.8e+00
—
—
—
2.2e+00
8.3e-01
cases:0.53%
controls:0.28%
cases:0.62%
controls:0.11%
—
—
—
—
—
—
cases:0.90%
controls:0.10%
cases:1.06%
controls:0.47%
11
58
2071
20678
13
22
2069
20714
—
—
—
18
21
1986
20032
18
78
1674
16690
Pure hypercholesterolaemia
E78.01 [2000501514]
-6.6e-02
3.9e-01
2.2e-01
3.9e+00
7.2e-01
2.9e-01
1.2e-01
cases:4.13%
controls:4.40%
cases:2.98%
controls:2.04%
cases:0.53%
controls:0.42%
cases:1.20%
controls:0.02%
cases:0.87%
controls:0.43%
cases:2.99%
controls:2.26%
cases:7.27%
controls:6.48%
86
912
1996
19824
62
424
2020
20312
11
88
2071
20648
25
5
2057
20731
18
88
2055
20613
60
454
1944
19599
123
1087
1569
15681
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
2.3e-01
2.9e-01
4.5e-01
1.8e+00
9.5e-01
3.8e-01
2.7e-01
cases:31.36%
controls:26.62%
cases:14.46%
controls:11.26%
cases:2.55%
controls:1.64%
cases:0.53%
controls:0.09%
cases:3.91%
controls:1.56%
cases:15.22%
controls:10.98%
cases:31.44%
controls:25.94%
653
5520
1429
15216
301
2335
1781
18401
53
341
2029
20395
11
18
2071
20718
81
322
1992
20379
305
2202
1699
17851
532
4349
1160
12419
ibuprofen
R02AX02 [1588667]
2.3e-01
2.9e-01
4.5e-01
1.8e+00
9.5e-01
3.8e-01
2.7e-01
cases:31.36%
controls:26.62%
cases:14.46%
controls:11.26%
cases:2.55%
controls:1.64%
cases:0.53%
controls:0.09%
cases:3.91%
controls:1.56%
cases:15.22%
controls:10.98%
cases:31.44%
controls:25.94%
653
5520
1429
15216
301
2335
1781
18401
53
341
2029
20395
11
18
2071
20718
81
322
1992
20379
305
2202
1699
17851
532
4349
1160
12419
azathioprine; oral, parenteral
L04AX01 [21603927]
9.4e-01
1.0e+00
—
—
1.2e+00
9.2e-01
1.0e+00
cases:1.20%
controls:0.47%
cases:0.82%
controls:0.29%
—
—
—
—
cases:0.29%
controls:0.09%
cases:0.85%
controls:0.34%
cases:1.12%
controls:0.41%
25
98
2057
20638
17
61
2065
20675
—
—
6
18
2067
20683
17
68
1987
19985
19
68
1673
16700
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
2.4e-01
4.7e-01
9.9e-01
—
1.2e+00
7.6e-01
5.0e-01
cases:3.36%
controls:2.67%
cases:2.98%
controls:1.88%
cases:0.91%
controls:0.34%
—
—
cases:1.21%
controls:0.37%
cases:3.94%
controls:1.89%
cases:6.62%
controls:4.10%
70
554
2012
20182
62
390
2020
20346
19
71
2063
20665
—
25
77
2048
20624
79
379
1925
19674
112
688
1580
16080
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.7e-02
3.4e-01
7.6e-01
1.9e+00
5.9e-01
2.8e-01
2.8e-01
cases:9.65%
controls:9.25%
cases:8.02%
controls:5.83%
cases:2.40%
controls:1.13%
cases:0.38%
controls:0.06%
cases:1.93%
controls:1.08%
cases:7.83%
controls:6.05%
cases:16.90%
controls:13.34%
201
1918
1881
18818
167
1208
1915
19528
50
235
2032
20501
8
12
2074
20724
40
223
2033
20478
157
1213
1847
18840
286
2237
1406
14531
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
4.8e-02
3.4e-01
7.7e-01
1.9e+00
5.9e-01
2.8e-01
2.8e-01
cases:9.70%
controls:9.29%
cases:7.97%
controls:5.83%
cases:2.40%
controls:1.13%
cases:0.38%
controls:0.06%
cases:1.93%
controls:1.08%
cases:7.88%
controls:6.10%
cases:16.90%
controls:13.32%
202
1926
1880
18810
166
1208
1916
19528
50
234
2032
20502
8
12
2074
20724
40
223
2033
20478
158
1223
1846
18830
286
2234
1406
14534
Cystitis
N30 [45563012]
5.6e-01
2.3e+00
2.3e+00
—
—
1.5e+00
7.7e-01
cases:0.82%
controls:0.47%
cases:1.25%
controls:0.12%
cases:0.24%
controls:0.02%
—
—
—
—
cases:0.55%
controls:0.12%
cases:1.30%
controls:0.61%
17
97
2065
20639
26
25
2056
20711
5
5
2077
20731
—
—
11
25
1993
20028
22
102
1670
16666
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
5.7e-02
1.9e-01
5.0e-01
2.7e+00
4.6e-01
3.7e-02
1.3e-01
cases:33.38%
controls:32.12%
cases:29.11%
controls:25.27%
cases:7.20%
controls:4.51%
cases:2.59%
controls:0.18%
cases:6.90%
controls:4.45%
cases:27.30%
controls:26.57%
cases:48.58%
controls:45.23%
695
6661
1387
14075
606
5239
1476
15497
150
936
1932
19800
54
38
2028
20698
143
921
1930
19780
547
5328
1457
14725
822
7585
870
9183
Pharmacy visit
OMOP4822462 [581458]
2.6e-01
4.8e-01
4.1e-01
1.5e+00
6.4e-01
3.5e-01
3.6e-01
cases:91.50%
controls:89.26%
cases:88.47%
controls:82.56%
cases:59.37%
controls:49.32%
cases:11.19%
controls:2.76%
cases:65.12%
controls:49.55%
cases:87.82%
controls:83.55%
cases:94.15%
controls:91.79%
1905
18509
177
2227
1842
17119
240
3617
1236
10227
846
10509
233
573
1849
20163
1350
10258
723
10443
1760
16754
244
3299
1593
15392
99
1376
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10886-0 [3005013]
3.2e-01
8.1e-01
2.2e+00
—
5.8e-01
4.0e-01
1.2e-01
cases:12.30%
controls:9.23%
cases:9.99%
controls:4.73%
cases:4.23%
controls:0.49%
—
—
cases:0.92%
controls:0.52%
cases:6.64%
controls:4.57%
cases:13.30%
controls:12.02%
256
1914
1826
18822
208
980
1874
19756
88
102
1994
20634
—
19
107
2054
20594
133
916
1871
19137
225
2015
1467
14753
Basophils [#/volume] in Blood
26444-0 [3006315]
1.6e-02
2.9e-01
6.8e-01
1.9e+00
6.1e-01
2.6e-01
2.3e-01
cases:9.89%
controls:9.75%
cases:8.17%
controls:6.25%
cases:2.21%
controls:1.13%
cases:0.38%
controls:0.06%
cases:2.03%
controls:1.12%
cases:8.23%
controls:6.49%
cases:17.55%
controls:14.49%
206
2022
1876
18714
170
1295
1912
19441
46
235
2036
20501
8
12
2074
20724
42
231
2031
20470
165
1301
1839
18752
297
2429
1395
14339
alprostadil; implant, parenteral
G04BE01 [21602646]
4.2e-01
1.1e+00
—
—
-1.0e+50
1.3e+00
1.4e+00
cases:1.15%
controls:0.76%
cases:0.67%
controls:0.24%
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.75%
controls:0.21%
cases:1.77%
controls:0.46%
24
157
2058
20579
14
49
2068
20687
—
—
0
12
2073
20689
15
42
1989
20011
30
77
1662
16691
Treatment of a patient needing special arrangements
WYA30 [2001310874]
7.3e-01
1.1e+00
—
—
—
1.1e+00
7.2e-01
cases:1.68%
controls:0.82%
cases:0.82%
controls:0.28%
—
—
—
—
—
—
cases:1.00%
controls:0.32%
cases:2.25%
controls:1.10%
35
170
2047
20566
17
59
2065
20677
—
—
—
20
64
1984
19989
38
185
1654
16583
Tubulo-interstitial nephritis, not specified as acute or chronic
N12 [45563004]
1.0e+00
2.3e+00
—
—
—
1.7e+00
1.3e+00
cases:0.29%
controls:0.10%
cases:0.48%
controls:0.05%
—
—
—
—
—
—
cases:0.25%
controls:0.04%
cases:0.71%
controls:0.18%
6
21
2076
20715
10
10
2072
20726
—
—
—
5
9
1999
20044
12
31
1680
16737
Instability of the detrusor vesicae muscle
N32.82 [2000503170]
1.0e+00
2.2e+00
—
—
—
—
1.5e+00
cases:0.38%
controls:0.14%
cases:0.34%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.14%
8
28
2074
20708
7
8
2075
20728
—
—
—
—
10
23
1682
16745
Teaching
WZC30 [2001310891]
2.9e-01
4.9e-01
1.0e+00
—
2.0e+00
1.1e+00
4.7e-01
cases:2.40%
controls:1.81%
cases:1.54%
controls:0.95%
cases:0.29%
controls:0.10%
—
—
cases:0.87%
controls:0.12%
cases:2.64%
controls:0.88%
cases:4.61%
controls:2.93%
50
376
2032
20360
32
197
2050
20539
6
21
2076
20715
—
18
24
2055
20677
53
177
1951
19876
78
492
1614
16276
Leukocyte morphology finding [Identifier] in Blood
11156-7 [3008757]
6.9e-01
1.8e+00
—
—
—
1.8e+00
8.2e-01
cases:0.34%
controls:0.17%
cases:0.34%
controls:0.06%
—
—
—
—
—
—
cases:0.45%
controls:0.07%
cases:0.65%
controls:0.29%
7
35
2075
20701
7
12
2075
20724
—
—
—
9
15
1995
20038
11
48
1681
16720
Chronic prostatitis
N41.1 [45539048]
1.4e-01
1.9e+00
—
—
—
1.6e+00
6.0e-02
cases:0.38%
controls:0.33%
cases:0.53%
controls:0.08%
—
—
—
—
—
—
cases:0.50%
controls:0.10%
cases:0.35%
controls:0.33%
8
69
2074
20667
11
16
2071
20720
—
—
—
10
20
1994
20033
6
56
1686
16712
Gas panel - Venous blood
24339-4 [3000991]
1.5e-01
4.3e-01
1.4e+00
—
1.4e+00
7.0e-01
4.5e-02
cases:1.54%
controls:1.32%
cases:1.34%
controls:0.88%
cases:0.58%
controls:0.14%
—
—
cases:0.48%
controls:0.12%
cases:2.00%
controls:1.00%
cases:2.90%
controls:2.77%
32
274
2050
20462
28
182
2054
20554
12
30
2070
20706
—
10
24
2063
20677
40
200
1964
19853
49
465
1643
16303
Polyuria
R35 [45539331]
8.4e-01
1.5e+00
1.6e+00
—
—
1.1e+00
4.6e-01
cases:2.11%
controls:0.92%
cases:1.68%
controls:0.37%
cases:0.29%
controls:0.06%
—
—
—
—
cases:0.90%
controls:0.29%
cases:2.13%
controls:1.36%
44
191
2038
20545
35
76
2047
20660
6
12
2076
20724
—
—
18
58
1986
19995
36
228
1656
16540
Prostate specific Ag [Mass/volume] in Serum or Plasma
2857-1 [3013603]
1.9e-01
7.2e-01
2.0e+00
1.7e+00
4.0e-01
4.1e-01
2.2e-01
cases:23.01%
controls:19.78%
cases:22.86%
controls:12.60%
cases:10.09%
controls:1.55%
cases:0.24%
controls:0.04%
cases:2.41%
controls:1.62%
cases:18.11%
controls:12.78%
cases:30.85%
controls:26.29%
479
4101
1603
16635
476
2613
1606
18123
210
322
1872
20414
5
9
2077
20727
50
336
2023
20365
363
2563
1641
17490
522
4408
1170
12360
Excision of lesion of parathyroid gland
BBA30 [2001300785]
2.0e+00
—
—
—
—
—
3.5e+00
cases:0.24%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:0.95%
controls:0.03%
5
7
2077
20729
—
—
—
—
—
16
5
1676
16763
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
5.9e-02
3.5e-01
7.4e-01
2.1e+00
5.6e-01
1.9e-01
2.6e-01
cases:9.75%
controls:9.24%
cases:8.02%
controls:5.77%
cases:2.26%
controls:1.09%
cases:0.38%
controls:0.05%
cases:1.83%
controls:1.06%
cases:7.29%
controls:6.12%
cases:16.55%
controls:13.31%
203
1917
1879
18819
167
1197
1915
19539
47
226
2035
20510
8
10
2074
20726
38
219
2035
20482
146
1227
1858
18826
280
2231
1412
14537
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
2.2e-02
2.9e-01
6.6e-01
1.9e+00
5.7e-01
2.3e-01
2.2e-01
cases:10.37%
controls:10.17%
cases:8.41%
controls:6.41%
cases:2.21%
controls:1.16%
cases:0.38%
controls:0.06%
cases:2.03%
controls:1.15%
cases:8.38%
controls:6.75%
cases:17.79%
controls:14.86%
216
2109
1866
18627
175
1330
1907
19406
46
240
2036
20496
8
12
2074
20724
42
239
2031
20462
168
1354
1836
18699
301
2491
1391
14277
Cathetrisation of vein
TPH04 [2001309597]
1.9e-01
5.3e-01
5.5e-01
—
1.5e+00
9.1e-01
5.1e-01
cases:3.75%
controls:3.12%
cases:2.26%
controls:1.34%
cases:0.38%
controls:0.22%
—
—
cases:0.72%
controls:0.17%
cases:3.19%
controls:1.32%
cases:5.91%
controls:3.63%
78
646
2004
20090
47
277
2035
20459
8
46
2074
20690
—
15
35
2058
20666
64
264
1940
19789
100
608
1592
16160
Monocytes [#/volume] in Blood
26484-6 [3001604]
1.3e-02
2.8e-01
6.6e-01
1.9e+00
6.1e-01
2.5e-01
2.3e-01
cases:9.85%
controls:9.73%
cases:8.07%
controls:6.22%
cases:2.16%
controls:1.12%
cases:0.38%
controls:0.06%
cases:2.03%
controls:1.11%
cases:8.18%
controls:6.47%
cases:17.43%
controls:14.39%
205
2018
1877
18718
168
1290
1914
19446
45
233
2037
20503
8
12
2074
20724
42
229
2031
20472
164
1298
1840
18755
295
2413
1397
14355
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
3.0e-01
5.8e-01
9.0e-01
—
1.0e+00
6.1e-01
2.6e-01
cases:7.49%
controls:5.66%
cases:5.14%
controls:2.94%
cases:1.10%
controls:0.45%
—
—
cases:1.40%
controls:0.51%
cases:5.49%
controls:3.07%
cases:10.87%
controls:8.64%
156
1174
1926
19562
107
610
1975
20126
23
94
2059
20642
—
29
106
2044
20595
110
615
1894
19438
184
1448
1508
15320
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83.9 [45547252]
—
—
-1.0e+50
—
—
2.1e+00
1.2e+00
—
—
—
—
cases:0.00%
controls:0.02%
—
—
—
—
cases:0.70%
controls:0.08%
cases:0.95%
controls:0.28%
—
—
0
5
2082
20731
—
—
14
17
1990
20036
16
47
1676
16721
pH of Urine by Test strip
5803-2 [3022621]
5.9e-01
1.2e+00
2.1e+00
—
—
5.2e-01
4.1e-01
cases:1.87%
controls:1.05%
cases:1.73%
controls:0.51%
cases:0.62%
controls:0.08%
—
—
—
—
cases:1.05%
controls:0.63%
cases:3.49%
controls:2.34%
39
218
2043
20518
36
105
2046
20631
13
16
2069
20720
—
—
21
126
1983
19927
59
393
1633
16375
Transluminal endoscopic extraction of calculus from bladder
KCE02 [2001305953]
3.3e+00
—
1.0e+50
1.0e+50
1.0e+50
—
—
cases:0.67%
controls:0.02%
—
—
cases:0.24%
controls:0.00%
cases:15.13%
controls:0.00%
cases:9.31%
controls:0.00%
—
—
—
—
14
5
2068
20731
—
5
0
2077
20736
315
0
1767
20736
193
0
1880
20701
—
—
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
1.5e+00
1.8e+00
—
—
—
—
1.3e+00
cases:0.53%
controls:0.12%
cases:0.34%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.16%
11
25
2071
20711
7
11
2075
20725
—
—
—
—
10
26
1682
16742
Abdominal ultrasound examination
JN3AE [2001305555]
5.5e-01
1.0e+00
—
—
1.6e+00
1.1e+00
6.2e-01
cases:2.69%
controls:1.57%
cases:1.39%
controls:0.51%
—
—
—
—
cases:0.34%
controls:0.07%
cases:1.30%
controls:0.42%
cases:3.19%
controls:1.74%
56
325
2026
20411
29
106
2053
20630
—
—
7
14
2066
20687
26
85
1978
19968
54
291
1638
16477
Monocytes/Leukocytes in Blood
26485-3 [3019069]
6.4e-02
3.4e-01
8.0e-01
1.9e+00
5.8e-01
2.6e-01
2.7e-01
cases:9.89%
controls:9.34%
cases:8.02%
controls:5.85%
cases:2.50%
controls:1.14%
cases:0.38%
controls:0.06%
cases:1.93%
controls:1.09%
cases:7.83%
controls:6.13%
cases:16.84%
controls:13.35%
206
1936
1876
18800
167
1213
1915
19523
52
237
2030
20499
8
12
2074
20724
40
226
2033
20475
157
1230
1847
18823
285
2238
1407
14530
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
6.5e-02
3.4e-01
7.6e-01
1.9e+00
5.6e-01
2.6e-01
2.7e-01
cases:10.18%
controls:9.60%
cases:8.21%
controls:5.97%
cases:2.45%
controls:1.16%
cases:0.38%
controls:0.06%
cases:1.93%
controls:1.12%
cases:8.03%
controls:6.33%
cases:17.20%
controls:13.74%
212
1991
1870
18745
171
1237
1911
19499
51
241
2031
20495
8
12
2074
20724
40
231
2033
20470
161
1270
1843
18783
291
2304
1401
14464
Ultrasound examination of scrotum
KF8AE [2001306187]
5.9e-01
2.0e+00
—
—
—
—
1.3e+00
cases:0.53%
controls:0.29%
cases:0.38%
controls:0.05%
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.32%
11
61
2071
20675
8
11
2074
20725
—
—
—
—
19
54
1673
16714
amoxicillin; oral, parenteral
J01CA04 [21602823]
1.3e-01
2.4e-01
1.1e+00
—
1.4e+00
4.3e-01
3.0e-01
cases:20.08%
controls:18.14%
cases:7.49%
controls:6.01%
cases:1.68%
controls:0.59%
—
—
cases:2.32%
controls:0.57%
cases:8.53%
controls:5.70%
cases:23.11%
controls:18.15%
418
3761
1664
16975
156
1247
1926
19489
35
123
2047
20613
—
48
117
2025
20584
171
1143
1833
18910
391
3043
1301
13725
Malignant neoplasm: Lateral wall of bladder
C67.2 [45586020]
4.2e-01
6.6e-01
—
—
—
1.8e+00
1.4e+00
cases:0.34%
controls:0.22%
cases:0.29%
controls:0.15%
—
—
—
—
—
—
cases:0.85%
controls:0.14%
cases:0.89%
controls:0.21%
7
46
2075
20690
6
31
2076
20705
—
—
—
17
29
1987
20024
15
36
1677
16732
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.6e-01
4.6e-01
8.7e-01
—
9.9e-01
5.1e-01
3.0e-01
cases:10.52%
controls:9.09%
cases:8.36%
controls:5.44%
cases:2.26%
controls:0.96%
—
—
cases:2.70%
controls:1.02%
cases:8.73%
controls:5.43%
cases:17.55%
controls:13.67%
219
1884
1863
18852
174
1129
1908
19607
47
199
2035
20537
—
56
211
2017
20490
175
1089
1829
18964
297
2292
1395
14476
Protein [Mass/volume] in Urine
2888-6 [3037121]
1.2e-02
9.2e-01
2.2e+00
—
—
8.9e-01
3.9e-01
cases:0.62%
controls:0.62%
cases:0.91%
controls:0.37%
cases:0.38%
controls:0.04%
—
—
—
—
cases:0.85%
controls:0.35%
cases:1.36%
controls:0.92%
13
128
2069
20608
19
76
2063
20660
8
9
2074
20727
—
—
17
70
1987
19983
23
155
1669
16613
Physical Medicine And Rehabilitation
25 [38004468]
3.1e-01
5.3e-01
1.1e+00
—
9.2e-01
6.6e-01
4.9e-01
cases:7.44%
controls:5.57%
cases:3.22%
controls:1.92%
cases:0.86%
controls:0.29%
—
—
cases:0.68%
controls:0.27%
cases:3.39%
controls:1.79%
cases:8.81%
controls:5.56%
155
1155
1927
19581
67
399
2015
20337
18
61
2064
20675
—
14
56
2059
20645
68
358
1936
19695
149
933
1543
15835
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
2.3e-01
4.7e-01
9.2e-01
—
1.4e+00
3.3e-01
2.9e-01
cases:10.13%
controls:8.23%
cases:6.29%
controls:4.03%
cases:1.54%
controls:0.62%
—
—
cases:1.88%
controls:0.48%
cases:6.14%
controls:4.50%
cases:16.19%
controls:12.60%
211
1707
1871
19029
131
835
1951
19901
32
128
2050
20608
—
39
100
2034
20601
123
902
1881
19151
274
2113
1418
14655
Thorax X-ray examination
GD1AA [2001303617]
1.7e-01
4.4e-01
7.7e-01
—
9.3e-01
5.0e-01
4.0e-01
cases:11.86%
controls:10.24%
cases:6.00%
controls:3.96%
cases:1.30%
controls:0.60%
—
—
cases:1.21%
controls:0.48%
cases:6.44%
controls:4.00%
cases:15.90%
controls:11.29%
247
2123
1835
18613
125
822
1957
19914
27
125
2055
20611
—
25
99
2048
20602
129
802
1875
19251
269
1893
1423
14875
Medical Oncology
90 [38004507]
5.0e-01
5.8e-01
5.5e-01
1.4e+00
7.4e-01
8.0e-01
3.9e-01
cases:6.24%
controls:3.89%
cases:4.51%
controls:2.59%
cases:1.59%
controls:0.92%
cases:0.24%
controls:0.06%
cases:1.93%
controls:0.93%
cases:5.44%
controls:2.51%
cases:6.80%
controls:4.69%
130
807
1952
19929
94
537
1988
20199
33
191
2049
20545
5
12
2077
20724
40
192
2033
20509
109
503
1895
19550
115
787
1577
15981
Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12841-3 [3001784]
1.5e-01
6.7e-01
2.0e+00
—
5.5e-01
3.0e-01
-3.8e-03
cases:16.67%
controls:14.70%
cases:14.84%
controls:8.20%
cases:6.53%
controls:0.90%
—
—
cases:1.59%
controls:0.92%
cases:10.23%
controls:7.82%
cases:18.97%
controls:19.03%
347
3049
1735
17687
309
1701
1773
19035
136
186
1946
20550
—
33
191
2040
20510
205
1568
1799
18485
321
3191
1371
13577
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
-7.9e-02
-1.6e-01
2.4e-01
3.0e+00
5.7e-01
1.1e-02
-1.1e-01
cases:2.74%
controls:2.96%
cases:1.59%
controls:1.86%
cases:0.53%
controls:0.41%
cases:0.48%
controls:0.02%
cases:0.68%
controls:0.38%
cases:2.00%
controls:1.97%
cases:3.61%
controls:4.03%
57
613
2025
20123
33
386
2049
20350
11
86
2071
20650
10
5
2072
20731
14
79
2059
20622
40
396
1964
19657
61
675
1631
16093
dutasteride; oral
G04CB02 [21602676]
5.4e-01
8.2e-01
8.0e-01
2.3e+00
9.3e-01
6.9e-01
2.4e-01
cases:3.75%
controls:2.22%
cases:3.46%
controls:1.55%
cases:0.86%
controls:0.39%
cases:0.24%
controls:0.02%
cases:1.35%
controls:0.54%
cases:3.14%
controls:1.60%
cases:4.08%
controls:3.25%
78
460
2004
20276
72
322
2010
20414
18
81
2064
20655
5
5
2077
20731
28
111
2045
20590
63
320
1941
19733
69
545
1623
16223
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
7.4e-01
1.4e+00
—
—
—
1.6e+00
3.3e-01
cases:1.10%
controls:0.53%
cases:0.62%
controls:0.15%
—
—
—
—
—
—
cases:0.65%
controls:0.13%
cases:0.83%
controls:0.60%
23
110
2059
20626
13
32
2069
20704
—
—
—
13
27
1991
20026
14
100
1678
16668
Prostate cancer
116 [2001600116]
6.2e-01
9.1e-01
—
—
—
1.4e+00
3.8e-01
cases:2.59%
controls:1.42%
cases:0.96%
controls:0.39%
—
—
—
—
—
—
cases:1.10%
controls:0.27%
cases:1.71%
controls:1.17%
54
294
2028
20442
20
81
2062
20655
—
—
—
22
55
1982
19998
29
197
1663
16571
Rehabilitation Hospital
283X00000X [38004285]
6.9e-01
1.6e+00
—
—
—
1.3e+00
1.3e+00
cases:0.77%
controls:0.39%
cases:0.62%
controls:0.12%
—
—
—
—
—
—
cases:0.35%
controls:0.09%
cases:1.00%
controls:0.29%
16
80
2066
20656
13
25
2069
20711
—
—
—
7
19
1997
20034
17
48
1675
16720
Intubation
WX704 [2001310820]
3.4e-01
9.3e-01
-1.0e+50
—
—
1.3e+00
6.5e-01
cases:1.10%
controls:0.79%
cases:0.82%
controls:0.32%
cases:0.00%
controls:0.03%
—
—
—
—
cases:1.10%
controls:0.29%
cases:1.95%
controls:1.03%
23
163
2059
20573
17
67
2065
20669
0
6
2082
20730
—
—
22
59
1982
19994
33
172
1659
16596
Parathyrin.intact [Moles/volume] in Serum or Plasma
14866-8 [3010566]
7.5e-01
4.4e-01
—
—
-1.0e+50
1.7e+00
1.2e+00
cases:0.67%
controls:0.32%
cases:0.43%
controls:0.28%
—
—
—
—
cases:0.00%
controls:0.03%
cases:1.25%
controls:0.23%
cases:1.36%
controls:0.41%
14
66
2068
20670
9
58
2073
20678
—
—
0
6
2073
20695
25
47
1979
20006
23
68
1669
16700
Eosinophils [#/volume] in Blood
26449-9 [3013115]
2.7e-02
2.7e-01
6.4e-01
1.7e+00
5.9e-01
2.3e-01
2.1e-01
cases:10.42%
controls:10.18%
cases:8.26%
controls:6.46%
cases:2.21%
controls:1.18%
cases:0.38%
controls:0.07%
cases:2.12%
controls:1.19%
cases:8.43%
controls:6.83%
cases:17.91%
controls:15.08%
217
2110
1865
18626
172
1339
1910
19397
46
245
2036
20491
8
15
2074
20721
44
247
2029
20454
169
1369
1835
18684
303
2529
1389
14239
Atrial fibrillation and flutter
I48 [45596206]
-1.8e-01
2.5e-02
1.2e-01
2.9e+00
4.3e-01
1.1e-01
8.9e-02
cases:7.93%
controls:9.37%
cases:5.52%
controls:5.40%
cases:1.15%
controls:1.02%
cases:1.01%
controls:0.06%
cases:1.59%
controls:1.04%
cases:5.74%
controls:5.15%
cases:11.47%
controls:10.59%
165
1943
1917
18793
115
1119
1967
19617
24
212
2058
20524
21
12
2061
20724
33
215
2040
20486
115
1033
1889
19020
194
1776
1498
14992
Left side
ZXA05 [2001311347]
2.5e-01
4.7e-01
—
1.0e+50
1.5e+00
7.8e-01
5.3e-01
cases:4.76%
controls:3.74%
cases:1.49%
controls:0.94%
—
—
cases:0.43%
controls:0.00%
cases:0.43%
controls:0.10%
cases:1.80%
controls:0.83%
cases:4.85%
controls:2.91%
99
776
1983
19960
31
194
2051
20542
—
9
0
2073
20736
9
20
2064
20681
36
166
1968
19887
82
488
1610
16280
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
7.5e-01
8.7e-01
9.6e-01
—
1.1e+00
1.2e+00
6.3e-01
cases:1.39%
controls:0.66%
cases:0.91%
controls:0.39%
cases:0.24%
controls:0.09%
—
—
cases:0.29%
controls:0.10%
cases:1.00%
controls:0.31%
cases:1.48%
controls:0.79%
29
137
2053
20599
19
80
2063
20656
5
19
2077
20717
—
6
20
2067
20681
20
62
1984
19991
25
133
1667
16635
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
6.5e-01
8.7e-01
—
—
—
2.0e+00
8.1e-01
cases:1.15%
controls:0.60%
cases:0.48%
controls:0.20%
—
—
—
—
—
—
cases:0.90%
controls:0.12%
cases:1.36%
controls:0.61%
24
125
2058
20611
10
42
2072
20694
—
—
—
18
25
1986
20028
23
102
1669
16666
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
8.7e-01
1.4e+00
—
—
—
1.3e+00
7.4e-01
cases:0.72%
controls:0.30%
cases:0.82%
controls:0.19%
—
—
—
—
—
—
cases:0.80%
controls:0.21%
cases:1.00%
controls:0.48%
15
63
2067
20673
17
40
2065
20696
—
—
—
16
43
1988
20010
17
81
1675
16687
Tissue Pathology biopsy report
66121-5 [40768804]
2.3e-01
2.8e-01
6.7e-01
—
1.4e+00
9.0e-01
4.1e-01
cases:9.32%
controls:7.56%
cases:3.65%
controls:2.78%
cases:0.53%
controls:0.27%
—
—
cases:1.30%
controls:0.31%
cases:6.49%
controls:2.74%
cases:11.82%
controls:8.18%
194
1567
1888
19169
76
576
2006
20160
11
56
2071
20680
—
27
64
2046
20637
130
549
1874
19504
200
1371
1492
15397
Intraoperative use of conventional X-ray imaging
ZXM10 [2001311446]
4.7e-01
1.2e+00
—
—
—
1.8e+00
9.6e-01
cases:0.86%
controls:0.54%
cases:0.53%
controls:0.16%
—
—
—
—
—
—
cases:0.90%
controls:0.15%
cases:1.54%
controls:0.60%
18
112
2064
20624
11
33
2071
20703
—
—
—
18
30
1986
20023
26
100
1666
16668
Decubitus ulcer and pressure area
L89 [45601235]
1.6e+00
1.4e+00
2.0e+00
—
—
5.1e-01
1.1e+00
cases:0.62%
controls:0.13%
cases:0.38%
controls:0.09%
cases:0.24%
controls:0.03%
—
—
—
—
cases:0.25%
controls:0.15%
cases:1.12%
controls:0.37%
13
26
2069
20710
8
19
2074
20717
5
7
2077
20729
—
—
5
30
1999
20023
19
62
1673
16706
tolterodine; oral
G04BD07 [21602640]
7.7e-01
1.5e+00
-1.0e+50
—
—
1.2e+00
5.0e-01
cases:1.01%
controls:0.47%
cases:0.72%
controls:0.16%
cases:0.00%
controls:0.03%
—
—
—
—
cases:0.60%
controls:0.17%
cases:0.77%
controls:0.47%
21
97
2061
20639
15
34
2067
20702
0
6
2082
20730
—
—
12
35
1992
20018
13
78
1679
16690

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1117
5346
3.25
157.59
6.4
3.2
—
—
—
0
0
402
1066
4.40
138.54
2.8
2.8
—
—
—
0
0
1699
11890
2.99
97.89
9.6
4.7
743.05
1098.56
e6/l
0.26
60
219
890
4778
2.46
86.57
4.2
2.8
4.60
3.79
e6/l
1.31
819
4379
1125
6774
2.37
83.56
6.2
3.6
200.26
94.77
e6/l
1.54
953
5322
1166
7360
2.26
74.49
7.4
4.1
213.46
113.06
e6/l
2.53
962
5487
1652
12259
2.46
69.23
8.0
4.5
2658.80
2.69
—
5
22
122
214
5.98
66.96
2.1
1.8
5.78
4.53
mmol/24h
2.50
114
194
961
5789
2.19
66.67
5.7
3.5
0.35
0.45
e6/l
1.81
794
4389
1151
7533
2.13
63.37
5.8
3.4
6.18
6.22
ph
0.62
722
4194
912
5465
2.15
63.24
5.5
3.4
4.65
79.69
estimate
—
6
32
1346
9403
2.14
61.72
6.7
3.8
0.00
0.00
estimate
0.50
346
2103
1356
9518
2.13
61.15
6.7
3.8
11.17
3.33
estimate
0.62
361
2123
1357
9567
2.12
59.95
6.7
3.9
0.01
0.17
estimate
0.55
335
1952
729
4106
2.17
58.23
5.1
3.0
602.38
556.71
mosm/kgh2o
6.84
645
3614
1252
8674
2.05
56.59
3.5
3.1
—
—
estimate
—
0
0
408
1859
2.47
53.25
4.5
2.6
0.32
0.48
e6/l
0.84
399
1793
1519
11522
2.06
50.59
6.1
5.8
6.89
6.90
mmol/l
0.04
1480
11044
1051
7084
1.94
48.68
6.8
3.9
0.07
0.02
estimate
1.10
252
1775
1319
9860
1.86
41.66
8.9
8.2
1.21
1.20
mmol/l
7.41
1134
8452
614
3595
1.99
41.64
5.2
3.2
1.48
0.90
e6/l
3.13
399
2006
583
3355
2.01
41.52
5.7
3.3
1.68
1.04
e6/l
2.14
363
1767
777
4954
1.89
40.63
6.0
3.4
0.04
0.03
estimate
0.16
238
1640
811
5311
1.84
38.46
3.1
3.2
356.86
368.47
umol/l
2.52
718
4610
907
6206
1.79
36.76
2.9
2.8
—
—
—
0
0
821
5483
1.80
35.89
6.7
4.0
0.02
0.00
estimate
0.49
306
1829
925
6423
1.77
35.21
5.5
4.7
—
—
—
0
0
1315
10131
1.76
34.34
7.2
7.0
11.58
12.94
umol/l
5.16
1261
9705
1303
10041
1.75
33.70
17.7
19.8
1.29
1.36
inr
5.13
1144
8552
32
0
+∞
33.42
1.2
0.0
317.63
—
umol/24h
—
32
0
1679
13977
1.89
33.04
10.0
8.8
83.05
81.96
u/l
0.24
1606
13293
865
5976
1.74
32.88
3.0
2.8
153.93
60.48
u/l
0.51
811
5546
1923
16819
2.27
32.55
25.8
19.6
28.09
28.50
mg/l
0.22
1722
14290
1168
8881
1.68
30.32
7.8
7.5
1.22
1.20
mmol/l
9.67
1084
8204
333
1736
2.08
30.16
2.6
2.1
0.03
0.01
estimate
0.33
59
350
698
4666
1.73
28.99
4.7
2.9
0.24
0.03
0.86
25
143
1151
8808
1.65
28.38
5.6
5.6
34.46
34.75
g/l
0.88
1076
8258
1946
17465
2.12
24.97
30.3
24.0
139.96
139.61
mmol/l
9.42
1923
17120
271
1408
2.06
24.50
4.7
4.5
97.84
104.85
ng/l
0.40
238
1226
1946
17489
2.11
24.49
30.5
24.2
4.00
4.02
mmol/l
2.92
1919
17123
864
6320
1.61
24.29
3.3
3.6
2.35
2.34
mmol/l
1.23
775
5704
418
2605
1.75
21.35
1.5
1.4
—
—
—
0
0
1014
7868
1.54
21.10
5.0
4.4
41.64
73.57
ng/l
1.92
828
6200
609
4220
1.62
20.68
6.9
4.1
1.02
1.02
kg/l
2.79
457
2913
454
2923
1.70
20.53
6.5
6.7
1.00
1.04
mmol/l
1.97
430
2738
1953
17876
1.94
18.76
34.2
26.0
90.04
88.19
umol/l
0.94
1938
17640
785
5907
1.52
17.98
5.3
4.5
7.39
7.40
ph
1.44
594
4321
183
930
2.06
17.42
2.7
2.2
0.05
0.00
estimate
0.44
41
259
1347
11357
1.49
17.30
7.1
6.0
3.92
3.72
ug/l
0.12
1215
10197
953
7508
1.48
17.22
2.6
2.3
74.75
77.00
nmol/l
1.68
834
6641
884
6873
1.48
17.00
4.7
4.1
—
0.68
—
0
22
1922
17622
1.80
16.68
14.7
13.1
27.28
27.01
u/l
0.09
1861
17039
1505
13051
1.50
16.25
4.7
4.4
14.08
13.31
mm/h
0.88
1391
12110
1956
18060
1.85
16.14
37.5
29.3
7.22
6.98
e9/l
4.34
1912
17569
1955
18057
1.85
15.99
37.4
29.2
91.56
91.78
fl
1.29
1937
17812
1955
18057
1.85
15.99
37.5
29.3
236.48
234.40
e9/l
0.70
1916
17641
1955
18059
1.84
15.95
37.4
29.1
30.39
30.57
pg
4.15
1937
17813
1955
18060
1.84
15.93
38.1
29.9
40.15
40.27
%
0.44
1935
17803
1955
18060
1.84
15.93
37.5
29.2
4.45
4.46
e12/l
0.26
1910
17571
31
58
5.41
15.90
1.9
1.1
158.42
189.29
mmol/24h
1.00
31
58
1955
18063
1.84
15.88
37.8
29.5
133.97
135.18
g/l
2.52
1939
17817
182
963
1.97
15.46
5.8
3.4
1.02
1.02
ratio
0.49
162
890
874
6894
1.45
15.06
2.4
2.3
—
—
—
0
0
882
6989
1.44
14.73
4.5
4.4
12.88
9.47
mg/mmol
0.56
647
4622
1235
10429
1.43
14.38
9.6
9.6
4.73
4.38
e9/l
3.94
1077
8992
646
4854
1.47
14.14
4.7
4.5
85.49
82.20
%
2.79
638
4768
248
1495
1.74
13.89
6.6
3.9
—
—
—
0
0
1056
8707
1.42
13.85
6.9
6.3
59.76
58.75
%
1.63
997
8317
257
1573
1.72
13.62
4.1
3.9
7.42
7.42
ph
0.00
223
1325
13
0
+∞
13.55
1.1
0.0
30.95
—
mg/24h
—
13
0
262
1623
1.70
13.28
4.2
3.9
5.17
5.11
kpa
0.49
251
1550
581
4323
1.47
13.22
6.0
3.7
0.13
0.15
—
8
55
110
517
2.19
12.84
6.9
3.9
—
—
—
0
0
1689
15248
1.49
12.84
4.8
4.7
1.91
2.02
mu/l
2.61
1512
13814
1066
8876
1.40
12.83
7.1
6.5
24.94
25.64
%
1.10
1007
8399
1052
8757
1.39
12.59
7.0
6.6
8.99
9.27
%
1.90
973
8205
1050
8742
1.39
12.53
7.0
6.6
0.59
0.65
%
2.95
973
8188
12
0
+∞
12.51
1.3
0.0
1.87
—
mmol/24h
—
12
0
52
173
3.06
12.33
2.3
1.9
1.34
1.21
u/field
0.11
29
92
1047
8747
1.38
12.06
6.9
6.5
2.80
2.90
%
0.70
971
8197
36
96
3.80
12.01
2.8
1.6
4.92
3.10
u/field
0.36
24
67
152
839
1.87
11.38
2.7
1.9
—
—
—
0
0
861
7020
1.38
11.28
3.8
3.5
8.38
7.85
mmol/l
2.99
714
5850
29
69
4.25
11.28
1.8
2.8
0.63
0.61
mmol/l
0.47
29
69
839
6842
1.37
10.86
3.7
3.6
66.94
53.90
mg/l
0.91
643
4702
303
2050
1.56
10.66
1.5
1.4
—
—
—
0
0
123
648
1.95
10.61
3.0
3.0
8.22
7.88
kpa
0.94
118
633
221
1388
1.66
10.58
3.4
2.7
6.00
6.03
ph
0.22
161
1001
504
3808
1.42
10.17
3.1
3.2
2.46
2.45
mmol/l
1.80
453
3418
319
2222
1.51
9.77
3.5
3.4
4.74
5.06
e9/l
0.37
267
1888
341
2410
1.49
9.74
4.7
3.8
5.68
5.83
kpa
2.10
332
2341
1127
9720
1.33
9.67
6.9
6.4
0.20
0.20
e9/l
0.26
974
8408
1114
9603
1.33
9.54
6.9
6.3
1.93
1.87
e9/l
0.26
975
8364
1066
9137
1.33
9.48
5.5
4.9
22.98
22.11
%
1.18
652
4836
9
0
+∞
9.38
1.1
0.0
310.44
—
mg/24h
—
9
0
276
1880
1.54
9.37
4.3
4.8
7.36
7.35
ph
0.14
216
1362
949
8016
1.33
9.27
3.4
3.2
174.58
171.14
ug/l
0.09
846
7410
1746
16144
1.42
9.26
8.1
7.2
40.82
40.37
mmol/mol
1.29
1610
14956
767
6283
1.34
9.25
2.3
2.3
178.31
255.56
u/l
2.08
720
5948
1764
16346
1.43
9.19
5.9
5.6
6.21
6.12
mmol/l
1.99
1579
14792
331
2352
1.48
9.17
4.7
3.8
1.53
1.76
mmol/l
0.55
275
2010
315
2223
1.49
9.03
2.8
2.9
7.78
10.22
umol/l
1.66
275
2001
1094
9457
1.32
8.95
6.8
6.1
0.04
0.04
e9/l
0.25
943
8039
1089
9418
1.31
8.84
6.8
6.1
0.63
0.63
e9/l
0.31
936
7994
1376
12297
1.33
8.80
3.8
3.7
14.97
14.95
pmol/l
0.06
1233
11045
733
5999
1.34
8.79
3.2
3.3
35.16
37.69
u/l
0.43
688
5666
287
2003
1.50
8.67
3.8
3.1
4.66
4.49
kpa
0.59
278
1944
805
6703
1.32
8.48
3.7
3.5
0.91
0.81
ug/l
1.37
597
4724
1795
16745
1.42
8.46
6.2
6.2
2.47
2.49
mmol/l
0.68
1635
15399
172
1076
1.65
8.36
4.2
4.1
—
—
—
0
0
613
4915
1.34
8.36
1.5
1.4
—
—
—
0
0
463
3553
1.39
8.34
3.4
3.3
0.80
0.82
mmol/l
1.77
427
3357
338
2454
1.45
8.34
4.8
3.9
7.38
7.38
ph
0.01
218
1474
1022
8816
1.30
8.23
2.4
2.3
88.20
92.57
pmol/l
2.56
625
4993
938
8001
1.30
8.21
16.4
12.6
0.00
0.00
e9/l
0.23
787
6522
296
2116
1.46
7.91
6.5
8.2
1.25
1.39
mmol/l
2.73
290
2077
236
1612
1.52
7.89
4.3
4.3
1.23
1.22
mmol/l
3.16
205
1408
103
571
1.84
7.68
2.4
2.2
132.50
129.75
g/l
0.49
86
455
778
6523
1.30
7.57
6.7
6.1
—
—
—
0
0
821
6938
1.30
7.51
3.4
3.4
1583.72
1896.30
ng/l
1.09
707
6108
325
2387
1.43
7.50
2.0
1.8
—
—
—
0
0
61
284
2.18
7.41
6.3
6.5
7.09
7.46
mmol/l
0.39
49
241
171
1111
1.59
7.15
4.3
3.5
24.49
24.97
mmol/l
0.97
166
1070
652
5376
1.30
7.09
7.6
6.5
—
—
—
0
0
1755
16437
1.36
7.02
5.6
5.4
4.25
4.32
mmol/l
2.33
1611
15195
482
3820
1.34
6.93
1.9
1.8
1131.50
1167.93
nmol/l
0.34
354
2907
1741
16323
1.34
6.63
5.5
5.3
1.31
1.36
mmol/l
5.32
1584
14954
667
5557
1.29
6.62
2.4
2.4
3.15
2.90
mg/l
1.27
570
4791
245
1747
1.45
6.61
2.9
2.6
30.54
69.00
u/l
0.77
212
1458
525
4243
1.31
6.53
1.9
1.8
22871429.28
25314700.46
pmol/l
0.04
411
3500
213
1490
1.48
6.34
4.0
3.3
131.52
128.03
g/l
1.51
208
1445
1477
13594
1.27
6.18
30.8
24.0
13.99
13.85
%
3.01
1464
13427
246
1779
1.43
6.16
2.9
2.4
204.24
173.20
ug/g
0.46
199
1434
33
127
2.62
6.14
3.5
3.0
—
—
—
0
0
483
3896
1.31
6.04
1.7
1.7
1.28
1.58
mg/l
1.36
391
3084
436
3471
1.32
5.99
1.9
2.1
30.02
30.10
s
0.10
427
3372
65
339
1.95
5.90
4.9
6.7
12.39
12.07
mg/l
0.22
60
318
11
12
9.21
5.78
1.3
1.2
—
—
—
0
0
164
1112
1.51
5.70
2.1
1.9
2.46
2.73
ug/l
0.13
144
976
77
431
1.82
5.65
3.9
3.5
28.26
32.10
mg/l
0.39
53
309
119
752
1.62
5.63
3.2
3.2
378.87
322.83
mg/l
0.31
62
345
464
3757
1.30
5.60
3.0
2.8
12.11
12.51
umol/l
0.43
420
3514
1217
11025
1.24
5.52
3.7
3.4
50.42
58.44
u/l
2.83
1123
10253
381
3009
1.32
5.51
2.1
2.1
—
—
—
0
0
710
6072
1.25
5.46
1.9
1.8
18.76
19.31
nmol/l
0.39
584
5157
270
2029
1.38
5.41
8.7
9.5
—
—
—
0
0
415
3326
1.31
5.39
3.0
2.8
22.38
22.83
%
0.16
379
3111
436
3536
1.29
5.17
2.9
2.8
2.20
2.21
g/l
0.26
394
3278
1665
15680
1.27
5.04
4.7
4.6
1.35
1.28
mmol/l
2.98
1502
14241
36
163
2.23
4.79
2.0
2.0
7.76
7.80
mmol/l
0.02
36
163
15
34
4.44
4.74
2.7
1.9
7.17
9.38
mg/l
0.81
15
29
232
1739
1.37
4.73
4.4
4.5
0.03
0.11
%
2.31
86
550
364
2923
1.29
4.62
2.7
2.5
1.72
1.76
%
0.42
320
2617
241
1828
1.36
4.56
4.2
4.4
0.89
0.88
%
0.04
94
637
122
826
1.51
4.33
4.2
4.2
24.68
24.74
mmol/l
0.08
116
762
290
2286
1.31
4.22
2.1
2.3
12.23
13.14
nmol/l
0.92
256
2015
90
573
1.60
4.21
3.4
4.2
—
—
—
0
0
227
1730
1.35
4.18
4.1
4.3
0.74
0.68
%
0.16
86
593
259
2015
1.32
4.14
2.5
2.2
0.19
0.20
g/l
0.66
231
1868
313
2501
1.29
4.12
1.2
1.3
—
—
—
0
0
281
2214
1.31
4.11
4.7
4.3
5.02
24.62
ug/l
3.22
233
1874
65
390
1.69
3.86
1.4
1.5
0.90
0.88
nmol/l
0.07
60
328
227
1753
1.33
3.83
4.8
4.6
0.18
0.10
%
0.21
82
518
82
525
1.58
3.78
1.4
1.5
251.51
255.28
ug/g
0.05
40
346
118
819
1.47
3.75
3.2
3.4
43.32
6186.45
u/ml
1.12
100
705
39
203
1.94
3.68
2.9
2.0
5811.89
3334.21
u/l
0.17
16
74
14
45
3.12
3.65
2.1
1.8
—
—
—
0
0
284
2298
1.27
3.39
5.2
5.2
32.65
32.63
%
0.01
196
1497
367
3062
1.24
3.36
1.5
1.6
2.64
2.76
g/l
0.46
222
1906
282
2286
1.27
3.32
2.6
2.5
65.94
67.48
e9/l
0.36
210
1698
82
544
1.53
3.27
4.1
3.5
2.51
1.67
index
0.28
41
308
278
2263
1.26
3.16
7.3
7.5
10.51
11.25
mmol/l
0.91
258
2164
9
20
4.51
3.11
1.6
1.2
—
—
—
0
0
118
851
1.41
3.10
1.4
1.3
—
—
—
0
0
30
153
1.97
3.05
1.8
1.4
0.96
1.09
promille
0.20
23
125
310
2568
1.24
3.03
8.0
8.5
95.14
95.21
%
0.05
304
2480
388
3291
1.22
3.03
1.2
1.2
0.95
1.72
u/ml
2.21
111
869
59
371
1.61
2.99
1.5
1.3
—
—
—
0
0
1421
13443
1.17
2.89
30.9
25.4
331.86
332.61
g/l
2.36
1408
13355
332
2794
1.22
2.80
7.8
8.3
0.73
0.88
mmol/l
0.28
277
2260
71
477
1.51
2.73
4.0
3.6
293.43
638.68
u/ml
0.50
66
445
333
2811
1.22
2.73
7.8
8.4
7.41
7.41
ph
0.05
190
1606
43
258
1.68
2.65
1.1
1.1
—
—
—
0
0
114
842
1.37
2.65
3.2
3.9
52.09
60.38
mg/l
0.41
97
701
201
1614
1.27
2.59
1.3
1.4
—
—
—
0
0
76
526
1.46
2.54
1.7
1.6
9.13
24.62
u/ml
2.94
11
107
113
841
1.36
2.52
3.2
3.9
46.91
72.66
mg/l
0.65
97
703
18
82
2.21
2.47
1.9
1.8
—
—
—
0
0
86
616
1.41
2.41
3.3
2.9
1.60
1.73
mg/l
0.87
76
545
25
131
1.92
2.40
1.6
2.4
6.54
6.81
mmol/l
0.26
16
89
633
5703
1.16
2.40
3.9
3.5
—
—
—
0
0
32
182
1.77
2.40
1.2
1.3
—
—
nmol/l
—
0
0
157
1236
1.29
2.38
3.8
2.7
0.62
0.62
%
0.12
157
1230
259
2166
1.22
2.34
1.4
1.3
507.41
455.86
titre
0.19
54
449
11
39
2.83
2.34
1.1
1.1
—
—
—
0
0
36
214
1.69
2.33
1.1
1.1
—
—
—
0
0
60
404
1.50
2.32
3.6
4.0
1.29
1.74
%
0.52
52
360
90
1219
0.73
2.32
2.0
2.1
3.77
3.53
ratio
0.83
70
996
159
1259
1.28
2.32
4.1
2.7
1.29
1.16
%
0.93
159
1252
20
98
2.05
2.31
1.9
1.2
—
—
—
0
0
318
2720
1.20
2.28
1.3
1.3
62.00
34.70
iu/ml
0.73
87
808
7
18
3.90
2.25
10.3
2.4
0.14
0.39
u/field
—
7
18
60
862
0.69
2.19
1.7
1.8
3.40
3.38
mmol/l
0.04
43
639
32
188
1.71
2.17
2.0
1.8
—
—
—
0
0
6
14
4.29
2.15
1.0
1.1
—
—
—
0
0
11
42
2.63
2.14
1.3
1.1
680.67
263.59
pmol/l
—
6
27
327
2821
1.19
2.14
7.8
8.4
5.08
5.08
kpa
0.06
318
2716
327
2821
1.19
2.14
7.8
8.3
12.13
11.85
kpa
0.47
319
2719
60
414
1.46
2.09
1.2
1.1
—
—
—
0
0
68
484
1.42
2.02
3.1
5.5
2.20
2.63
mmol/l
0.69
46
326
124
970
1.30
2.02
1.3
1.4
—
—
—
0
0
142
1134
1.27
1.97
1.7
1.5
—
—
—
0
0
22
119
1.86
1.97
1.8
1.7
—
—
—
0
0
54
371
1.47
1.94
1.8
1.4
—
—
—
0
0
9
33
2.73
1.93
4.0
6.7
9.13
8.59
mmol/l
—
9
33
458
4092
1.15
1.92
4.3
4.3
433.90
691.64
ng/l
0.48
361
3524
123
968
1.29
1.92
2.1
2.4
—
—
—
0
0
28
165
1.71
1.91
1.3
1.2
—
—
—
0
0
28
165
1.71
1.91
2.4
2.3
14.79
16.37
%
1.38
28
165
41
267
1.55
1.90
3.6
3.9
59.13
57.40
%
0.20
33
230
15
72
2.09
1.86
1.1
1.1
—
—
—
0
0
16
79
2.03
1.85
2.2
1.8
38.89
39.30
g/l
0.08
16
79
102
788
1.31
1.84
3.1
3.6
4.41
4.39
pmol/l
0.07
90
697
5
12
4.17
1.82
1.0
1.2
—
—
—
0
0
16
80
2.01
1.80
1.3
1.3
1451.99
169.75
ug/l
—
9
32
101
784
1.30
1.77
1.2
1.2
—
—
—
0
0
14
68
2.07
1.70
1.4
1.7
—
—
—
0
0
29
179
1.63
1.70
4.3
3.8
14.20
11.68
index
0.57
15
114
99
774
1.29
1.66
3.4
3.7
1.57
2.85
ratio
1.44
56
449
32
204
1.58
1.65
1.3
1.2
—
—
—
0
0
174
1456
1.21
1.62
8.3
10.3
24.10
24.11
mmol/l
0.01
168
1430
59
431
1.38
1.57
1.4
1.4
11.47
8.41
u/l
1.12
50
349
97
764
1.28
1.56
1.2
1.2
133.33
130.86
u/ml
0.02
31
273
40
273
1.47
1.54
1.1
1.1
11.80
24.80
iu/ml
—
5
50
195
1660
1.19
1.53
2.5
2.7
—
—
—
0
0
288
2534
1.16
1.51
1.3
1.3
11.83
11.77
u/ml
0.00
98
924
746
6962
1.11
1.51
2.0
1.9
1.43
1.32
mmol/l
2.59
587
5745
49
350
1.41
1.50
1.6
1.2
—
—
—
0
0
119
966
1.25
1.50
2.2
2.6
4.21
4.13
g/l
0.42
107
886
22
131
1.69
1.49
1.0
1.2
125.91
94.16
pmol/l
2.48
22
131
205
1758
1.18
1.48
2.0
1.6
—
—
—
0
0
55
402
1.38
1.48
3.0
3.4
58.42
59.11
%
0.11
55
402
9
37
2.44
1.48
12.2
11.4
5.49
5.92
mmol/l
—
9
37
20
117
1.72
1.45
1.6
1.5
—
—
—
0
0
47
336
1.41
1.44
1.4
1.4
30.90
22.54
iu/l
0.85
39
282
118
965
1.24
1.41
2.2
2.6
3.87
3.75
g/l
0.38
106
884
9
40
2.26
1.40
1.3
1.2
—
—
—
0
0
19
111
1.72
1.39
2.2
2.2
130.60
148.30
ng/l
0.17
19
111
191
1639
1.18
1.39
2.6
2.3
351.37
378.83
nmol/l
1.20
180
1512
12
60
2.01
1.38
3.6
1.8
0.56
1.05
ug/l
1.06
12
55
21
128
1.65
1.33
1.1
1.1
—
—
—
0
0
20
121
1.66
1.30
2.9
1.6
15.95
16.54
nmol/l
0.14
20
109
91
731
1.26
1.29
1.1
1.2
—
—
—
0
0
231
2027
1.16
1.28
2.5
2.8
66.35
66.12
g/l
0.15
211
1858
8
35
2.29
1.27
1.0
1.0
—
—
—
0
0
68
529
1.29
1.25
1.7
1.6
9250.50
15872.74
e6/l
1.51
48
365
11
56
1.97
1.22
2.0
1.5
0.00
0.05
estimate
0.49
11
56
100
820
1.23
1.20
1.3
1.3
—
—
—
0
0
231
2051
1.14
1.11
2.8
2.4
6.36
7.45
ug/l
0.48
183
1821
7
31
2.26
1.10
2.1
4.4
35.86
40.19
umol/l
—
7
26
43
320
1.35
1.09
1.9
1.4
169.00
157.95
au/ml
0.22
12
93
23
152
1.52
1.09
1.3
1.3
—
—
—
0
0
24
161
1.50
1.06
1.0
1.1
1.20
2.55
eliau/ml
—
5
57
40
296
1.36
1.06
1.1
1.1
—
—
—
0
0
230
2051
1.14
1.05
1.9
1.6
—
—
—
0
0
24
348
0.69
1.04
1.0
1.2
1.45
1.49
g/l
0.25
24
348
32
229
1.40
1.03
1.0
1.1
—
—
—
0
0
265
2392
1.12
1.00
1.9
1.7
—
—
—
0
0
58
458
1.27
1.00
1.4
1.2
—
—
—
0
0
43
326
1.33
0.99
1.4
1.2
361.59
275.17
u/ml
0.67
22
188
423
3917
1.10
0.99
5.8
4.9
—
—
—
0
0
15
92
1.63
0.97
1.7
2.2
814.00
1134.73
u/ml
0.47
15
92
121
1036
1.18
0.97
1.5
1.3
76.06
60.67
au/ml
—
10
81
105
888
1.19
0.96
1.5
1.6
—
—
—
0
0
167
1471
1.15
0.93
3.3
2.9
10.97
10.82
g/l
0.14
154
1354
51
401
1.28
0.92
1.6
1.4
1016.25
606.00
e6/l
0.22
40
310
10
55
1.82
0.92
1.6
1.5
10.95
8.27
mmol/l
—
10
55
109
930
1.18
0.92
1.3
1.3
174.51
287.29
u/ml
1.76
103
863
28
201
1.40
0.91
1.6
1.4
96399.25
108355.24
e6/l
0.05
20
139
26
185
1.41
0.89
1.2
1.3
7.33
7.42
mmol/l
0.05
18
158
5
102
0.49
0.89
1.6
1.6
6.08
7.63
u/l
—
5
90
10
56
1.79
0.87
1.1
1.1
—
—
—
0
0
36
272
1.33
0.87
1.2
1.3
—
—
—
0
0
50
396
1.27
0.86
1.5
1.4
52.81
31.69
e6/l
0.27
36
293
30
221
1.36
0.85
1.7
1.5
67.95
62.91
%
0.30
19
141
140
1229
1.15
0.84
1.5
1.7
1.54
1.52
g/l
0.11
119
1057
121
1053
1.16
0.82
1.2
1.3
—
—
—
0
0
65
535
1.22
0.82
1.5
1.7
—
—
—
0
0
129
1131
1.15
0.80
2.8
2.5
14.84
19.02
au/ml
0.44
14
83
68
565
1.21
0.79
2.4
2.4
206.46
115.71
ug/min
0.32
33
339
39
304
1.29
0.78
1.9
2.3
0.85
1.36
g/24h
1.02
25
187
14
207
0.67
0.72
1.1
1.1
0.30
1.86
u/ml
—
7
113
50
407
1.23
0.72
2.0
2.1
0.94
0.88
%
0.32
31
293
19
134
1.42
0.71
1.5
1.6
—
—
—
0
0
14
93
1.51
0.69
3.5
3.3
—
—
—
0
0
248
2287
1.10
0.67
1.4
1.5
—
—
—
0
0
82
706
1.17
0.67
2.1
2.0
20.42
21.29
s
1.45
71
647
19
136
1.40
0.66
1.3
1.1
—
65.72
—
0
5
7
44
1.59
0.65
1.3
1.3
28.43
28.82
s
—
7
44
26
198
1.32
0.64
1.3
1.2
—
—
—
0
0
5
29
1.73
0.64
1.2
1.4
59.00
65.21
ug/l
—
5
29
172
1563
1.11
0.63
10.4
10.6
94.53
93.75
%
1.27
172
1556
146
1616
0.90
0.62
1.6
1.5
—
—
—
0
0
122
1090
1.13
0.61
4.5
4.6
36.94
36.90
°c
0.50
122
1078
0
21
0.00
0.60
0.0
1.0
—
41.53
—
0
21
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
73
630
1.16
0.60
1.5
1.7
3.96
6.48
iu/ml
0.62
14
156
17
122
1.40
0.60
1.4
1.1
—
—
—
0
0
14
97
1.45
0.59
1.4
1.5
1.54
1.31
mm
—
8
73
30
237
1.27
0.58
2.4
2.5
—
—
—
0
0
32
255
1.26
0.58
3.6
5.1
305.96
340.34
umol/l
0.77
24
228
14
98
1.43
0.56
1.4
1.5
—
—
—
0
0
8
124
0.64
0.54
1.1
1.2
—
—
—
0
0
11
74
1.49
0.53
2.2
1.6
1.85
13.18
nmol/l
1.08
11
65
62
535
1.16
0.53
1.9
2.8
26.71
34.28
umol/l
2.73
52
477
95
848
1.13
0.51
2.3
2.6
9.95
10.59
g/l
0.76
82
760
129
1174
1.11
0.50
2.2
2.0
1.18
1.43
g/l
0.76
113
1078
203
1892
1.08
0.47
2.7
3.1
253.32
249.27
ng/l
0.03
187
1743
7
48
1.46
0.46
1.7
1.4
89.00
218.90
nmol/24h
—
7
48
14
103
1.36
0.45
1.6
1.6
—
—
—
0
0
15
112
1.34
0.44
1.4
1.1
—
—
—
0
0
12
86
1.40
0.44
3.9
3.4
—
—
—
0
0
40
339
1.18
0.44
3.2
3.5
4.68
4.41
e9/l
0.27
40
339
20
157
1.28
0.43
1.1
1.1
—
—
—
0
0
9
130
0.69
0.43
1.6
1.1
—
—
—
0
0
57
500
1.14
0.42
1.1
1.2
48.00
102.71
titre
—
5
48
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.6
—
1.55
—
0
7
21
168
1.25
0.40
1.8
1.2
0.35
0.42
g/l
0.66
11
123
21
168
1.25
0.40
1.8
1.2
2.68
2.93
g/l
0.21
12
123
21
168
1.25
0.40
1.8
1.2
4.79
6.93
g/l
2.27
12
124
8
61
1.31
0.39
1.1
1.3
—
—
—
0
0
35
297
1.18
0.39
1.1
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
11
148
0.74
0.38
2.2
2.7
—
—
—
0
0
28
233
1.20
0.38
2.6
2.0
—
8.80
—
0
5
33
280
1.18
0.37
1.5
1.7
0.52
0.96
g/l
2.44
18
224
36
417
0.86
0.36
1.5
1.7
—
—
—
0
0
43
375
1.15
0.36
1.5
1.4
—
—
—
0
0
22
180
1.22
0.36
2.2
1.4
27.44
23.80
%
0.19
14
109
25
208
1.20
0.35
1.5
1.2
—
—
—
0
0
6
45
1.33
0.33
1.2
1.1
—
—
—
0
0
14
177
0.79
0.33
1.1
1.0
2.38
4.44
u/ml
—
8
89
6
46
1.31
0.33
1.0
1.0
—
—
—
0
0
41
360
1.14
0.32
3.1
1.9
24.52
26.43
ug/l
0.12
41
354
33
285
1.16
0.32
1.4
1.5
—
—
—
0
0
33
285
1.16
0.32
1.4
1.5
—
—
—
0
0
33
285
1.16
0.32
1.4
1.5
—
—
—
0
0
33
285
1.16
0.32
1.4
1.5
—
—
—
0
0
20
165
1.21
0.31
2.7
2.2
—
—
—
0
0
49
437
1.12
0.31
1.1
1.2
—
—
—
0
0
38
334
1.14
0.30
1.5
3.2
168.07
92.66
u/ml
0.22
38
319
16
130
1.23
0.28
2.3
2.8
42.14
37.23
%
—
7
80
50
451
1.11
0.27
1.2
1.3
66.66
41.84
u/l
0.24
44
395
9
118
0.76
0.27
1.3
1.0
—
—
—
0
0
35
309
1.13
0.27
1.4
1.6
—
—
—
0
0
8
66
1.21
0.26
1.0
1.0
—
—
—
0
0
8
66
1.21
0.26
1.0
1.0
—
—
—
0
0
50
551
0.91
0.26
16.1
11.5
—
—
—
0
0
5
73
0.68
0.26
3.2
1.3
50.10
64.73
%
—
5
62
26
225
1.16
0.26
1.5
1.2
1.75
4.91
u/ml
2.37
12
105
13
160
0.81
0.26
1.2
1.0
804.13
614.19
ng/l
—
8
104
20
170
1.18
0.24
1.8
1.2
—
—
—
0
0
21
180
1.17
0.23
2.7
2.2
600.00
639.83
ml
0.16
12
109
17
143
1.19
0.23
2.7
2.8
27.25
38.22
mg/l
0.48
12
114
5
38
1.32
0.23
1.2
1.4
—
—
—
0
0
21
181
1.16
0.22
1.4
1.4
—
—
—
0
0
23
200
1.15
0.22
1.2
1.1
—
—
—
0
0
23
200
1.15
0.22
1.2
1.1
—
—
—
0
0
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
5
42
1.19
0.21
1.2
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
81.50
—
0
10
0
13
0.00
0.21
0.0
1.2
—
0.02
—
0
6
10
80
1.25
0.20
31.3
30.2
90.20
116.51
ug/l
—
10
68
6
50
1.20
0.19
1.2
2.7
3.33
713.94
ug/l
—
6
50
26
234
1.11
0.16
1.2
1.2
—
—
—
0
0
37
340
1.09
0.16
2.2
2.8
—
—
—
0
0
8
69
1.16
0.16
4.6
2.5
23.75
30.74
%
—
8
69
41
443
0.92
0.16
1.9
1.6
—
—
—
0
0
8
71
1.13
0.16
1.6
2.0
—
—
—
0
0
26
287
0.90
0.16
1.5
1.5
—
—
—
0
0
15
172
0.87
0.15
1.0
1.0
0.87
1.83
u/ml
—
7
73
20
178
1.12
0.15
1.2
1.2
—
—
—
0
0
10
85
1.18
0.12
1.1
1.5
2.95
3.57
mmol/l
—
10
76
61
581
1.05
0.12
1.2
1.2
0.24
0.96
u/ml
—
5
47
24
220
1.09
0.11
2.2
1.5
17.87
37.66
ng/l
2.35
24
220
25
230
1.09
0.11
1.1
1.3
285.58
277.17
mosm/kgh2o
0.63
19
168
16
178
0.90
0.11
1.3
1.3
—
—
—
0
0
117
1134
1.03
0.11
1.1
1.2
—
—
—
0
0
34
319
1.07
0.10
1.4
1.5
—
—
—
0
0
21
193
1.09
0.10
1.2
1.2
—
—
—
0
0
13
116
1.12
0.09
5.1
3.3
12.62
13.26
%
3.28
13
116
30
319
0.94
0.09
6.2
1.8
—
—
—
0
0
7
66
1.06
0.08
1.0
1.3
34.29
21.30
%
—
7
50
7
67
1.04
0.08
1.0
1.0
1535.00
1454.22
miu/ml
—
7
67
8
78
1.03
0.07
1.0
1.2
—
—
—
0
0
41
428
0.96
0.07
1.0
1.1
—
—
—
0
0
7
84
0.83
0.07
1.0
1.0
—
—
—
0
0
65
630
1.03
0.07
1.0
1.1
—
—
—
0
0
24
226
1.06
0.06
1.3
1.3
15.13
13.85
u/l
0.10
24
207
53
512
1.04
0.06
3.5
3.3
0.73
0.86
nmol/l
1.89
40
407
34
325
1.05
0.06
1.8
1.8
2.16
4.14
iu/l
2.81
13
113
40
389
1.03
0.03
1.5
1.3
59.43
63.13
mmol/l
0.27
23
318
27
260
1.04
0.03
1.4
2.3
—
—
—
0
0
17
162
1.05
0.02
1.0
1.2
—
—
—
0
0
12
114
1.05
0.00
1.2
1.2
150.17
137.85
nmol/l
0.39
12
114
15
144
1.04
0.00
1.6
1.4
153.34
224.99
pmol/l
0.54
15
144
15
149
1.01
0.00
8.1
2.6
—
—
—
0
0
32
321
1.00
0.00
5.9
2.0
—
—
—
0
0
75
755
0.99
0.00
1.4
1.6
0.24
0.36
mg/l
1.19
30
366
13
126
1.03
0.00
1.9
1.6
81.85
92.56
umol/l
0.87
13
126
13
128
1.02
0.00
1.1
1.4
—
—
—
0
0
32
322
0.99
0.00
1.8
2.4
—
—
—
0
0
35
352
0.99
0.00
1.3
1.5
4578.33
4186.51
e6/l
0.04
24
249
32
323
0.99
0.00
5.7
1.9
—
—
—
0
0
32
323
0.99
0.00
6.2
1.9
—
—
—
0
0
31
313
0.99
0.00
1.4
1.4
102011.50
90438.15
e6/l
0.07
20
186
13
133
0.98
0.00
1.5
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
0.18
—
0
6
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
8.4
—
102.25
—
0
8
8
79
1.01
-0.00
1.0
1.1
—
—
—
0
0
5
53
0.94
-0.00
7.2
4.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
36.98
—
0
5
5
52
0.96
-0.00
4.0
1.6
—
—
—
0
0
8
87
0.92
-0.00
1.4
1.2
155.63
457.61
u/l
—
8
82
5
53
0.94
-0.00
1.0
1.1
—
—
—
0
0
5
57
0.88
-0.00
1.0
1.3
9.40
10.67
mm/h
—
5
57
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
77
0.91
-0.00
1.0
1.2
—
0.07
—
0
7
6
59
1.02
-0.00
1.0
1.6
—
0.31
—
0
13
8
85
0.94
-0.00
1.0
1.1
119.03
223.40
iu/ml
—
8
85
30
300
1.00
-0.00
5.9
2.0
—
—
—
0
0
21
210
1.00
-0.00
1.5
1.6
1356.54
979.16
mu/l
0.46
16
175
5
52
0.96
-0.00
1.6
1.3
137.00
138.58
mmol/l
—
5
38

Mortality – FinRegistry

↥

Association

Association between endpoint N14_CALCULOWER and mortality.

Females

Parameter HR [95% CI] p-value
N14_CALCULOWER 1.812 [1.52, 2.16] < 0.001
Birth year 0.987 [0.98, 1.0] 0.008

During the follow-up period (1.1.1998 — 31.12.2019), 398 out of 1853 females with N14_CALCULOWER died.

Males

Parameter HR [95% CI] p-value
N14_CALCULOWER 1.241 [1.11, 1.38] < 0.001
Birth year 0.98 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2580 out of 8052 males with N14_CALCULOWER died.

Mortality risk

Mortality risk for people of age

years, who have N14_CALCULOWER.

N-year risk Females Males
1 0.133% 0.16%
5 0.89% 1.114%
10 2.155% 2.884%
15 4.038% 5.312%
20 6.862% 8.746%

Relationships between endpoints

↥

Index endpoint: N14_CALCULOWER – Calculus of lower urinary tract

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data